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Abstract 
Otitis media (OM) is one of the most common causes of hearing loss (HL) in neonates and 
infants.  The correct identification of OM is critical in the management thereof.  Research has 
confirmed that high frequency tympanometry (HFT) should be a part of the newborn hearing 
screening (NHS) as it reliably and accurately identifies OM.  Although it is imperative that HFT 
equipment is available to audiologists working with neonates and infants, there is a dearth of 
information regarding the use of HFT in South Africa.  The purpose of this study was to 
determine the use of HFT by South African audiologists in clinical practice.  In addition, the pass 
and refer rates between HFT and other screening tests used in the identification of possible 
middle ear pathology in neonates and infants were determined. 
 
A non-experimental, descriptive, cross-sectional survey design was used to describe the use of 
HFT in clinical practice.  A total of 113 questionnaires, completed by paediatric audiologists, 
were analysed.  Results indicate that only 50% of audiologists had access to and included HFT in 
their test battery.  These participants mainly worked in government hospitals (n=25) and private 
practice (n=23).  The rest of the participants reported HFT to be unavailable, mainly due to lack 
of equipment, clinical protocols and training in conducting and interpreting HFT. 
 
A correlation research design was used to determine the pass and refer rates of HFT and other 
screening tests used in the identification of possible middle ear pathology.  Participants were 
neonates and infants from birth to six months of chronological age (N2=303 ears) (mean 
gestational age=37 weeks; SD=4.03).  For the four hearing screening tests the highest pass rates 
were obtained using low frequency tympanometry (LFT) (right ear = 84%; left ear = 86%).  In 
the three hearing screening tests the highest pass rates were obtained using LFT (right ear = 99%; 
left ear = 93%).  However, the agreement of LFT with other screening tests was poor in both the 
four and three hearing screening tests.  The results confirm that HFT and otoscopy had the best 
agreement in both the four (0.7237 and 0.7983) and three hearing screening tests (0.5062 and 
0.6264) in terms of pass and refer rates bilaterally.    
 
The findings suggest the need for promoting improved training at undergraduate level and 
clinical practice within the area of paediatric audiology, specifically regarding the use of HFT in 
the identification of possible middle ear pathology in neonates and infants.  
 
Keywords: high frequency tympanometry, otitis media, clinical practice, pass rate, refer rate 
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Glossary 
Admittance  
This refers to the ease with which acoustic energy is transmitted in the outer and middle 
ear.  Admittance is measured in mmho (Clark, Roeser & Mendrygal, 2007). 
Conductive Hearing Loss  
This type of HL is a result of problems in the external and middle ear that impacts the 
transmission of sound from the external auditory canal (EAC) to the inner ear; however there are 
no problems with the inner ear.  Conductive hearing loss (CHL) presents with normal bone 
conduction results.  It is also associated with presence of middle ear pathology which can be 
either treated medically or surgically (Vinson, 2001). 
False Negative Results 
When the test outcome is a negative in the presence of a disease, this results in a false 
negative (Steffens & Krishnan, 2003). 
False Positive Results 
When the test outcome is a positive in the absence of a disease, this results in a false 
positive (Steffens & Krishnan, 2003). 
High Frequency Tympanometry 
 Tympanometry is the indirect measurement of the compliance and impedance of the 
tympanic membrane (TM) and middle ear system.  High frequency tympanometry (HFT) utilises 
high frequency probe tones (such as 668 Hz, 800 Hz and 1000Hz).  The use of HFT has shown 
xv 
USE OF HFT IN SOUTH AFRICA 
 
to be sensitive in the identification of middle ear pathologies in neonates and infants, whose 
middle ear systems are mass-dominated (Kei et al., 2003).   
Infant 
This term is used to describe a baby from one to 12 months of age (Aehlert & Vroman, 
2011). 
Mass Susceptance 
Mass susceptance is the admittance offered by mass elements in the middle ear system of 
the neonate or infant (Shahnaz, 2007). 
Middle Ear Effusion  
Middle ear effusion (MEE) is the buildup of fluid (effusion) in the middle ear (Gelfand, 
2009).  This causes the colour of the tympanic membrane (TM) to change and impairs the 
mobility of the TM, making it stiff, for instance (Al-Khatib, 2010). 
Neonate 
The term neonate is used to describe a baby from birth to one month of age (Aehlert & 
Vroman, 2011). 
Pass Screening Test Result/Rate 
This indicates a negative test.  It implies that the individual does not present with a 
disease and therefore no further follow up is required (Meyer, 2000; Spivak, 2007). 
Paediatric Population 
The paediatric population is defined as those persons aged between birth and 18 years of 
age (European Medicines Agency, 2007). 
xvi 
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Peak Susceptance  
Susceptance (B) is energy flow that is associated with reactance and the susceptance 
tympanograms; it is expected to notch first before the conductance tympanograms.  The 
measured susceptance includes effects of the volume of the ear canal, the stiffness of the TM as 
well as mechanical stiffness of the middle ear system (Stach, 2003; Roberts, 2007; Moser, 2009).  
Peak Compliance 
The point of maximum mobility on a tympanogram that refers to the degree of mobility 
of the middle-ear system (Minnesota Department of Health [MDH], 2009). 
Refer Screening Test Result/Rate 
This indicates a positive test as it implies the individual does present with a disease, 
therefore further follow up is required (such as diagnostic testing) (Meyer, 2000; Spivak, 2007). 
Screening Test 
It is a simple test performed on a large number of people to identify those who have or 
are likely to develop a particular disease.  No screening test can divide normal and abnormal 
individuals with complete accuracy as it is not intended to give a diagnosis (Screening test, n.d; 
Moore & De Costa, 2005; Gelfand, 2009). 
Static Acoustic Immittance 
This evaluates the ease of flow of acoustic energy through the middle ear system.  In 
order to determine this measurement, immittance is established under the positive pressure (+200 
daPa) artificially induced in the ear canal.  Thereafter, determination is made with the TM in its 
xvii 
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most compliant position, which maximises conduction through the middle ear space (Bess & 
Humes, 2008).  
True Negative Results 
When the test outcome is a negative in the absence of a disease, this results in a true 
positive (Steffens & Krishnan, 2003). 
True Positive Result 
When the test outcome is a positive in the presence of a disease, this results in a true  
positive (Steffens & Krishnan, 2003). 
Tympanometric Peak Pressure  
Tympanometric peak pressure (TPP) is the representation of air pressure in daPa at which 
the peak of tympanograms occurs (Stach, 2003).  Various factors result in the change of TPP, 
such as variation in ear canal pressure during tympanometry.  This is associated with variation in 
the middle ear volume with movement of the eardrum (Gerber, 1996). 
Tympanograms 
Tympanograms are graphic representations of mobility of the TM as a function of 
mechanically varying the air pressure in a hermetically sealed ear canal (Clark et al., 2007
1 
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       Chapter One 
Orientation 
This chapter provides an orientation to the study and includes the background and 
rationale for conducting the study.  An outline of each of the chapters is also included. 
Background  
Middle ear infections (such as otitis media [OM]) are the most common cause of hearing 
loss (HL) during early childhood years (Deiner, 2010).  Due to this high prevalence rate and 
association with varying degrees of conductive hearing loss (CHL), tympanometry forms an 
important component of the screening test protocol to identify middle ear pathology in neonates 
and infants (Health Professionals Council of South Africa [HPCSA], 2007; Swanepoel et al., 
2007).  Tympanometry is a highly sensitive method used to screen for middle ear pathologies 
(Bluestone & Klein, 2007).  However, the use of low frequency tympanometry (LFT) in 
neonates and infants often result in higher false positive rates.  Therefore, it is recommended that 
high frequency tympanometry (HFT) forms part of the screening protocol to assist in clarifying 
false positive screening results (Kent, 2004; HPCSA, 2007; Swanepoel et al., 2007).   
The anatomical and acoustical differences between that of a neonate or infant and an 
adult middle ear system implies that adult tympanometry protocols are not appropriate for the 
use in neonates and infants (Baldwin, Sutton, Gravel & Low, 2008).  It has been found that HFT 
is the most reliable measure in the evaluation of the mass-dominated middle ear system of 
neonates and infants (Swanepoel et al., 2007).   
Although HFT is readily available in a number of tympanometers today (Petrak, 2002), 
the high cost of HFT equipment often precludes its use in primary care practice (Al-Khatib, 
2010).  It has been reported that the shortage of equipment in South Africa is one of the main 
2 
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obstacles for the successful implementation of newborn hearing screening (NHS) programmes 
(Theunissen & Swanepoel, 2008). 
NHS protocols advocate for the use of otoacoustic emissions (OAEs) and/or automated 
auditory brainstem response (AABR) measures (Joint Committee on Infant Hearing [JCIH], 
2007; HPCSA, 2007).  Results obtained from these screening tests may be affected by middle ear 
pathologies resulting in the neonate or infant failing the hearing screening (Holte, Margolis & 
Cavanaugh, 1991; Purdy & Williams, 2000; JCIH, 2007).  It is therefore important to include 
HFT when identifying middle ear pathologies in paediatrics (birth to six months of age).  HFT 
has been shown to present with the most significant correlation with OAEs and otoscopy (Purdy 
& Williams, 2000; Kent, 2004; HPCSA, 2007; JCIH, 2007; Swanepoel et al., 2007; Garcia, De 
Azevedo & Testa et al., 2009).   
Despite this, LFT is still used in neonates and infants between the ages of birth and six 
months.  It has however been found that the use of a low frequency (LF) probe tone is unreliable 
in this population due to its poor sensitivity in identifying middle-ear pathologies (Swanepoel et 
al., 2007).  This can be attributed to the fact that HFT is less straightforward to interpret than 
LFT (Baldwin, 2006).   
As there are limited clinical guidelines available for the use and interpretation of HFT, 
audiologists should carefully interpret results in combination with other audiological results 
(American Speech-Language-Hearing Association [ASHA], 2004).  Although many normative 
studies on HFT have been published, the use of these norms has proved clinically challenging for 
clinicians (Wilson, 2008).  There is a need for standard clinical protocols and guidelines for 
interpretation of HFT to promote its extensive application in the clinical paediatric setting 
(Wilson, 2008).   
3 
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The rapid implementation of universal newborn hearing screening (UNHS) programmes 
has also exposed a need for a reliable screening test of middle ear functioning.  This will allow 
for the timely identification of middle ear pathology and for differentiation between sensori-
neural hearing loss (SNHL) and CHL (Van Rooyen, 2006).  Correct identification of middle ear 
status in the neonatal and infancy period can direct timely and appropriate referrals to medical 
and audiological personnel.  This in turn will lead to improved efficacy of NHS programmes 
(Swanepoel et al., 2007).   
Even though the importance of HFT in neonates and infants has been confirmed, there is 
limited information available on the current clinical practice in South Africa.  As a result this 
research study aimed to address the following research questions:  
 How readily available is HFT in audiology departments or practices in South Africa? 
 Do South African audiologists have HFT clinical protocols available to provide guidance 
in correctly and accurately identifying middle ear pathologies in neonates or infants? 
 Are South African audiologists aware of the clinical applications of HFT and theoretical 
background of a neonate's or infant's middle ear system?  
 What is the level of agreement between the pass and refer rates of hearing screening tests 
(HFT, LFT, otoscopy and DPOAE) used in the identification of possible middle ear 
pathology in neonates or infants? 
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Chapter Outlines 
This dissertation is comprised of six chapters, namely: 
Chapter One 
This chapter provides an introduction to the study as it describes the rationale for, and 
importance of conducting the study.  An outline for every chapter is herewith is also provided.  
Chapter Two 
 This chapter provides a broad overview of HL, NHS and OM.  It also provides 
information on maturational changes, tympanometry and requirements for performing HFT.  
This chapter further focuses on the interpretation of HFT, validation of testing and hearing 
screening tests used in NHS. 
Chapter Three 
 The methodology chapter illustrates the aims of the study and the research design 
utilised and describes the various research phases.  It further includes the pilot study results, 
description of the main studies as well as the data collection procedures.  Furthermore, it 
addresses the reliability, validity and ethical principles of the study. 
Chapter Four 
This chapter presents the results obtained from the two main studies, namely the survey 
questionnaires and hearing screening.  The results are presented in relation to the aims of the 
study.  
Chapter Five 
This chapter highlights trends and differences in the data obtained from the survey 
questionnaire and hearing screening.  This allows for conclusions to be drawn with regard to the 
use of HFT in neonates and infants.  
5 
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Chapter Six 
This chapter provides a summary of the results obtained for the current study followed by 
a critical review, implications of the study and recommendations for future research. 
Reference and Appendices 
This section provides all the references used for the current study and appendices, which 
provides important information for understanding the data collection procedures. 
. 
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Chapter Two                                                                                                                                  
Literature Review 
This chapter provides a broad overview of hearing loss.  It provides information on otitis 
media, maturational changes of the infant’s middle ear system, tympanometry and requirements 
for performing HFT.  This chapter further focuses on the interpretation of HFT and validation of 
testing, high risk factors of hearing loss, and hearing screening tests used in newborn hearing 
screening. 
Prevalence of Hearing Loss 
‘Hearing impairment (HI) in children across the world constitutes a particularly serious 
obstacle to their optimal development and education, including language acquisition’ (World 
Health Organization [WHO], 2010, p.7).  There is an increase in the prevalence of HL globally 
(Swanepoel, Delport & Swart, 2004; HPCSA, 2007).  Preliminary reports in South Africa 
estimate that approximately 17 babies are born with hearing loss (HL) in South Africa every day 
(Copley & Friderichs, 2010).  HL is the most commonly occurring birth abnormality, thus the 
early identification and diagnosis of neonates and infants with HL is vital (Swanepoel et al., 
2007; Alexiades & Hoffman, 2008). 
  Otitis Media 
One of the most common causes of HL in the paediatric population is middle-ear 
infection (Zand, Routree & Walton, 2003).  Otitis media (OM) has been reported as the most 
frequently occurring middle ear infection in neonates and infants (Zand et al., 2003; National 
Institute of Deafness and Other Communication Disorders [NIDCD], 2010; Marschark & 
Hauser, 2012).  OM is defined as the inflammation of the middle ear, which is mainly a result of 
Eustachian tube (ET) dysfunction (Stach, 2010a).  There are three types of OM namely; acute 
7 
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otitis media (AOM), otitis media with effusion (OME), and chronic otitis media with effusion 
(COM) (Pichichero, 2013).   
Literature indicates that OM affects 75% to 95% of the paediatric population (McCabe & 
Racanello, 2006).  OM-related HI has a prevalence of 30.82 per 10 000 births.  It has been 
reported that annually 21 000 people die due to complications of OM (e,g. acute mastoiditis and 
meningitis) (Dodson & Peng, 2009; Monasta et al., 2012).  The prevalence of OM is the highest 
during the first two years of a child’s life and declines with age (Stach, 2010a).   
 Maturational Changes of the Infant Middle Ear System 
Anatomical changes. 
There are many anatomical differences between the infant and adult middle ear system.  
Anatomically, the external auditory canal (EAC) in neonates and infants are narrower, shorter 
and straighter in orientation when compared to an adult (Cai, 2010).  The EAC increases rapidly 
in diameter and length in early infancy (Keefe & Bulen, 1993).  In infants, the wall of the EAC 
comprises of cartilage and soft tissue which makes the structure flexible and compliant (Anson & 
Donaldson, 1981).  As the infant matures, the cartilage and canal wall becomes thicker and bone 
is formed.  This results in more rigidity, stiffness and decreased compliance of the structures 
(Anson & Donaldson, 1981).  In adulthood the inner two-thirds of the EAC is bony and the outer 
third is made of soft-tissue (Anson & Donaldson, 1981).  These changes affect the impedance of 
the infant EAC; as canal volume increases, impedance decreases (Keefe, Bulen, Arehart & 
Burns, 1993). 
In the middle ear structure, the tympanic cavity of a neonate and infant is smaller than 
that of an adult ear (Ikui, Sando, Haginomori & Sudo, 2000).  The middle ear cavity will reach 
adult size by approximately six months of age (Baldwin, 2006; Keefe & Bulen, 1993).  Within 
8 
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this time other middle ear structures such as the ossicular joints and the stapes footplate 
attachment to the oval window tightens.  In addition, fusion of the tympanic ring results in the 
decrease in resistance (Anson & Donaldson, 1981).  As maturation proceeds, bone erosion of the 
stapes occurs.  This results in the reduction of bone density and thus an overall decrease in mass 
(Meyer, Jardine & Deverson, 1997).   
At birth the tympanic membrane (TM) is located horizontally to the EAC.  The TM 
gradually becomes vertical until it reaches the adult position (50° to 60°) at around three to four 
years of age (Eby & Nadol, 1986).  According to Roush (2001, as cited in Cai, 2010) the TM is 
also thicker and more vascular if compared to the TM of an adult.  Furthermore, according to 
Eavey (1993, as cited in Cai, 2010) the unabsorbed foetal tissue (e.g. mesenchyme), remaining 
amniotic fluid and cellular debris may be present within the tympanic cavity up to five months 
after birth.  This together with a thicker TM possibly contributes mass to the middle ear system 
and decreased compliance.  Therefore, as the infant matures there is an overall decrease in mass 
and resistance in the middle ear system (Cai, 2010).  Within the first six to seven months of life, 
the middle ear system thus transforms from a mass-dominated to a stiffness-dominated system 
(Baldwin et al, 2008). 
Acoustical differences.   
As a result of maturational changes in the anatomy of the EAC and middle ear system, 
the acoustic response properties within these structures also changes considerably over the first 
two years after birth (Lantz, Petrak & Prigge, 2004).  The middle ear is a mechano-acoustic 
system which consists of three components: stiffness, mass and resistance (Wiley & 
Stoppenbach, 2002).  
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There are a number of elements within the EAC and middle ear space that dictates 
stiffness.  These include ligaments, the TM and the air enclosed in the ear canal and middle ear 
space (Purdy & Williams, 2000).  The stiffness elements exert effects at low frequencies and are 
related to the enclosed volume of air in the outer and middle ear (Popelka & Hunter, 2013). 
The mass of the middle ear is affected by the pars flaccida of the TM, ossicles and the 
perilymph in the cochlea (Purdy & Williams, 2000).  These components are responsible for 
controlling the transmission of the high frequency (HF) response of the middle ear (Cai, 2010).   
 Resistance is the cause of energy loss through dissipation of heat (Lantz et al., 204). 
Resistance is independent of frequency and determines the dissipation of acoustic energy known 
as acoustic conductance (Ga) or acoustic resistance (Ra) in the impedance system (Popelka & 
Hunter, 2013).  The form of the frequency response is controlled by the resistive elements such 
as the ossicular joints, the annular ligament around the footplate of the stapes, and cochlear fluids 
(Cai, 2010).   
Stiffness, mass and resistance in combination interact and determine the impedance or 
opposition to the flow of energy of the middle ear system and allow successful sound 
transmission to the cochlea (Lantz et al., 2004; Wiley & Stoppenbach, 2002).  These properties 
contribute to the total acoustic impedance or total acoustic admittance.   
Acoustic impedance (Za in acoustic ohms) refers to the total opposition of flow to the 
middle ear system to the flow of acoustic energy (Popelka & Hunter, 2013).  It constitutes of 
resistance (R) and reactance (X), which in turn has two components namely compliant reactance 
and mass reactance (Palmu, 2001).  Acoustic admittance (Ya in acoustic ohms) is the amount of 
acoustic energy that travels into the middle ear system (Popelka & Hunter, 2013).  It constitutes 
of conductance (G) and susceptance (B), which has two components namely compliance and 
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mass susceptance (Palmu, 2001).  Acoustical impedance and acoustical admittance are reciprocal 
and is described as the following:  
Za = 1                                                                                                                                         
                               Ya      
 
Ya = 1                                                                                                                                                                                       
                             Za 
 The total acoustic susceptance, determined through a vectorial sum of the stiffness and 
mass elements, is used to identify whether the middle ear system is mass- or stiffness-dominated 
(Popelka & Hunter, 2013).  A stiffness-dominated middle ear system is present when the total 
acoustic susceptance (Ba) is positive between 0º and 90º phase, whilst a mass-dominated middle 
ear system is present when the total acoustic susceptance (Ba) is negative between 0º and 90º 
phase (Popelka & Hunter, 2013). 
In the neonatal and infant middle ear system the mass and resistive elements are high and 
their middle ear system can thus be described as mass-dominated (Holte, Margolis & 
Cavanaugh, 1991; Shahnaz, Miranda & Polka, 2008).  A mass-dominated middle ear system has 
an influence on the conductance of high frequencies into the cochlea (Cai, 2010).  As the cochlea 
is found to be mature at the time of birth; the middle ear system in neonates and infants may be 
responsible for the loss of energy transfer into the cochlea during the conduction of sound 
(Abdala & Keefe, 2006).  
  Energy transmission into the neonate and infant middle ear is reported to be most 
efficient in the 1000 Hz- 4000 Hz range (Holt et al, 1991; Baldwin, 2006).  Frequencies below 
500 Hz resulted in the transmission of decreased power into the middle ear system of neonates 
and infants less than four months of age.  This is a result of ear canal wall vibration and 
resonance (Baldwin, 2006).  These differences between the neonate or infant and adult disappear 
by the age of six months (Baldwin, 2006).  
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In addition, the shorter EAC length in neonates and infants results in a higher resonant 
frequency when compared to adults (Cai, 2010).  As a result of the small ear canal diameter and 
compliant EAC wall in neonates and infants, there is decreased resonance gain (Saunders, Doant 
& Cohen, 1993).  Thus, in neonates and infants the resonance of the EAC occurs at higher 
frequencies and exhibits a lower gain than that seen in the adult EAC (Saunders et al., 1993).  
Research has confirmed these above findings.  In a study conducted by Meyer et al. 
(1997) the resonant frequency of an infant was measured.  Repeated measurements between the 
ages of two weeks and six and a half months were made.  Results revealed that the resonant 
frequency remained below 550 Hz until the infant was three and half months old (Meyer et al., 
1997).  An average adult middle ear resonant frequency of 900 Hz (range 800 Hz to 1200 Hz) 
was measured by four months of age.  This was supported by research conducted by Lantz et al. 
(2004) and Silman and Silverman (1991) who reported that between three to four months of age 
resonant frequency similar to those found in the adult ear were measured in neonates and infants.  
This supports the theory that the infant middle ear changes from a mass- to stiffness-dominated 
system (Silman & Silverman, 1991; Meyer et al., 1997; Baldwin, 2006).  Otoscopy and 
tympanometry is used in medical and audiological practice to evaluate the middle ear system. 
Identification of OM 
The goal of screening for middle ear pathologies is to identify individuals who may have 
the disease but in whom it would otherwise go unidentified (Bluestone & Klein, 2007).  Current 
clinical methods used for the identification of OM in neonates and infants include HFT 
tympanometry and otoscopic examination (Kent, 2004).  
Otoscopy is the subjective examination that is performed to inspect the ear canal and the 
TM for malformations or any presence and absence of OM that may impede on the neonate or 
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infant’s hearing (Kent, 2004; Easterbrooks & Estes, 2007).  Otoscopic examination is also 
essential to determine if there is any obstruction in the ear canal that would preclude placement 
of a probe for acoustic immittance screening, thereby confounding the tympanometric results 
(Kent, 2004).   
The examination of the EAC and middle ear are usually performed by otolaryngologists, 
general practitioners, nurses and audiologists using an otoscope.  There are various types of 
otoscopes available namely a standard otoscope, a pneumatic otoscope, otomicroscope and a 
video-otoscope (Wilson, 2008).  The sensitivity and specificity of some of the otologic 
instruments available are described in Table 2.1.  
Table 2.1 
Sensitivity and Specificity of Otologic Instruments 
Instrument Studies 
Sensitivity 
(%) 
Specificity 
(%) 
Standard otoscope KC et al. (2007) 78.7 22.2 
Pneumatic otoscope Lee & Yeo (2004) 38.5 97.2 
Shiao & Guo (2005) 77.3 90.5 
Harris et al. (2005) 100 84.5 
KC et al. (2007) 33.3 90.4 
Otomicroscope Lee & Yeo (2004) 100 61.5 
Video otoscope Shiao & Guo (2005) 100 97.8 
 
Paediatricians and audiologists generally make use of a standard otoscope to identify the 
presence or absence of middle ear pathology.  Audiologists in addition perform tympanometry to 
detect the presence of middle ear pathology (Kent, 2004; Wilson, 2008).  A standard otoscope 
has been found to have the lowest sensitivity and specificity (Wilson, 2008).  However, it is 
reported to be a useful screening tool (O’Malley & Haynes, 2010).  Pneumatic otoscopes are 
most often used by otolaryngologists to improve diagnostic accuracy of OM (Alper, Bluestone, 
Casselbrant, Dohar & Mandel, 2004).  These instruments however do not always improve 
13 
USE OF HFT IN SOUTH AFRICA 
 
diagnostic accuracy of OME in the paediatric population when compared to a standard otoscope 
(Al-Khatib, 2010).   
When performing an otoscopic evaluation, a small ear speculum is utilised and the pinna 
is gently pulled downwards in order to straighten the horizontal ear canals of the neonate or 
infant to obtain a clear view of the ear canal and TM (Cavaliere & Sansoucie, 2013; 
Hockenberry, 2012).   
The challenge of performing an otoscopic evaluation is the difficulty in visualizing the 
TM in neonates and infants.  This is due to the small external meati which are often filled by 
vernix caseosa, debris and cerumen making it challenging to identify common landmarks of the 
middle ear system (Baldwin, 2006).  Vernix is commonly present in the ear canals of neonates 
and usually disappears within 1 or 2 weeks after birth (Whitaker, 2001).  It is reported that 70 % 
of infants of two to six months of age require cerumen removal in order to improve visualization 
of the outer and middle ear (Carlson & Carlson, 2003). 
Otoscopically, a normal TM appears pale, grey and translucent with visual projections of 
the malleus, short lateral process and manubrium.  Furthermore, a reflective cone of light is 
visible (Mangione, 2008).  In the presence of the ear infection the TM can also be found to be 
bulging or retracted. It is therefore important that the examination of an eardrum should take the 
vascularity, mobility, integrity as well as position into consideration (Chiocca, 2011; White, 
Duncan & Baumle, 2013).   
Tympanometry 
Tympanometry is defined as “the dynamic measure of acoustic immittance in the external 
ear canal as a function of change in air pressure in the ear canal” (Fowler & Shanks, 2002, p. 
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175).  The tympanometer records compliance of the TM, which offers quantitative information 
on structural function and the presence of middle ear effusion (MEE) (Al-Khatib, 2010).   
There are various types of tympanometry currently and routinely used in clinical practice, 
namely low frequency tympanometry (LFT) and multi-frequency tympanometry (MFT) (Harris, 
Hutchinson & Moravec, 2005).  Several HF probe tones have also been studied such as 660Hz, 
880 Hz and 1000 Hz.  However, 1000Hz probe tone is currently the highest frequency available 
on commercial clinical tympanometers and is known as HFT (Wilson, 2008).   
The use of LFT (226 Hz probe tone) has been validated for use in adults.  This frequency 
probe tone is especially relevant as it is below the normal adult resonance of approximately 900 
Hz, negating the effects of mass and resistance.  The adult middle ear system is also stiffness-
dominated below this frequency (Lantz et al., 2004).   
HFT (1000Hz probe tone) is however advocated for the use in neonates and infants due 
to the greater mass contribution, higher resistance and lower compliance in the middle ear (Purdy 
& Williams, 2000; Alaerts, Luts & Wouters, 2007).  This HF probe tone allows for the 
measurement of admittance where mass susceptance is significant (Purdy & Williams, 2000). 
The mass components are larger in HF probes.  In HF probe tones (1000Hz) the involvement of 
every anatomical structure is changed and the acoustic admittance measured at the middle ear 
inlet becomes more predominated by the mass (Holte et al., 1991; Kei et al., 2003; Silva. 
Novaes, Lewis & Carvallo, 2007).   
 Tympanometry is used in clinical practice to determine the presence of middle ear 
pathology (Al-Khatib, 2010).  
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Use of Tympanometry in Neonates and Infants.     
Low frequency tympanometry.  Although tympanometry is used to detect middle ear 
pathologies, there is still controversy regarding the use of LFT and HFT in the neonates and 
infants.  Despite confirmation that the neonate and infant middle ear system is mass-dominated, 
LFT is still used in this population.   
Research conducted by Baldwin (2006) to determine the sensitivity and specificity of 
LFT in neonates and infants below five months of age revealed poor sensitivity (0.02%) in 
correctly identifying the presence of MEE.  This has been confirmed by other studies that found 
that LFT were reported to produce false positive and false negative results when performed on 
neonates or infants under seven months of age (Meyer et al., 1997; Purdy & Williams, 2002; 
Macedo de Resende et al., 2012).  It is postulated that the physiological differences between the 
neonate or infant and adult middle ear transmission system may be a contributing factor to these 
false positive and false negative rates (Keefe & Levi, 1996; Petrak, 2002).   
Meyer et al. (1997) suggests that LFT are valid in infants from four months of age when 
the middle ear system reaches an adult middle ear resonant frequency and has transformed from 
a mass-dominated to stiffness-dominated system.  The use of LFT in older infants is supported 
by a number of research studies describing the sensitivity and specificity of LFT in infants older 
than 7 months of age (Table 2.2).  
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Table 2.2  
Sensitivity and Specificity of LFT in Infants over Seven Months of Age 
Studies 
Sensitivity 
(%) 
Specificity 
(%) 
Shiao & Guo (2005) 89.4 81.8 
Lee & Yeo (2004) 87.5 0 
Watters, Jones & Freeland (1996, as cited in  Harris, Hutchinson 
& Monroe, 2005) 
91 79 
Palmu, Puhakka, Rahko & Takala (1999, as cited in Harris et al. 
2005) 
94  
Mills (1987) and Finitzo, Friel-Patti, Chinn & Brown (1992)  80-90 71-100 
Harris et al. (2005) 80 100 
KC, Guragain & Sinha (2007) 98.9 14.8 
 
Longitudinal studies are however required to establish the variability in the age at which 
LFT becomes valid (Baldwin, 2006; Baldwin et al., 2008).  
High frequency tympanometry.  The use of HFT in the neonate and infant population has 
been studied extensively (Keefe & Levi, 1996; Rhodes, Margolis, Hirsch & Napp,1999; 
Margolis, Bass-Ringdahl, Hanks, Holte & Zapala, 2003; Baldwin, 2006; Alaerts et al., 2007; 
Garcia et al., 2009; Kei & Mazlan, 2012).  There is however still controversy regarding the age 
range for which HFT is most appropriate (Hoffman et al., 2013).  
Both the JCIH (JCIH, 2007) and ASHA (ASHA, 2004) recommends the use of HFT for 
neonates and infants from birth to six months of age.  The guidelines are based on research 
confirming the validity of HFT results in this age range (Keefe & Levi, 1996; Rhodes et al., 
1999; Baldwin, 2006; Alaerts et al., 2007; Garcia et al., 2009; Kei & Mazlan, 2012).  Two 
studies validated the use of HFT in neonates (Kei et al., 2003; Margolis et al., 2003).  However, 
in these studies, the age effects were not evaluated (Alaerts et al., 2007).  Baldwin (2006) found 
HFT to have a high sensitivity in detecting middle ear pathology in infants below the age of five 
months. 
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A more varied age-dependent protocol is suggested by Alaerts et al. (2007) in which both 
HFT and LFT are used.  In neonates and infants younger than three months of age it is suggested 
that only HFT is performed.  For infants between three and nine months of age HFT should be 
performed; and in cases of failure, LFT must be carried out as confirmation of pathology (Alaerts 
et al., 2007).  The suggestions were made because Alaerts et al. (2007) deemed HFT to be most 
reliable in neonates and infants up to the age of three months.  This view was supported by 
Macedo de Resende et al. (2012).  The limitation of the Alaerts et al. (2007) study was that the 
presence or absence of middle ear pathology was not confirmed with an otoscopic examination. 
Hence, results cannot be generalised to all neonates and infants (birth to 36 weeks) as different 
tympanometric results may be obtained in those with confirmed middle ear pathology (Baldwin, 
2006).  The clinical relevance of HFT up to the age of nine months was supported by Hoffman et 
al. (2013).  The age of participants in the Hoffman et al. (2013) study did however not report any 
information on the age of participants (such as gestational age [GA] or corrected age [CA]) at the 
time of testing.   
Baldwin et al. (2008) however recommended that HFT should only be used up to six 
months CA (Baldwin et al., 2008).  His findings were supported in recent studies (Table 2.3).   
Table 2.3 
Sensitivity and Specificity of HFT in Infants Under Six Months of Age 
Studies 
Sensitivity 
(%) 
Specificity 
(%) 
Baldwin (2006) 99 89 
Swanepoel et al. (2007) 57 95 
Garcia et al. (2009) 11.1-95 41.7-60 
 
HFT is therefore the frequency of choice in neonates and infants due to its high 
sensitivity in correctly detecting middle ear components in early infancy (Kent, 2004; HPCSA, 
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2007; Swanepoel et al., 2007).  Some studies however reported decreased sensitivity of HFT in 
this population (Swanepoel et al., 2007).  Decreased sensitivity could be associated with the 
presence of MEE in a number of ears with present but decreased OAEs (Sutton, Gleadle & 
Rowe, 1996; Kei et al., 2003).  This causes an overlap of true positive HFT results and false 
negative OAE results which results in decreased immittance sensitivity (Swanepoel et al., 2007).  
 The possible implications of not performing HFT with neonates and infants of the 
appropriate age are that it may lead to inaccurate identification of middle ear pathologies 
(Bosaghzadeh, 2011; ASHA, 2004).  Untreated and recurrent middle-ear pathologies may result 
in a temporary HL.  This may result in delayed speech and language development and poor 
academic performance (ASHA 2004; Bosaghzadeh, 2011; Marschark & Hauser, 2012).   
Research findings have revealed that HFT is sensitive in accurately identifying middle 
ear pathologies in neonates and infants when compared to other types of tympanometry 
screening tests (Kent, 2004; HPCSA, 2007; Johnson & Seaton, 2012; Wilson, 2008, Stach, 
2010b).  Therefore HFT is recommended to be included as part of the paediatric test battery, both 
in the NHS programmes and for diagnostic clinical practice (HPCSA, 2007; ASHA, 1997).  It is 
imperative though that clinicians performing HFT in neonates and infants have appropriate 
clinical skills in performing and interpreting HFT.  
Requirements for Performing HFT  
Knowledge and training is necessary in performing tympanometry.  Personnel 
performing hearing screening usually include audiologists and speech therapists (Al-Khatib, 
2010).  Individual state regulations may allow additional people to perform screening (Kooper, 
2008). 
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According to the HPCSA (2007) HFT is recommended to be included in NHS in order 
for effective implementation of early hearing detection and intervention (EHDI) programmes.  
The implementation for an effective EHDI programme also relies on an interdisciplinary team 
approach which include the following team members: audiologists, paediatricians and or general 
practioners, otolaryngologists, speech therapists, nurses, community workers, other early 
intervention professionals and interpreters where needed.  Therefore, it may be assumed that 
some of the above mentioned team members may perform tympanometry if efficient and 
comprehensive training is provided.  
There is limited information with regard to who specifically performs tympanometry and 
provides training in South Africa.  Qualified audiologists are trained professionals who generally 
are trained personnel in performing routine and specialised hearing evaluations (screening and 
diagnostic).   
It is the audiologist’s responsibility to ensure efficient training and supervision of support 
personnel (ASHA, 1997).  Audiologists evaluate the middle ear status by performing 
tympanometry (Northern & Downs, 2002).  Professionals or personnel other than audiologists 
who are involved in performing hearing screening, should have knowledge on the following after 
training: (i) the goal of hearing screening; (ii) familiarity with audiologic equipment and 
requirements for an appropriate test environment; (iii) how to instruct on screening procedures; 
(iv) the criteria for passing and failing the hearing screening; (v) how to report results; (vi) how 
to follow up with parents; and (vii) how to test neonates or infants (Kooper, 2008).  
In addition, clinicians should also have essential clinical skills in the interpretation of 
HFT.  HFT is being more implemented in NHS and has not been completely put into clinical 
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practice due to difficulties in interpreting HF tympanograms (Alaerts et al., 2007).  Hence, 
training is important especially due to the complexity of understating the fundamentals of HFT. 
Interpretation of HFT and Validation of Testing 
This section provides an overview on the various norms and classification systems 
available for the interpretation of HF tympanograms.     
The quantification of tympanometric measurements is important as this allows for 
suitable guidelines to be developed in order to compare tympanometric measurements obtained 
in various clinical settings (Fowler & Shanks, 2002).  For more precise characterization of 
tympanograms it is important to make use of both quantitative and qualitative data.  This 
includes the height of the tympanograms; estimated middle ear air volume; description of the 
tympanograms shape close to the peak (tympanograms gradient and width); and tympanograms 
peak pressure (TPP) (Fowler & Shanks, 2002; Northern & Downs, 2002). 
Several normative studies on HFT have been published in light of the widespread 
implementation of NHS programmes (Swanepoel et al., 2007).  Normative guidelines have been 
suggested by Margolis et al. (2003) and Kei et al. (2003).  These studies have created 5
th
 to 95
th
 
percentile data for a number of test parameters which may be used as a pass or fail criteria for 
HFT (Kei et al., 2003; Margolis et al., 2003; Swanepoel et al., 2007).  
 Normative data described by Kei et al. (2003) were obtained from full term neonates 
who had no risk for HL, and with present transient otoacoustic emissions (TEOAEs) which were 
successfully measured in 87.9% of normal neonates.  Kei et al. (2003) also classified HF 
tympanograms as described in Table 2.4. 
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Table 2.4 
Classification of tympanograms (Kei et al., 2003) 
Configuration of Tympanograms Classification 
Peak tympanograms Normal 
Flat sloping tympanograms Abnormal 
Double peaked Normal (according to Swanepoel et al. 2007) 
Indeterminate Other unclassified tympanograms 
 
  In addition, it is suggested using the 5
th
 percentile for positive tail (+ 200 daPa) peak 
compensated static admittance as a pass or fail criteria given a value of 0.39 mmho.  However, 
there is uncertainty with regard to transferring the norms from one age group to another and 
therefore may only serve as a guideline (Kei et al., 2003; Baldwin, 2006, Baldwin et al., 2008)   
Margolis et al. (2003) obtained normative data from a group of full term infants who 
were screened with distortion product otoacoustic emissions (DPOAEs); a group of neonates 
from the neonatal intensive care unit (NICU); and well-babies.  The 5
th
 percentile for static 
admittance for NICU and full term infants was identical, allowing a single pass-fail criterion. 
Using that criterion, well-babies who passed a DPOAE screen presented with a 91% pass rate 
and presented with a higher static admittance than those who failed (Margolis et al., 2003). 
Therefore it was recommended that a single cut-off value for static admittance of 0.6 mmho is 
useful for neonates and infants from birth to one month chronological age (Margolis et al., 2003).  
However, the sensitivity of this criterion was found to be very low.  The use of these data may 
result in tympanograms with small peaks being classified as abnormal (Baldwin et al., 2008).  
According to Baldwin (2006) these studies have not validated their findings on a group of 
neonates and infants with reliable evidence of middle ear pathologies. 
Swanepoel et al. (2007) obtained normative data from a bigger sample of full term 
neonates (birth to one month of age) than Kei et al. (2003) and Margolis et al. (2003).  The 
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normative data obtained in this study demonstrate the important effects of age range and gender 
on tympanograms and the factors required to be taken into consideration when compiling norms 
(Swanepoel et al., 2007).  This was not found to be taken into consideration in Kei et al. (2003) 
and Margolis et al. (2003) studies.  
Mazlan et al. (2009) also aimed to establish normative data using the component 
compensation method from full term neonates and infants who had no risk for HL, passed 
TEOAEs and had single peaked HF tympanograms results.  It was found that these normative 
values could only provide a starting point for the interpretation of HFT results (Mazlan et al., 
2009).   
Marchant et al. (1986) devised a classification system from neonates and infants below 
five months of age, where a baseline was drawn between pressures of +300 and -400 mmho and 
peak susceptance was measured above the baseline (Baldwin, 2006).  It was recommended that a 
peak susceptance of ≤ 0 mmho (absence of a discernible peak) may indicate the presence of 
MEE (Baldwin et al., 2008).  However, peaks at negatives pressures were not considered 
abnormal (Hoffman et al., 2013).  Baldwin (2006) used an adaptation of Marchant’s 
methodology to interpret admittance tympanometry instead of susceptance.  A vertical line was 
drawn from the baseline to the peak either above or below the baseline (between between +200 
and -400 daPa) and tympanograms were classified as described in Table 2.5. 
Table 2.5 
Classification of HF tympanograms (Baldwin, 2006) 
Presence of Peak above or Below Baseline Classifications 
Tympanograms above baseline Positive peak: Normal 
Tympanograms below baseline or undulating 
in shape 
Negative peak: Abnormal 
Indeterminate 
Tympanograms could not be classified as 
positive or negative peaks 
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In addition, positive peaks were categorised as normal irrespective of its size, hence 
smaller peaks which fell under indeterminate tympanograms would be reclassified as normal. 
Therefore, this method was found to decrease the number of unclassifiable traces with the use of 
HFT (Baldwin; 2006).  Baldwin et al. (2008) further describes two ways to classify 
tympanograms in Table 2.6. 
Table 2.6                            
Classification Methods for Tympanograms 
Method Description 
Classification of 
tympanograms by patterns 
LF tympanograms have been effectively classified by pattern in adults 
with the use of the Jerger/Liden classification system. (Liden 1969; 
Jerger 1970).  However, these systems have not been usefully applied to 
the neonatal and infant population as this method produces a high rate of 
false positive results and numerous unclassified tympanograms.  This 
leads to the dismissal of HFT in this population (Marchant et al., 1986; 
Kei et al., 2003; Baldwin, 2006; Cai, 2010).  The LF tympanograms are 
typically single-peaked and easier to interpret.  More complex patterns 
are obtained when the probe tone is increased resulting in multi-peaked 
tympanograms (Lantz et al., 2004). 
 
Classification of 
tympanograms by 
quantitative measure 
Classifying HF tympanograms by a quantitative measure (peak 
susceptance or peak compliance) as described by numerous studies above 
(Marchant et al., 1986; Kei et al., 2003; Margolis et al., 2003; Baldwin, 
2006; Swanepoel et al., 2007).  This method has been usefully applied to 
neonates and infants under six months of age (Marchant et al., 1986; 
Sutton et al., 1996) 
 
 Numerous studies have also reported the use of the Vanhuyse model of tympanometric 
shapes to interpret tympanometric patterns (Alaerts et al., 2007).  This model categorises the 
tympanograms based on the number of peaks or extrema on the B (susceptance) and G 
(conductance) tympanograms and predicts four tympanometric patterns at the 678 Hz probe tone 
(Cai, 2010; Bosaghzadeh, 2011).  According to Alaerts et al. (2007) the Vanhuyse model has 
shown to be suitable for identifying 1000 Hz tympanograms as 99% of the neonates and infants 
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tympanograms could be classified.  However, the interpretation of tympanometric patterns is 
more complicated using the Vanhuyse model compared to the simple visual admittance 
classification methods.  By simply looking at the B and G tympanograms pattern, middle ear 
pressure and the mobility of the TM are not taken into consideration and therefore the Vanhuyse 
model is less applicable to clinical hearing assessments (Alaerts et al., 2007). 
The interpretation of HFT has been reported as challenging for clinicians.  Factors 
contributing to the challenges experienced are the lack of normative data and difficulties 
interpreting HF tympanograms (Margolis et al., 2003; Baldwin, 2006; Baldwin et al., 2008; Cai, 
2010; Marchant et al., 1986; Sutton et al., 1996).  There is no universal agreement on the 
interpretation of HFT data (Kei & Mazlan, 2012).  As a result there are limited clinical protocols 
available for HFT; hence careful interpretation of results is required in combination with other 
audiological results (ASHA, 2004; Kei & Mazlan, 2012).  
Newborn Hearing Screening 
High risk population and high risk factors of hearing loss. 
The universal detection of infant HL requires universal screening of all infants (Task 
Force on Newborn and Infant Hearing, 1999).  Screening involves two approaches, namely to 
identify neonates and infants who have significant sensori-neural hearing loss (SNHL), CHL 
and, neural HL at birth, and to identify neonates and infants who are at risk of delayed onset or 
progressive HL (Stach, 2010a).  The challenge with any screening is to identify all individuals 
who are at risk and, with similar accuracy, those who are not at risk (Stach, 2010a). 
  The use of the high risk registry in isolation (e.g. family history of deafness) is only able 
to identify 50% of neonates and with congenital HL during NHS (Task Force on Newborn and 
Infant Hearing, 1999).  Literature has found that neonates and infants presenting with mild to 
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moderate HL are easily missed and may only be identified in the second year of life (Zamani, 
Daneshjou, Ameni & Takand, 2004).  It has further been found that half of the neonatal 
population present with risk factors.  It is therefore important that all neonates and infants obtain 
a hearing screening after birth or at least within the first three months of life.  In several countries 
universal screening is not possible and therefore all those with high risk factors for HL should be 
screened (Zamani et al., 2004).  
In South Africa there are financial and social constraints which impede the successful 
implementation of UNHS.  These constraints need to be addressed in order to ensure that the 
goals of a UNHS programme are achieved (South African Speech-Language- Hearing 
Association [SASLHA], 2011).  One alternative is to perform targeted neonatal hearing 
screening (TNHS) (SASHLA, 2011).  TNHS is where high risk groups in the neonatal 
population are targeted (Kriek, 2006).  This group includes neonates in intensive care units 
(ICUs) and other high care facilities.  TNHS is more affordable than UNHS and hence it is more 
likely that the program will be successful in this country (SASLHA, 2011).  There are a number 
of high risk factors and risk indicators associated with permanent congenital, delayed-onset, or 
progressive HL in childhood (JCIH, 2007). These include: 
 Caregiver concerns with regard to speech, language and hearing developmental delay. 
 Family history of permanent childhood HL. 
 Neonatal intensive care (NICU) for more than 5 days. 
 Extracorporeal membrane oxygenation (ECMO). 
 Assisted ventilation. 
 Ototoxic medication or loop diuretics. 
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 Hyperbilirubinemia that requires transfusion: Premature infants and infants with low birth 
weight are at greater risk for high bilirubin levels. 
 Known physical findings associated with a syndrome e.g. white forelock. 
 In utero infections e.g. cytomegalovirus (CMV), herpes, rubella, syphilis, and 
toxoplasmosis. 
 Craniofacial anomalies e.g. cleft palate 
 Syndromes associated with HL or late-onset HL e.g. Waardenburg syndrome 
 Neurodegenerative disorders e.g. Frederich ataxia 
 Culture-positive postnatal infections associated with HL e.g. bacterial and viral 
meningitis. 
 Head trauma e.g. basal skull or temporal bone fracture which requires hospitalization. 
 Chemotherapy. 
The most frequently occurring risk factors are ototoxic medications (>70%); severe birth  
asphyxia (>50%); mechanical ventilation less than 5 days (>25%); low birth weight (LBW) 
(>20%); parental/physician concerns (>15%); and ECMO (>10%) (Cone-Wesson, et al., 2000; 
Hall, 2007).  The HPCSA Position Statement on EHDI (2007) states that infants who also 
present with a unilateral refer result on screening tests are at risk of a late-onset or progressive 
bilateral HL.  
In South Africa, two additional contextual risk factors that may result in an acquired, late-
onset or progressive HL have been included, namely maternal human immunodeficiency 
syndrome (HIV) and malaria (HPCSA, 2007).  Infants  born of HIV or acquired 
immunodeficiency syndrome (AIDS) infected mothers are at high risk of HL due to their very 
low birth weights and increased susceptibility in acquiring meningitis, viral encephalitis and 
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CMV.  In the case of malaria, the disease is prevalent in many areas of South Africa and the 
medication used in the treatment of malaria is ototoxic (HPCSA, 2007).  
Hearing Screening Tests Used in Newborn Hearing Screening   
 Early detection of HL is essential for the provision of the correct support for hearing 
impaired neonates and infants to facilitate equal opportunities in society (WHO, 2010).  EHDI 
services are essential for the identification of neonates or infants with a HL before one month of 
age; to obtain audiological diagnostic evaluations by three months of age, and to commence 
intervention, which includes hearing amplification and language intervention before six months 
of age (Morton & Nance, 2006; WHO 2010).  
The most common cause of referral on NHS is CHL, the majority of which is secondary 
to OM (Boone, Bower, & Martin, 2005; Doyle, Burggraff, Fujikawa, & Macarthur, 1997).  
Hence the recommendation by HPCSA (2007) and ASHA (1997) for the inclusion of HFT in 
NHS protocol in order to assist in more accurate identification of OM in neonates and infants 
(HPCSA, 2007; Johnson & Seaton, 2012).  Current procedures used to identify neonates and 
infants with HL stipulate that objective physiologic measures should be utilised, namely OAEs 
and AABR (HPCSA, 2007; JCIH, 2007).  Both these measures are easy to perform, non-invasive 
and record the “physiologic activity underlying normal auditory functions” (JCIH, 2007, p. 903).  
However, there are distinct differences between these two measures. 
OAEs are low intensity sounds produced within the inner ear (Coenraad, 2011).  These 
sounds are responses of the cochlea that are recorded by a sensitive microphone which is 
securely fitted in the ear canal (Kemp, 2002; Coenraad, 2011).  The cochlear responses are 
caused by the auditory stimulation which results in the motion of the sensory outer hair cells 
(Kemp, 2002).  OAE measurements provide information on the condition of the peripheral 
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auditory system, which includes the outer ear, middle ear and cochlea; it is frequently used to 
screen hearing in neonates and infants and can partially estimate hearing sensitivity within a 
limited range (Kemp, 2002, JCIH, 2007; Coenraad, 2011).  OAE screening procedures alone are 
not capable of detecting mild HLs or isolated frequency region losses (JCIH, 2007).  Therefore 
sensitivity and specificity of this screening test need to be considered for NHS as it may be 
affected by screening protocols, population being screened as well as other test variables (Coates 
& Gifkins, 2003).   
There are four types of OAE measurements, namely; spontaneous otoacoustic emissions 
(SOAEs), TEOAEs, DPOAEs and sustained-frequency otoacoustic emissions (SFOAEs) 
(Campbell, 2012).  All types of OAE present with a high degree of sensitivity to changes in the 
cochlea (Kemp, 2002).  The estimated sensitivity for OAEs has shown to range from 80% to 
98% (Coates & Gifkins, 2003). 
DPOAEs and TEOAEs have both been used for NHS (Campbell, 2012).  In clinical 
practice, TEOAEs have been used mainly for NHS.  TEOAEs have been clinically used for a 
longer period and have shown better validation when associated with behavioral audiometric 
thresholds (Campbell, 2012).  TEOAEs are stimulated by transient clicks or tone bursts which 
are of short and faster duration and therefore have limited frequency specificity (Campbell, 
2012).  TEOAEs are also more tolerant to noise and movement than DPOAEs (Cunningham, 
2011).  The presence of TEOAEs suggests that hearing sensitivity should be 30dB HL or better 
(Kemp, 2002; Campbell, 2012).  DPOAEs have been used at a low stimulus level (e.g. 65/55 dB 
SPL) as a screening procedure.  It allows for greater frequency specific information to be 
recorded as it allows higher frequencies than TEOAEs to be tested (Kemp, 2002; Campbell, 
2012).  DPOAEs can also obtain responses from individuals with mild to moderate HL for which 
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TEOAEs are absent.  It further presents with better reliability with audiometric thresholds 
(Kemp, 2002 & Campbell, 2012).  
OAE screening performed on neonates and infants can be challenging as it may not be 
possible to obtain results in the LF range (< 1000Hz) (American Academy of Audiology [AAA], 
2011).  High ambient noise levels have been reported in hospital settings and have been found to 
affect the low frequencies (250Hz and 500Hz) (Olusanya, Wirz & Luxon, 2008a; Olusanya, 
Wirz & Luxon, 2008b).  Noise levels have also been reported to affect 1000 Hz (Gorga et al, 
2000).  More reliable OAE results have shown to be obtained at 2000, 3000 and 4000 Hz (Gorga 
et al, 2000).  However, there has been no appropriate pass or refer criteria for the HF range 
(>1000Hz) (AAA, 2011).  Another limitation is the fact that OAEs are unable to detect any 
neural dysfunction such as eighth nerve or auditory brainstem disorders (JCIH, 2007; Coenraad, 
2011).  
In contrast, AABR measurements provide information on the peripheral auditory system, 
the eighth nerve and the brainstem auditory pathway (JCIH, 2007).  It can therefore detect 
conditions such as auditory neuropathy in the paediatric population who are hard of hearing but 
present with normal OAEs (Coates & Gifkins, 2003).  
It is important to note that both these physiologic screening test are not a true test of 
hearing sensitivity.  The results of both these screening tests can be affected by outer or middle 
ear dysfunction (JCIH, 2007; Harlor & Bower, 2009).  OAEs will be absent in the presence of 
ear canal debris, MEE, otosclerosis or ossicular discontinuity (Kemp, 2002).  This results in the 
neonates or infants failing the hearing screening in the presence of normal cochlear and/or neural 
function (JCIH, 2007).  OAEs are therefore very sensitive to middle ear conductive components. 
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Hence, AABR is the preferred measure in NHS as it can be recorded in the first few hours of life 
when OAEs cannot be obtained (Kemp, 2002).   
It is also important to correlate the results of other audiological screening tests with 
tympanometric results in order to better determine the hearing condition in neonates and infants 
(Carmo, de Oliveira Costa & Momensohn-Santos, 2013).  HFT is also found to be in agreement 
with otoscopy and OAEs (Koivunen, Uhari, Laitakari, Alho & Luotonen, 2000; Swanepoel, 
Hugo &  Louw, 2006; Garcia et al., 2009; Kilic et al., 2012; Camboim et al., 2012).  HFT 
presents with a correlation with OAEs in both the evaluation of normal ears and ears with middle 
ear pathologies (Camboim et al., 2012).  In comparison to LFT, this LF probe tone is found not 
to be in agreement with OAEs and otoscopy (Garica et al., 2009; Kilic et al., 2012).  LFT 
presents with results more consistent with OAEs in the presence of a normal middle ear 
(Camboim et al., 2012).  
However, immittance screening is reported to be less accurate in identifying the absence 
of a middle ear pathology resulting in an increased percentage of false-positive rates (Bluestone 
& Klein, 2007; Swanepoel et al., 2007).  Significant efforts have been made to reduce the 
number of false positive results by producing comprehensive screening protocols.  However, 
there is still no definitive data supporting the validity of immittance measurements for screening 
(Keefe, Zhao, Neely, Gorga &Vohr, 2003; Bluestone & Klein, 2007).  This leads to over referral 
rates, increased expenses, reduced programme efficacy, and increased anxiety for parents 
(Thornton, Kimm, Kennedy & Cafarelli-Dees, 1993; Mencher & DeVoe, 2001; Bluestone & 
Klein, 2007).  
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Despite this, it is commonly agreed among researchers that immittance screening is easy 
to perform, non-invasive and reliable (Bluestone & Klein, 2007). These factors would favor the 
use of immittance screening to identify middle ear pathologies (Bluestone & Klein, 2007). 
Normative values and objective pass or fail criteria are useful for both the neonatal or infant and 
adult population; however differences between the various criteria exist, as well as doubt with 
regard to feasibility of norms used with different age groups (Baldwin, 2006).  Therefore no 
specific pass or fail criteria has yet been established and additional assessments are required to 
be performed in the neonatal and infant population to confirm middle ear pathology (Baldwin, 
2006).  Problems have also been highlighted with the use of these objective data (Baldwin et al., 
2008; Wilson, 2008).  Problems may include test parameters, non-standardized compensated 
versus uncompensated tympanograms as well as a lack of clarity on how development influences 
the need for age specific norms based on chronological age in weeks or months (Wilson, 2008). 
Unfortunately the difficulties in establishing a “gold standard” to determine the presence 
of middle ear fluid in neonates and infants have been an unclear factor in developing 
tympanometry (Baldwin, 2006, p. 418).  The use of tympanometry can be validated by 
determining a link between the results of other reference tests of auditory function (Baldwin, 
2006).  Therefore the current study aims to determine the use of HFT by South African 
audiologists in clinical practice as well as the pass and refer rates of HFT in comparison to other 
screening test used in the identification of possible middle ear pathology.  
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Chapter Three                                                                                                                            
Methodology 
This chapter describes the aims of the study; research design utilised and elaborates on 
the research phases.  The pilot study results, description of the main study, data collection and 
analysis procedures, as well as reliability and validity are explained.  
Research Aims 
Main aim 1.  To describe the use of HFT in current paediatric audiological clinical 
practice in South Africa. 
Sub-aims. 
 To determine the availability of HFT equipment for screening and diagnostic paediatric 
audiological assessments.  
 To determine the current clinical practice of HFT in paediatric audiological assessments. 
 To determine audiologists’ knowledge of the clinical application of HFT and theoretical 
background of the infant’s middle ear system.  
Main aim 2.  To determine the pass and refer rates of screening tests (e.g. HFT, LFT, 
otoscopy and DPOAEs) used in the identification of possible middle ear pathology in neonates or 
infants. 
Main aim 3.  To determine the agreement of the pass and refer rates between HFT and 
other screening tests (LFT, otoscopy, DPOAEs) used in the identification of possible middle ear 
pathology in neonates or infants.  
Research Design 
A quantitative research approach was employed for the purpose of this study.  A non-
experimental, descriptive, cross-sectional survey design was used to describe the use of HFT in 
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clinical practice in South Africa, whilst a correlation research design was used to determine the 
agreement of the pass and refer rates between HFT and other screening tests used in the 
identification of possible middle ear pathology in neonates or infants. 
Non-experimental research involves the systematic collection of data and does not 
require control groups, randomization of subjects or statistical controls (Terry, 2012).  
Descriptive research allows for the description of variables being studied as they exist naturally 
and is important in its own right as a source of essential knowledge (Gravetter & Foranzo, 2012).  
It is a useful approach to identify patterns and relationships in the data, and there is no 
manipulation of variables (Hauser, 2012). 
A cross-sectional survey design is a procedure where the researcher administers a survey 
to a sample or the entire population of individuals to describe the attitudes, opinions, behaviours 
or characteristic of the population at a specific point in time (Creswell, 2012).  It provides 
information in a short amount of time and for a large number of participants to be accessed 
(Terry, 2012; Cottrell & McKenzie, 2011).  This method of collection also provides a description 
of the individual’s responses to questions, information about a wide variety of different variables 
and is fairly easily administered (Gravetter & Foranzo, 2012).  Although this type of method 
presents with disadvantages (e.g. limited in inferring causation and is unable to establish 
directionality), trends can be established (Salazar, Crosby & Diclemente, 2006).  
A correlation research design is a procedure where the researcher “measures the degree 
of association (or relation) between two or more variables with the use of statistical procedure of 
correlational analysis” (Bauer & Brazer, 2012, p. 217).  The limitation of this research design is 
its susceptibility to faulty interpretation as the researcher works with groups or variables that 
have been self-selected (selection bias) (Polit & Beck, 2009, p. 161).  This limitation was 
34 
USE OF HFT IN SOUTH AFRICA 
 
addressed by determining the inter-rater reliability of the tympanometry results.  In addition the 
researcher discussed the screening results with the research assistants prior to interpreting the 
results and providing feedback to parents or caregivers of the neonate and infant participants.  It 
furthermore does not demonstrate causation among the measured groups or variables (Stangor, 
2011).  This has been acknowledged as a limitation of the current study.  Despite this, this 
research design provided the researcher with opportunity to describe the pass and refer rate 
agreement between screening tests used in the identification of possible middle ear pathology in 
neonates or infants.   
Research Phases 
This research process comprised three phases, namely the developmental phase, pilot 
study phase and main study phase.  These phases are described in Table 3.1. 
Table 3.1 
Research Phases 
Research Phases Objectives 
Developmental phase 
To develop measuring instruments to be used in the study. 
To identify and select appropriate audiological equipment to be used 
in the study. 
 
Pilot study phase 
To validate and finalise the measuring instruments, data collection 
procedures, site and equipment needs. 
 
Main study phase 
 
 
 
Phase 1 survey questionnaire: 
 Distribution of questionnaires. 
 Data analysis. 
Phase 2 hearing screening: 
 Selection of site and participants. 
 Application of all measuring instruments. 
 Data analysis. 
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Pilot Studies 
A pilot study is conducted prior to the main study and follows the design of the main 
study as closely as possible in order to ensure that the research is feasible (Taylor & Roberts, 
2006; Offredy & Vickers, 2010).  The pilot study improves the success, effectiveness of the 
research study and validity of the data collection tool (Liamputtong & Ezzy, 2007).  Two pilot 
studies were conducted at the Dr. George Mukhari Academic Hospital, a tertiary hospital in Ga-
Rankuwa. 
Pilot study 1: Survey questionnaire. 
Objectives.  The objectives of this pilot study were: 
 To determine the clarity of the questions. 
 To determine the ease of completion. 
 To determine that time required for completion of the questionnaire. 
 To determine the ease of accessing, sending and receiving the survey 
questionnaires via the Survey Monkey website (Survey Monkey, n.d.). 
Participants.  Convenience sampling was used to select pilot study participants.  Six 
participants that met the same inclusion criteria as for the main study were included in the pilot 
study.  These participants were dually qualified as speech therapists and audiologists.  All the 
participants were female and worked at government hospitals in the Gauteng Province.  They all 
currently practiced as paediatric audiologists and had an average of four years’ experience in this 
field.  These participants were not included in the main study.  
Procedures.  All participants were informed of the nature of the study and written 
informed consent was obtained prior to inclusion in the study (Appendix A).  The survey 
questionnaire was either distributed via Survey Monkey or as hard copies.  Two participants 
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completed the survey via the Survey Monkey website.  On the e-mail cover letter, audiologists 
were informed that consent to participate in this study was assumed by completing and returning 
the survey questionnaire (Appendix B).  Four audiologists completed hard copies of the survey 
questionnaires.   
Results and recommendations.  The objectives, results and recommendations from the 
first pilot study are presented in Table 3.2.
USE OF HFT IN SOUTH AFRICA            37 
 
Table 3.2 
 
Survey Questionnaire: Objectives, Measuring Instruments, Results and Modifications 
 
Objectives Measure Results Modifications 
To determine the clarity 
of the questions 
 
 
 
 
Survey questionnaire 
(Appendix C) 
There were 12 questions that 
appeared to be similar and difficult 
to understand. 
Headings for each section required 
to be more clearly stated. 
 
Similar questions were grouped together as 
well as stated more clearly for better 
understanding. 
More options were provided where necessary 
in order to obtain more specific and reliable 
responses. 
It was also made clear that HFT referred to the 
use of 1000Hz probe tone only. 
To determine the ease 
and time taken in 
completing the 
questionnaire 
Participants timed themselves 
and provided feedback to the 
researcher. 
It took approximately 25 minutes to 
complete. 
The anticipated time for completion was 
included in the information leaflet.  
To determine the ease of 
sending questionnaires 
as well as receiving and 
accessing survey data 
via the Survey Monkey 
website. 
 
The researcher performed a 
trial in using the Survey 
Monkey website. 
Feedback was obtained from 
participants who received the 
questionnaire via email. 
A few spelling errors were noted. 
A number of ‘missing responses’ 
was also noted on the 
questionnaires. The researcher 
found the Survey Monkey website 
very user friendly with a good 
support service provided. It was 
easy to design the survey 
questionnaire as well as send and 
receive the questionnaires via the 
website. Participants reported they 
received the questionnaire easily 
through e-mail; there was no 
difficulty in accessing, completing 
and returning the questionnaire.  
All spelling errors were corrected. 
Every question was made mandatory in order 
to decrease the number of missing responses. 
Therefore, more options were provided to the 
applicable and not applicable questions.  
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Pilot study 2: Hearing screening. 
Objectives.  The objectives of this pilot study were: 
 To determine the ease of utilising the hearing screening form. 
 To determine the estimated total time required for screening each participant and 
providing the caregiver with immediate feedback.  
 To determine the ease of using the audiological screening equipment. 
 To determine the feasibility of the site for data collection. 
Participants.  Convenience sampling was used to select participants.  A total of nine 
participants who met the same participant selection criteria as for the main study were included 
in this pilot study.  Pilot study participants were not included in the main study.  These 
participants were either in- or out patients from Dr. George Mukhari Academic Hospital and 
were recruited from the paediatric outpatient department (POPD), paediatric wards and the 
Speech Therapy and Audiology Department.  A demographic profile of the participants screened 
is presented in Table 3.3. 
Table 3.3 
Demographic Profile of Participants for Pilot Study 2 
Demographic Information Gender Mean Range SD 
Gender 
7 Males 
   
2 Females 
Birth weight (grams)  2605.56 1250-3990 912.17 
Current age (in days)  46.38 28-112 44.55 
Gestational age  (in weeks)  38.25 32-40 2.65 
 
Procedure.  Permission was obtained from the Chief Executive Officer (CEO) prior to 
conducting the pilot study (Appendix D).  Hearing screening was performed in the paediatric in-
patient wards and two outpatient departments (OPDs) at the Dr. George Mukhari Academic 
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Hospital.  Informed consent was obtained from all the parents and/or caregivers prior to the 
testing (Appendix E). 
Results and recommendations. 
The objectives, results and recommendations from the pilot study are presented in Table 
3.4.
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Table 3.4 
 
Hearing Screening: Objectives, Measuring Instruments, Results and Modifications 
 
Objectives 
Measuring 
Instruments 
Rationale Results Modifications 
To determine 
the ease of 
utilizing the 
hearing 
screening 
checklist. 
Hearing screening 
form (Appendix F) 
A hearing screening 
form was required for 
documentation of 
case history, results 
obtained from the 
hearing screening and 
recommendations. 
The hearing screening 
form was easy to 
complete. 
It was noted that more 
specific results were 
required to be recorded 
for otoscopic and 
DPOAE results. 
Minor grammatical and 
alignment errors were 
also evident on the 
form. 
Modification to the hearing screening form 
was made based on the results of the pilot 
study.  
Numerous options were also provided for 
possible otoscopic results as well as various 
frequencies tested for DPOAEs.  
All grammar and alignment errors were also 
corrected. 
To determine 
the ease of 
using the 
audiological 
screening 
equipment. 
Various types of 
equipment was 
included: 
 Titan Suite 
(combination of 
a tympanometer, 
DPOAE & 
AABR). 
 GSI 39 Auto 
Tympanometer. 
 Madsen 
AccuScreen 
Handheld OAE 
screener. 
 
Important to 
determine the 
suitability of 
equipment for data 
collection such as the 
ease of use, 
availability and 
portability of 
equipment. 
 
The Titan Suite was 
not found to be feasible 
for the purpose of this 
study.  The reasons for 
this included: 
 High sensitivity to 
movement and 
noise. 
 Increased testing 
time. 
 
For the main study the  following 
equipment were selected: 
 Standard otoscope.  
 Portable GSI 39 Auto Tympanometer. 
 Madsen AccuScreen handheld OAE 
Screener. 
It was also recommended to make use of 
the Maico MB11 to conduct AABR testing 
(due to time and cost effectiveness).  
However, the AABR measurement was 
excluded from the main study as this piece 
of equipment was not readily available for 
the time period required 
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Objectives 
Measuring 
Instruments 
Rationale Results Modifications 
To determine 
the feasibility 
of the site for 
data 
collection. 
Sites explored: 
 Dr George 
Mukhari 
Academic 
Hospital. 
 Rahima Moosa 
Mother and Child 
Hospital. 
 Children’s 
Homes. 
Access to potential 
research participants 
and suitability of 
sites such as noise 
levels and space had 
to be determined.  
The most challenges to 
data collection were 
identified at the Dr 
George Mukhari 
Academic Hospital.  
The challenges 
included:   
 High noise levels. 
 Limited space. 
The most suitable sites for data collection 
were Rahima Moosa Mother and Child 
Hospital and two Children’s homes in 
Gauteng. 
 
 
To determine 
the estimated 
total screening 
time 
Timer Important for 
planning for data 
collection. 
Screening time with the 
Titan Suite ranged 
between 30 and 45 
minutes and excluded 
caregiver feedback.  
High noise levels and 
equipment challenges 
contributed to the time 
required for screening.    
Other equipment used 
decreased the screening 
time  
By implementing all recommendations, 
screening time per participant decreased 
resulting in the increase of the number of 
participants seen per day. 
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Main Study 
This section provides a description of the participants, sample size, participant selection 
criteria as well as the measures and equipment used in both phases of the main study.  This is 
followed by a description of the sites, various data collection procedures and ethical 
considerations. 
Main study phase 1: Survey questionnaire. 
Sampling strategy.  A non-probability, convenience sampling strategy was used for this 
phase of the main study.  Non-probability sampling allows the researcher to select available 
individuals that represent the characteristics the researcher seeks to study (Chatburn, 2011; 
Creswell, 2012).  It is suitable to generalize findings to the population of South African 
audiologists (Creswell, 2012).  It is also an easy, inexpensive and less time consuming technique 
(Jackson, 2012).  
Sample size.  The study included a total of 113 questionnaires.  Contact details of 
potential participants were obtained from the two professional associations in South Africa, 
namely South African Association for Audiologists (SAAA) and South African Speech-
Language Hearing Association (SASLHA) (SAAA, personal communication, February 2, 2013; 
SASLHA, personal communication, February 8, 2013).  Questionnaires were distributed via 
Survey Monkey to the e-mail addresses obtained or as hard copies at the Provincial Forums 
attended by audiologists employed in the government sector.  The total sample size has been 
described in Table 3.5. 
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Table 3.5 
Description of the Total Sample Size of Survey Questionnaires (N1 = 113) 
Number of 
Questionnaires  
Distributed 
Number 
 
Number 
Included 
in Study 
 
 
Method 
 
 
 
Received 
 
Incomplete 
 
Complete 
Did not meet 
inclusion 
criteria 
N 
Survey 
Monkey 
1238 230 57 119 54 98 
Hard copies 60 19* 4 15 0 15 
Total 1298 249 61 134 54 113 
* Low return rate as many audiologists reported to have completed the survey online 
 
The response rate has been calculated as it provides guidance with regard to the 
representativeness of the sample respondents (Rubin & Babbie, 2013).  The response rate was 
19.1%, which according to Rubin and Babbie (2013) is poor.  However, response rate guidelines 
have no statistical basis and there have been few agreements as to what represents an acceptable 
response rate (Rubin & Babbie, 2013).  A “demonstrated lack of response bias” is much more 
important than a high response rate and therefore surveys with low response rates can have value 
(Maxfield & Babbie, 2009, p. 83; Rubin & Babbie, 2013). 
It must be acknowledged that although questionnaires were sent to all audiologists 
registered with SAAA and SASLHA, not all of these individuals met the inclusion criteria.  It is 
therefore assumed that only a small percentage of these audiologists are currently working in the 
field of paediatric audiology and therefore a relatively good response rate has been obtained. 
Participant selection criteria.  This section stipulates the inclusion and exclusion criteria 
used for professionals completing the survey questionnaire (Table 3.6). 
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Table 3.6 
Survey Questionnaire: Participant Selection Criteria 
Inclusion Criteria Exclusion Criteria Rationale 
Qualified audiologists 
Audiology mid-level workers 
or assistants, speech therapists, 
acousticians, audiometricians, 
paediatricians, ear-, nose- and 
throat (ENT) specialists and 
general practitioners. 
Audiologists are professionals who 
perform acoustic immittance 
measurements in order to accurately 
identify a conductive component 
within the middle ear system (Wilson, 
2008; Clark & Benson, 2008).  
Audiologists are also the most likely 
population to make use of HFT in 
their current clinical practice. 
Required to be 
currently practicing 
and working with the 
paediatric population. 
Audiologists not currently 
working with the paediatric 
population 
For the purposes of this study, 
paediatrics is defined as children from 
birth to six years of age.  Hearing 
screening of young children up to the 
age of six years should include 
tympanometry (Cherry & Rubinstein, 
2012). 
 
Participant description: Audiologists.  The majority of the participants (70%; n=79) 
were dually qualified as Speech Therapists and Audiologists (STAs), whilst the rest of the 
participants (30%; n=34) were qualified as audiologists only.  On average, participants were 
practicing in the field of audiology for 6.9 years (range: 3 months to 34 years; SD=7.32) and 
paediatric audiology for 6.2 years (range: 3 months to 33.3years; SD=7.06).  Most participants 
(92%; n=104) worked with both paediatrics and adults, whilst the rest (8%; n=9) only worked 
with paediatrics.  The most common population age range reported by participants was birth to 
geriatrics (76%; n=86) and 12 months to geriatrics (12%; n=14). 
The majority of participants reside in Gauteng (59%; n=67), followed by Kwa-Zulu Natal 
(12%; n=13), the Western Cape (9%; n=10) and the rest of South Africa (20%; n=23).  It is 
USE OF HFT IN SOUTH AFRICA        45 
 
evident that participants are representative of the provinces where the majority of the participants 
were found to be registered with the HPCSA (HPCSA, personal communication, May 2, 2013). 
Measures.  The measure was self-developed by examining current evidence-based 
practice and research (Appendix C).  Questions were designed to probe main aim one and its 
related sub-aims.  The questionnaires were developed to obtain context-specific information as 
no other measures exploring the South African context were available.  The questionnaire 
included both open- and close ended questions.  Open-ended questions allowed participants to 
generate responses within their experiences (Creswell, 2012).  Close-ended questions provided a 
“greater uniformity” and are more easily processed than open ended questions (Babbie, 2010, p. 
256).  The questionnaire included a total of 30 questions, in five sections.  Details regarding the 
content of the questionnaire are presented in Table 3.7. 
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Table 3.7 
Description of Self-developed Questionnaire 
Section 
Type of 
Questions 
Information Obtained Rationale 
Biographical 
information  
Closed 
and open 
ended 
Participant workplace 
(public vs. private) 
Qualification 
Current role  
Clinical experience 
Clinical practice, training and work 
experience may affect a participant’s 
confidence in performing and 
interpreting HFT to reliably detect 
middle ear pathologies (Burkey, Lippy, 
Schuring & Rizer, 1999; Lantz et al., 
2004). 
Equipment  
 
Closed 
and open 
ended 
The availability and 
inclusion of 
tympanometry in 
paediatric audiological 
test battery. 
Types of tympanometry 
tests used.  
The availability, inclusion 
and use of HFT 
equipment. 
Population and age-group 
for which HFT is used. 
Acoustic immittance measures are one 
of the most important current clinical 
methods for evaluating the middle ear 
system in neonates and infants (Kent, 
2004).  HFT and LFT are routinely used 
in clinical practice (Harris et al., 2005).  
There is however a lot of controversy for 
which population age group LFT and 
HFT should be utilised (Alaerts et al., 
2007; Baldwin, 2006; Baldwin et al., 
2008; Garcia et al., 2009; Lantz et al., 
2004; Mazlan et al., 2009; Wilson, 
2008). 
Current 
clinical 
practice 
 
Closed 
and open 
ended 
Availability of clinical 
protocols/guidelines. 
Interpretation and 
classification of HFT. 
Challenges faced. 
Practical aspects.  
 
Paediatric audiologists must have the 
appropriate protocols for screening 
neonates and infants (Ditty, 2012).  The 
interpretation and classification of HFT 
is controversial in the neonatal and 
infant population and has been found to 
be clinically challenging for clinicians 
(Baldwin, 2006; Baldwin et al., 2008; 
Cai, 2010).  
Knowledge Closed 
and open 
ended 
Purpose and clinical 
application of immittance 
measures. 
Anatomical and 
acoustical differences. 
Maturational changes. 
“Audiologists must have the appropriate 
knowledge and skill necessary for the 
use of current paediatric hearing 
evaluation methods and procedures” 
(Lewis, 2000, p. 173).  
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Main study phase 2: Hearing screening. 
Sampling strategy.  A non-probability, convenience sampling strategy was used for this 
phase of the main study.  Permission was obtained from all sites to conduct the research 
(Appendices G– I).  Written informed consent was obtained from parents or care givers prior to 
testing (Appendix E).     
Description of sites.  Hearing screening was performed at three sites (Table 3.8).  These 
sites were specifically chosen as potential participants were readily available within the specific 
data collection time-frame.    
Table 3.8 
Description of Sites 
Site Description 
Rahima Moosa 
Mother and 
Child Hospital 
This is a secondary level hospital located in Coronationville (Johannesburg).  
More than 10 000 births occur annually at this hospital, therefore there are a 
very busy, neonatal, premature and Kangaroo Mother Care (KMC) unit.  The 
neonatal unit admits approximately 2 000 babies each year.  Hundred and 
thirty eight neonates and infants met the participant inclusion criteria and 
were include in the study.  These participants were recruited from the medical 
wards, KMC unit, Audiology OPD and neonatal follow-up clinic.  
Doors of Hope 
Children’s 
Mission 
This organisation has three baby homes; two situated in Glenvista and one in 
Berea.  They provide a temporary Christian home for all babies and children 
who are abandoned, abused and orphaned.  At this site it is the standard 
operating procedures that all newly admitted neonates and infants undergo 
hearing screening.  Eleven neonates and infants at the Glenvista baby home 
met the participant inclusion criteria and were include in the study.  
Mother Teresa  Mother Teresa is situated in Yeoville (Johannesburg) and provides care for 
abandoned children.  Four neonates and infants at Mother Teresa that met the 
inclusion criteria were included in the study. 
 
Participant selection criteria.  The participant inclusion and exclusion criteria are 
presented in Table 3.9.    
 
 
 
USE OF HFT IN SOUTH AFRICA        48 
 
Table 3.9 
Hearing Screening Participant Selection Criteria 
Inclusion Criteria Exclusion Criteria Rationale 
Neonates or infants from 
(birth to six months 
chronological age) with or 
without any high risk factors 
for HL. 
Infants older than six 
months of age. 
 
This age range is selected according to 
the age ranges stated in the literature for 
which HFT should be used for (Alaerts 
et al., 2007; Baldwin, 2006; Baldwin et 
al., 2008; Wilson, 2008).  HFT is also 
useful in identifying middle ear 
pathologies in neonates and infants with 
risk factors for HL(e.g. prematurity) 
(Kilic et al.,2012; Do Carmo et al., 
2012; Garcia et al.,2009; Hoffman et 
al., 2013). 
 
Sample size.  The hearing screening was performed on 153 paediatric participants and 
303 ears (N2).  For three of the participants only unilateral testing could be conducted due to 
participants being restless during the screening.  It is important to note that not all screening tests 
were performed on all participants due to challenges experienced with the equipment (Table 
3.10)
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Table 3.10 
Number of Ears Screened (N2=303) 
Number of Hearing 
Screening Tests 
Performed 
Hearing Screening 
Tests 
Ear Number of Ears 
4 
Otoscopy 
Right 79 
Left 79 
226Hz probe tone 
Right 79 
Left 79 
1000Hz probe tone 
Right 79 
Left 79 
DPOAEs 
Right 30 
Left 38 
3 
Otoscopy 
Right 73 
Left 73 
226Hz probe tone 
Right 72 
Left 73 
1000Hz probe tone 
Right 72 
Left 73 
 
Participant description. The majority of participants included were male (n=79; 52%). 
Birth history information (e.g. birth weight, GA and high risk factors) could only be obtained 
from 141 participants as caregivers were unable to provide the information.  At the Mother 
Teresa children’s home information of the participants birth weight and GA were not available.  
The least neonates or infants were screened at Mother Teresa children’s home.  This was due to 
the neonates or infants being very restless, hence reliable results could not be obtained and were 
excluded from the main study.  The demographic profile of participants screened at each sites is 
presented in Table 3.11.
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Table 3.11 
 
Demographic Profile of Participants at each Sit
Site Participants Gender Birth Weight (in grams) GA(in weeks) 
Chronological Age (in 
days) 
 N M F Mean Range SD Mean Range SD Mean Range SD 
Rahima Moosa  
Mother and Child 
Hospital 
138 71 67 2634.88 860-5300 899.95 37.36 25-42 3.99 47.86 2-180 53.47 
Mother Teresa 4 3 1 - - - - - - 142.5 120-180 28.72 
Doors of Hope 
Children’s Mission 
11 5 6 2647.14 1400-3500 773.70 34.60 28-40 4.67 87.36 30-180 51.26 
Total 153 79 74 2635.49 860-5300 891.67 37.26 25-42 4.03 53.17 2 - 180 55.56 
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The majority of participants tested (n=103; 67%) presented with high risk factors for HL. 
The various risk factors found at each site is presented in Table 3.12.  At Mother Teresa 
children’s home no information was available as to whether the participants presented with any 
high risk factors for HL.   
Table 3.12  
High Risk Factors for HL Present in Participants at each Site (n = 103) 
Site High Risk Factors N % 
Rahima Moosa Mother and 
Child Hospital (n=98) 
NICU 29 30 
Neonatal jaundice 33 34 
Prematurity 56 57 
Meningitis 1 1 
Birth asphyxia 2 2 
Maternal HIV 15 15 
Caregiver concerns 3 3 
Cranio-facial anomalies 2 2 
Mechanical ventilation 32 33 
Ototoxic medication 4 4 
Syphillis 1 1 
Low birth weight 24 24 
Hyperbilirubinemia 1 1 
Doors of Hope Children’s 
Mission (n=5) 
Prematurity 4 80 
Maternal HIV 3 60 
Ototoxic medication 3 60 
Low birth weight 1 20 
 
Measures and equipment.  This section describes the hearing screening form, hearing 
screening test protocol and audiological equipment used. 
Hearing screening form.  The researcher developed a hearing screening form to record all 
relevant data as per the aim of this study (Appendix F).  This form included four sections, 
namely the demographic information of the neonates and infants, high risk factors for HL, 
audiological screening test results and recommendations (Nicholas & Martin, 2012).  More detail 
is provided in Table 3.13. 
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Table 3.13 
Description of Hearing Screening Form 
Sections 
Information 
Obtained 
Rationale 
Demographic 
information 
Gender 
Birth weight 
Current weight 
Gestational age` 
Infants who are premature present with a number of 
risk factors that is usually associated with birth 
weight (Littleton & Engebretson, 2009).  LBW (< 
2500 g) and small gestational age (SGA) are factors 
linked to prematurity and places the neonate or 
infant at risk of HI (Littleton & Engebretson, 2009).  
High risk factors Provides information 
if whether or not the 
neonate and infant is 
at risk for HL. 
The high risk factors included on the screening 
form assist the audiologists in identifying neonates 
and infants who may be at risk for various types of 
HL and auditory neuropathy (JCIH, 2007; HPCSA, 
2007). 
Audiological 
screening tests: 
 Otoscopy 
 DPOAEs  
 HFT and LFT 
Results obtained from 
these tests provide an 
indication if patients 
may be at risk of the 
following: 
 Middle ear 
pathologies. 
 CHL. 
 SNHL (cochlear 
involvement). 
 Auditory 
neuropathy. 
Reliability: 
Correlation of results. 
These screening tests are found to be sensitive to 
middle ear pathologies resulting in neonates and 
infants failing the NHS.  HFT has therefore also 
been recommended as a critical addition to NHS 
due to its reliable means of assessing a neonate’s or 
infant’s middle ear system (Nicholas & Martin, 
2012; Baldwin, 2006).  HFT has also shown to 
present the most significant correlation with OAEs 
and otoscopy (Garcia et al., 2009). 
Recommendations Parents/caregivers 
may require the 
following depending 
on the NHS results: 
 Rescreening. 
 Further diagnostic 
audiological 
evaluation. 
 Possible referrals 
to be made to other 
professionals (e.g. 
otolaryngologists, 
speech therapists). 
 Follow up 
appointments. 
Neonates and infants, who fail the NHS according 
to the hospital protocol, are required to be referred 
for a rescreening or for a further audiological 
diagnostic testing and/or referred to other 
professionals if required (Nicholas & Martin, 
2012).  
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Hearing screening test protocol.  Protocols establish a level of efficiency and offer 
clinical guidance in providing care and assist the clinician in evaluating data quickly (Clark & 
Benson, 2008).  A protocol was specifically developed for the purposes of this study (Table 
3.14).  
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Table 3.14 
Hearing Screening Test Protocol 
Screening Tests 
Measuring 
Instruments/Equipment 
Rationale 
Testing 
Conditions 
Frequencies 
Tested 
 
Informed consent 
Case history  
Informed consent form 
(Appendix E) 
Hearing screening form 
(Appendix F) 
 
Case history is the essential starting point of 
any audiologic evaluation.  It provides 
relevant information with regard to the nature 
of the auditory problem; reflects on the 
possible contributory factors of the hearing 
disorder and allows the audiologist to 
determine the clinical testing strategies 
(Stach, 2010a). 
Caregiver or 
parent to be 
present to 
obtain case 
history. 
N/A  
Otoscopic 
examination 
Otoscope 
Speculae 
Disinfectant 
 
Otoscopic examination of the ear canal, TM 
and middle ear is the foundation for the 
identification and treatment of otologic 
diseases (Postic, 2000). 
 
Calm or 
sleeping 
neonate or 
infant. 
Ensure correct 
positioning of 
neonate or 
infant. 
N/A  
Tympanometry 
testing 
 
 
Portable GSI 39 Auto 
Tympanometer 
Tympanometry is an objective measure that 
determines the mobility of the TM, air 
pressure of the middle ear and volume of the 
ear canal (Cherry & Rubinstein, 2012).  
Middle ear disorders which are frequently 
occurring in neonates and infants can be 
detected by simple analysis of the results 
obtained from tympanometry (Maico 
Diagnostics, 2010). 
Calm or 
sleeping 
neonate or 
infant. 
LFT (226 Hz) 
HFT (1000Hz) 
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Screening 
Tests 
Measuring 
Instruments/Equipment 
Rationale 
Testing 
Conditions 
Frequencies 
Tested 
DPOAEs  
 
 
Madsen AccuScreen 
handheld OAE Screener 
 
OAEs offer an “efficient, non-invasive 
objective indicator” of appropriate cochlear 
functioning (Kemp, 2002, p. 223).  It is also 
an important measure used for differential 
diagnosis, monitoring of treatment and assists 
in the selection of hearing aids and surgical 
options (Kemp, 2002).  DPOAEs allow 
greater frequency specificity and permits 
higher frequencies to be recorder.  It can also 
obtain responses for individuals with mild to 
moderate HL (Kemp, 2002; Campbell, 2012). 
Quiet environment 
and sleeping neonate 
or infant. 
The following 
frequencies 
were tested: 
 1000 Hz 
 2000 Hz 
 3000Hz 
 4000Hz 
 5000Hz 
 6000Hz 
Parent and 
caregiver 
feedback 
Graphic representation of 
the ear 
 
It is important for every parent or caregiver to 
know what the hearing screening results mean 
and what the next step should be.  It is also a 
good opportunity to assist parents or 
caregivers in understanding the importance of 
monitoring language development and 
hearing (White, 2008). 
  
Infection 
control 
SASLHA guidelines 
(2011) 
Frequent and thorough hand washing with an 
antiseptic agent as well as the use of 
disposable equipment is recommended to 
reduce the chance of spreading infections.  
Probe tips and speculae were disinfected with 
alcohol swabs and/or Milton before use. 
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Testing parameters and norms. 
Otoscopic examination.  Otoscopy is a subjective examination that is performed to 
examine the ear canal and the TM for malformations, obstructions or any signs of infection that 
may impede on the neonate or infant’s hearing (Easterbrooks & Estes, 2007).  When performing 
an otoscopic examination, a small ear speculum is utilised and the pinnae is gently pulled 
downwards in order to straighten the horizontal ear canals of the neonate or infant to obtain a 
clear view of the ear canal and TM (Cavaliere & Sansoucie, 2013; Hockenberry, 2012). 
Several options were stipulated on the hearing screening form (Appendix F). 
Otoscopically, a normal TM appears pale, gray, and translucent with visual projections of the 
malleus, short lateral process and manubrium.  Furthermore, a reflective triangular cone of light 
is visible as well as the pars flaccid and pars tensa (Mangione, 2008).  The TM can also be found 
to be bulging or retracted; therefore the examination of an eardrum should take the vascularity, 
mobility, integrity as well as position into consideration (Chiocca, 2011).  These aspects are 
essential for the identification of middle ear pathologies and ET dysfunction (White, Duncan & 
Baumle, 2013).  However, it is important to note the presence of cerumen, vernix and other 
debris as these may partially or completely obstruct the visualization of the TM (Carlson & 
Carlson, 2003; Chiocca, 2011; Cavaliere & Sansoucie, 2013).  Vernix is usually present in the 
ear canals of neonates and generally disappears by one or two weeks after birth (Whitaker, 
2001).  It is reported that 70 % of infants of two to six months of age require cerumen removal in 
order to improve the accuracy in identifying possible middle ear pathologies (Carlson & Carlson, 
2003).  The criteria and interpretation for otoscopic examination has been presented in Table 
3.15. 
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Table 3.15 
Criteria and Interpretation of Otoscopic Examination 
Otoscopic Criteria Interpretation of Results 
Normal TM: Pale, gray, translucent, cone of light, visible 
projections of the malleus, short lateral process, manubrium, 
and visible pars flaccida and pars tensa. 
Normal 
Dull TM Abnormal 
Red TM Abnormal 
Bulging TM Abnormal 
Retracted TM Abnormal 
Infection Abnormal 
Vernix Abnormal 
 
The findings of the otoscopic examination were correlated with tympanometric results as 
presented in Table 3.16. 
Tympanometry. 
LFT (226Hz probe tone).  A description, classification and norms utilised to analyse LF 
tympanograms are presented in Table 3.16. 
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Table 3.16 
Norms and Analysis of LF Tympanograms (Liden, 1969; Jerger, 1970) 
Classification: Types 
of Tympanograms 
Description Norms Result Possible Pathologies 
A Presents with a discernible peak, 
where there is a systematic 
increase in middle ear 
compliance due to the decrease 
in ear canal air pressure from 
+200 mmH20 to atmospheric 
pressure 0 mmH20 (Maico 
Diagnostics, 2010). 
 
ECV: 0.26 to 0.96 
(GSI, 2011) 
daPa: +50 to (-150) 
(Clark et al., 2007; Maico 
Diagnostics, 2010) 
c/z: 0.3 to 1.5 
(Maico Diagnostics, 2010) 
Normal No middle ear pathology present 
(Harlor & Bower, 2009; Maico 
Diagnostics, 2010; GSI, 2011) 
 
 
 
 
 
B Presents with no clear peak over 
the air pressure range of +200 
daPa to -400 daPa. Therefore the 
tympanograms presents as a flat 
line (GSI, 2011). 
ECV: 0.26 to 0.96 
(GSI, 2011) 
daPa: No pressure (NP) 
(Clark et al., 2007; Maico 
Diagnostics, 2010) 
c/z: NP 
(Maico diagnostics, 2010) 
 
Abnormal 
MEE 
Occluded cerumen 
Probe against canal 
Perforation 
Otosclerosis 
Cholesteatoma 
(Harlor & Bower, 2009; Maico 
Diagnostics, 2010; GSI, 2011) 
C 
 
 
 
 
Presents with a negative pressure 
peak and may appear as a 
“rounded maximum point”, 
instead of a “distinct peak” 
(Maico Diagnostics, 2010, p. 
14). 
ECV: 0.26 to 0.96   
(GSI, 2011). 
daPa: exceeding the normal 
limits (> -150dapa). 
(Maico Diagnostics, 2010) 
c/z: 0.3 to 1.5  
(Maico Diagnostics, 2010) 
Abnormal ET dysfunction 
Pre/Post OM 
Barometric pressure changes 
(Harlor & Bower, 2009; Maico 
Diagnostics, 2010; GSI, 2011) 
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Classification: Types 
of Tympanograms 
Description Norms Result Possible Pathologies 
Ad Presents a high compliant 
middle ear system (Maico 
Diagnostics, 2010). 
 
 
ECV: 0.26 to 0.96   
(GSI, 2011) 
daPa: -50 to (+150)  
(Maico Diagnostics, 2010) 
c/z: >1.5 
(Maico Diagnostics, 2010) 
Abnormal Ossicular discontinuity   
(Harlor & Bower, 2009; Maico 
Diagnostics, 2010; GSI, 2011) 
As This is a “shallow” type of 
tympanogram. When air 
pressure in the ear canal is 
decreased the middle ear 
compliance simultaneously 
decreases to a minimum value 
(Maico Diagnostics, 2010, p. 
13). 
 
ECV: 0.26 to 0.96   
GSI (2011) 
 daPa: -50 to (+150)  
(Maico Diagnostics, 2010) 
c/z: < 0.3  
(Maico Diagnostics, 2010) 
Abnormal Stiff middle ear system 
TM scarring 
Otosclerosis    
(Harlor & Bower, 2009; Maico 
Diagnostics, 2010; GSI, 2011) 
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HFT (1000Hz probe tone).  There are numerous normative data or guidelines available 
for the interpretation of HFT (Marchant et al., 1986; Sutton et al., 1996; Margolis et al., 2003; 
Kei et al., 2003; Baldwin, 2006; Swanepoel et al., 2007; Mazlan et al.2009).  However, there are 
limited clinical protocols available and no universal agreement for the interpretation of HFT 
(ASHA, 2004; Kei & Mazlan, 2012).  Hence, for the purpose of this study HF tympanograms 
were classified and interpreted using percentile areas as described in Table 3.16.  These were the 
guidelines provided in the equipment manual for GSI 39 Auto Tympanometer (GSI, 2011). The 
researcher was also trained by a well-trained representative of the equipment supplier on the use 
of this method of classification and interpretation of HF tympanograms.  
The choice of method for HFT interpretation could affect the validity of results.  Due to 
the subjective nature of the interpretation (Hoffman et al., 2013), tympanograms may be 
inaccurately classified.  However, a number of clinical studies have indicated the effectiveness of 
a simple normal or abnormal classification of HF tympanograms for neonates and infants less 
than 6 months of age (Baldwin et al., 2008).  This method of interpretation is also used in an 
international NHS protocol (Baldwin et al., 2008).  With this method, a significantly improved 
intra-tester agreement was reported (Baldwin et al., 2008).  In order to limit the subjective 
interpretation, the HFT result screen on the equipment has clear indicators (dotted lines) to 
delineate the percentile area.  This assisted in more accurately classifying and interpreting the HF 
tympanograms.  
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Table 3.17 
Classification of HF Tympanograms according to Percentile Areas (GSI, 2011). Reprinted with permission. 
Normal HF Tympanogram Abnormal HF Tympanograms 
  
 
The alphabet letter indicates the 5
th
, 50
th
 and 
95
th
 percentiles for admittance values at the 
positive tails (+200 daPa) and peak relative to 
the negative tail (+400 daPa).  
 
The vertical lines indicate the 5
th
 and 95
th
 
percentile for TPP. 
 
The dotted lines are the area within which 
normal HF tympanograms should be 
recorded. 
     Indicative of possible ET dysfunction               Indicative of possible COM 
USE OF HFT IN SOUTH AFRICA       62 
  
 
DPOAEs.  The test parameters for DPOAE testing were as follows (GN Otometrics, 
2014): 
 Evaluation method: Noise weighted phase statistics. 
 Stimulus: Primary tone pair, f2/f1 = 1.24. 
 Test frequencies: f2 range 1, 2,3,4,5 and 6 KHz 
 Test level: L1/L2=59/50 dB SPL. 
 Display: DPOAE level, test progress, noise level and DP-Gram 
 Result display: Overall pass or refer result, DP-Gram with DPOAE and noise 
level. The pass and refer results were interpreted as normal and abnormal 
respectively for all screening test results.  
 A pass result (unilaterally or bilaterally) was obtained if a minimum of four out of 
the six frequencies reached a pass. 
Interpretation and correlation of hearing screening results.  In summary all the results 
were interpreted as normal and abnormal in order to ensure uniformity, ease of interpretation and 
correlation of results with other hearing screening tests.  
Audiological equipment.  The following audiological equipment was used: 
 Otoscope and speculae 
 Portable GSI 39 v3 Auto Tympanometer (recently calibrated) (Appendix J) 
 Madsen AccuScreen handheld OAE Screener (recently calibrated) (Appendix K) 
 Probe tips 
 Antiseptic agent 
 Alcohol swabs and Milton  
 
USE OF HFT IN SOUTH AFRICA       63 
  
 
Data Collection 
Ethical considerations.  The researcher adopted the ethical principles as described in the 
Declaration of Helsinki (World Medical Association [WMA], 2008).  The four major ethical 
principles, namely autonomy, beneficence, non-maleficence and justice guided this research 
study (Breen, Cordner, Thomson & Pleuckhahn, 2010).  These four ethical pillars do not stand 
on their own but are interpreted and applied as explanations for clinical decisions using 
structures of reasoning and thinking developed by moral philosophers.  The following ethical 
principles were adhered to in this study (Breen et al., 2010): 
Human ethics review committee and permission.  A study that requires the involvement 
of human participants and access to confidential information necessitates ethical clearance from 
a formally constituted human ethics review committee (Taylor & Roberts, 2006; Lewis, 
Sheringham, Kalim & Crayford, 2008).  Ethical clearance was obtained from the University of 
the Witwatersrand’s Human Research Ethics Committee before the research study was 
commenced (Appendix L). 
Permission to conduct the research was obtained from all the sites.  Informed consent was 
obtained from the CEO of Rahima Moosa Mother and Child Hospital (Appendix G) and the two 
children’s homes (Appendix H & Appendix I). 
Confidentiality.  All information obtained during the course of this research study, 
including personal participant information and research data was kept strictly confidential.  
Participant numbers were allocated to all participants.  The raw data will be locked in the 
research supervisor’s office to ensure safe keeping of the raw data and destroyed after a period of 
five years. 
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Autonomy.  Participation in this study was voluntary.  Participants had the right to 
withdraw from this study at any time without any negative consequences.  If they decided to take 
part in this study, they were informed about the nature and predictable benefits of the study.  The 
participants were informed that consent to participate in the study was assumed if he/she 
completed and returned the survey questionnaire. 
Beneficence.  The researcher should act in the best interest of the participant (Breen et 
al., 2010).  As this study involves human subjects the researcher ensured that respect, safety and 
wellbeing of the participants took precedence over all other interests.  
Non-maleficence.  Although no direct harm came to participants during the study, the 
researcher considered the time involved for each participant to participate in the study. 
Justice.  This incorporates notions of equal and fair distribution of resources based on the 
analysis of benefits and burdens of decision (Breen et al., 2010).  Justice was assured by 
approaching the parents or caregivers of all potential participants at the hospital site.  These 
individuals therefore had the opportunity to have their children’s hearing screened.  The 
inclusion of the two children’s homes as data collection sites provided them with the opportunity 
to have all the neonates’ and infants’ hearing to be screened.  The benefits and risks of the study 
were thus fairly distributed and that all participants were treated equally. 
Research personnel.  Three research assistants assisted with some aspects of data 
collection.  All were female and dually qualified as speech therapists and audiologists.  On 
average, they had 3.6 years of experience in the field of paediatric audiology.  
Prior to data collection, the purpose and nature of the study was explained to the research 
assistants.  They were provided with the hearing screening protocol (that included getting 
informed consent) and were given the opportunity to ask clarifying questions.  Training was 
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provided prior to data collection on the following aspects: (i) obtaining informed consent; (ii) 
obtaining case history information from caregivers and, if available, hospital files; (iii) 
performing the otoscopic examination; (iv) providing feedback to the caregivers on results 
obtained, and (v) recording of results.  The screening protocol was revised on the day of data 
collection in order to ensure the research assistants clearly understood what was required of 
them.  
Research assistants were only required to record information obtained from caregivers 
and hospital files as well as what was visualized during the otoscopic examination.  The 
researcher was present at all times to confirm otoscopy results, if requested.  Interpretation of 
otoscopic findings, as normal or abnormal, was only made by the researcher.  The tympanometry 
and DPOAE screening was only performed by the researcher as the researcher was the only one 
trained by the suppliers of the equipment on how to perform and interpret the screening test 
results.  Screening results and recommendations for every participant was discussed as a team 
(researcher and research assistants) prior to providing the parents or caregivers with the 
feedback.  
Data collection procedures.  The procedures for data collection during all phases of the 
research are described below: 
 Ethical clearance was obtained from the HREC of the University of 
Witwatersrand to conduct this study (Appendix L). 
 All measuring instruments were developed and audiological equipment was hired 
(Appendix C & Appendix F) (Table 3.7 & Table 3.13).  
 Permission was obtained from Dr. George Mukhari Academic Hospital to conduct 
the pilot study (Appendix D). 
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 Two pilot studies were conducted to finalize the measuring instruments and 
determine the equipment to be used in the study.   
 During the main study phase the following procedures were followed: 
Main study phase 1: Survey questionnaire. 
 All potential participants were contacted via email with the use of the Survey 
Monkey website.  This communication included a cover letter describing the 
study (Appendix B) and the survey questionnaire (Appendix C).  It was assumed 
that participants had consented to participate in the study by completing and 
returning the survey questionnaire.  Only participants who returned the completed 
questionnaire and met the inclusion criteria were included in the study.   
 In addition, the researcher also distributed hard copies of the survey questionnaire 
to delegates at the Mpumalanga and Gauteng provincial forums. 
 Once the survey questionnaires were returned the raw data were encoded 
according to the data definitions and checked for any capturing errors.  
Main study phase 2: Hearing screening. 
 Permission was obtained from all sites to conduct the study (Appendix G-I).  At 
Rahima Moosa Mother and Child Hospital consent was obtained by the Chief 
Executive Officer (CEO) of the hospital (Mrs. S. Jordaan).  At Mother Teresa 
permission was obtained from the House Mother, whilst the Baby Care Manager 
at Door of Hope Children’s Mission gave permission.  Audiological equipment 
used was recently calibrated (Appendix J & Appendix K). 
 Written informed consent was obtained prior to the testing from parents or 
caregivers of participants recruited from hospitals (Appendix E).  The House 
USE OF HFT IN SOUTH AFRICA       67 
  
 
Mother from Mother Teresa and the Baby Care Manager at Door of Hope 
Children’s Mission as the appointed caregivers of the children in their centers 
provided written informed consent for inclusion in the study. 
 An interpreter was available for caregivers who were not proficient in English.  
 Three research assistants rotated and were trained by the researcher to assist with 
some aspects of data collection. 
 Participants were allocated participant numbers and these numbers were recorded 
on the data collection forms. 
 All hearing screening tests (where possible) were applied during this phase of the 
study.  Research assistants obtained informed consent and case history, performed 
the otoscopic examination, provided feedback to parents or caregivers and 
documented results on the data collection forms.  Tympanometry and DPOAE 
screening was only performed by the researcher. 
 Only one participant was screened by the research team at a time thus eliminating 
the possibility of double entry of participants. Once hearing screening was 
completed the parents or caregivers were provided with immediate results and 
recommendations for further management (if required) explained.  
 Data were captured on an excel spread sheet and reviewed for accuracy. 
Reliability and Validity 
Reliability.  Reliability refers to the consistency or stability of a measuring instrument 
(Jackson, 2012).  Inter-rater reliability was the strategy implemented to ensure reliability. 
Inter-rater reliability.  Inter-rater reliability is a “measure of consistency” that evaluates 
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the percentage of agreement of observation made by raters (Jackson, 2012, p. 70).  Inter-rater 
reliability was determined by requesting a second person to review 25% of tympanometry tests 
results.  The second rater was an audiologist (and part-time lecturer) with eight years clinical 
experience in the field of screening and diagnostic audiology.  The second rater was provided 
with minimal information regarding the outcomes of the research study.  No analysed results 
were provided to the rater in order to decrease the bias in the analysis of tympanometry results.  
The following formula provided a means to determine the percentage of agreement (Jackson, 
2012): 
Inter-rater reliability   =  Number of Agreements x  100 
                                                     Number of possible Agreements 
    
 
The inter-rater reliability was 88%.  According to Doron, Chan, Tamir, Lenhardt (2002) a 
good percentage agreement should be between the ranges of 90–98 %.  Results that the 
researcher and rater disagreed on were reviewed and re-analysed using clinical guidelines and 
theoretical background in order to further increase the reliability of interpreting the results as 
accurately as possible.  This resulted in both the researcher and rater reaching agreement.  
Inter-tester reliability.  This is the consistency of measurements when more than one 
individual who takes the measurement indicates agreement of the measurement taken by 
different examiners (Kaplan, 2006).  Inter-tester reliability was not documented despite research 
assistants requesting confirmation of the otoscopic findings.  This is acknowledged as a 
limitation of the study.  However, the correlations of screening test results were discussed as a 
team prior to providing feedback to parents or caregivers.  This was done to ensure that all 
results were interpreted accurately. 
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Validity.  Validity is the ability of a study to measure what it claims (Davis & Bremmer, 
2006).  There are two types of validity measures that relate to this study, namely face- and 
content validity. 
Face validity.  The judgment that an instrument is assessing what it is supposed to, is 
mainly based on the coherent link between the questions and the objectives of the study.  The 
establishment of this link is known as face validity (Kumar, 2005).  Two audiologists were 
approached to determine the face validity of the survey questionnaire and hearing screening 
form.  These audiologists had an average of eight years clinical experience in the field of 
paediatric audiology.  The pilot study also assisted in establishing face validity as further 
changes were made to the measuring instruments thereafter. 
Content validity.  Content validity is the accuracy of procedures and equipment to 
measure what they claim to measure (Kumar, 2005). 
Survey questionnaire and hearing screening form.  It is equally important that the 
questions or items cover the full range of the issue being measured (Kumar, 2005).  The items of 
instruments were assessed in order to determine if they adequately represent the content areas 
they are intended to measure (Kumar, 2005; Rubin, 2008).  These validity measures were 
applicable to this study as it evaluated whether the questionnaire and hearing screening form are 
measuring what they are supposed to in order for the researcher to obtain appropriate data for 
this study.  The content of the developed measuring instruments were mainly validated through 
the pilot study.  The results obtained from the pilot study assisted in determining whether 
appropriate information was being retrieved for the purpose of the study.  
Hearing screening tests.  Calibration of equipment ensures accurate functioning of 
equipment, thus contributing to the validity of results (Valente, Fernandez & Monroe, 2011).  All 
USE OF HFT IN SOUTH AFRICA       70 
  
 
the equipment utilised in the study was recently calibrated.  It is also necessary for current and 
relevant calibration standards to be used for audiological equipment.  This is to ensure that 
results obtained on different equipment, in different settings at different times can be accurately 
compared (Wood, 1995).  Calibration standards were in accordance with those prescribed by the 
South African Bureau of Standards (SABS 0154-1; 0154-2), thereby ensuring that the results 
were accurate and valid. 
As DPOAEs are affected by noise levels, noise levels were kept to the minimum by 
conducting the hearing screening in a sound proof room where available (hospital).  At the 
children’s homes screening was conducted in a quiet room and every attempt was made to 
minimize noise levels in the vicinity of the room where the hearing screening was conducted.   
DPOAEs and tympanometry screening tests were repeated in order to ensure replicable 
results. 
Data Analysis   
The data were documented on all the relevant measuring instruments and encoded 
according to the data definitions.  All the data were computerized for statistical analysis with the 
Statistical Analysis System (SAS) software. Results were analysed utilising a variety of 
statistical procedures, as listed in Table 3.18 and displayed in tables and figures in the results 
section of this report. 
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Table 3.18 
Description of Statistical Methods  
Statistical Procedures Statistical Methods 
Descriptive statistics: 
 Measures of central 
tendency e.g. mean 
 Measures of variability 
e.g. range and standard 
deviation (SD) 
 Frequency distributions 
 
Descriptive statistics are techniques that assist in describing a set 
of data (Gravetter & Foranzo, 2012).  The goal of descriptive 
statistics is to organise and summarise information (Gravetter & 
Foranzo, 2012).  Mean, range and SD was used to analyse the 
survey questionnaires in order to describe the use of HFT in 
current paediatric audiological clinical practice in South Africa.  
Descriptive statistics further allowed the researcher to look at 
frequency patterns through the use of contingency tables.  
Contingency tables are joint frequency distribution of two or 
more variables.  When two variables are involved it is known as a 
two way contingency table (Powers & Xie, 2008).  Two way 
contingency tables were used to determine the pass and refer rates 
of the screening tests.  
Measures of agreement: 
 Cohen’s kappa 
Cohen’s kappa is a measurement of agreement that attempts to 
correct chance (Gravetter & Forzano, 2012).  It provides values 
similar to a correlation coefficient.  The values of kappa range 
from 0 – 1.00 with higher indicating better agreement (Kelly, 
2009).  Cohen’s kappa was used to determine the agreement of 
the pass and refer rates of the various hearing screening tests. 
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Chapter Four 
Results 
This chapter presents the results in relation to the aims of the study.  This chapter will 
first describe the results of the first phase of the main study (survey questionnaire) and then the 
last phase of the main study (hearing screening). 
Main Study Phase 1: Survey Questionnaire 
Main aim 1: Use of HFT in current clinical practice. 
The aim of this survey was to describe the use of HFT in current paediatric audiological 
clinical practice in South Africa.  The findings are presented according to the following sub-
aims:  
 The availability of HFT equipment in audiology departments for screening or diagnostic 
paediatric audiological assessments.  
 The current clinical practice of HFT in paediatric audiological assessments. 
 Audiologists’ knowledge of the clinical application of HFT and theoretical background of 
the infant’s middle ear system.  
Availability of tympanometry equipment in paediatric audiology departments or 
practices.  The total sample included 113 (N1) participants.  Ninety four percent of the 
participants (n=106) indicated that they have access to a tympanometer in their practice or 
department.  Of these participants, only fifty percent (n=53) had access to a HFT.  Only six 
percent of participants (n=7) did not have access to a tympanometer.  They indicated that this 
was due to a lack of equipment (as a result of budgetary constraints) and broken equipment. 
Participants were also required to indicate their workplace and were allowed to select 
more than one option.  Participants (94%; n=106) who reported to have access to tympanometry 
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were found mainly to be working in the public health sector such as government hospitals (49%; 
n=52) and primary health care clinics (6%; n=6).  Forty percent of participants (n=38) worked in 
private practices and 11% in private hospitals (n=12).  The rest of the participants worked in the 
educational setting (6%; n=6) and universities or non-profit organizations (8%; n=9).  
 More specifically participants who have HFT (50%; n=53) are found to be mainly 
working in government hospitals (47%; n=25) and private practice (43%; n=23). 
 
Figure 4.1. Workplace of participants with HFT. 
Participants who do not use HFT (53%, n=60) include those that have access to a 
tympanometer but have no HFT available (88%; n=53) and those that have no access to a 
tympanometer resulting in no HFT being available in their clinical setting (12%; n=7).  These 
participants (53%, n=60) were found mainly to working in the public health sector such as 
government hospitals (52%; n=31) and primary health care clinics (12%; n=7).  Twenty percent 
of participants (n=17) worked in private practices and 10% in private hospitals (n=6).  The rest 
of the participants worked in the educational setting (5%; n=3) and universities or non-profit 
organizations (7%; n=4). 
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Current clinical practice of HFT in paediatric audiological assessment. 
Inclusion of HFT in paediatric audiological assessments.  The majority of participants 
(98%, n=104) who have access to tympanometry reportedly included tympanometry in their 
basic paediatric test battery.  Two of these participants (2%; n=2) did not include tympanometry 
in their basic paediatric test battery due to time constraints. 
Participants (98%; n=104) were requested to indicate which type of tympanometry test 
was conducted for the paediatric population in their clinical practice.  Participants could choose 
more than one option.  LFT (78%; n=81), was found to be used by most of the participants 
followed by HFT (51%; n=53).  MFT (13%; n=13) and 667Hz probe tone (5%; n=6) was the 
type of tympanometry least used by participants.  Eight percent of participants (n=9) were unsure 
as to which type of tympanometry was used in their clinical practice, as they were unaware of 
what the settings were on their tympanometer. 
Many participants also reported using a combination of two or more tympanometry tests 
in their clinical practice (Table 4.1). 
Table 4.1 
Tympanometry Tests Used in Combination 
 
 
 
 
 
 
LFT and HFT are found to be used in combination by a majority of the participants 
(n=45). These participants (n=45) are found to be mainly working in government hospitals 
(n=21; 47%) and private practice (n=21; 47 %) and a smaller percentage in private hospitals 
Type of Tympanometry 
Tests 
n % 
LFT and HFT 45 85 
MFT and HFT 4 8 
MFT and 667Hz 1 2 
LFT and 667Hz 3 6 
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(n=6; 13%), universities (n=5; 11%), private schools (n=2; 4%) and government schools (n=2; 
4%). 
The use of HFT for neonates and infants with definitive middle ear pathologies was then 
explored. Fifty percent of all participants (n=53) completed this section on how often HFT is 
included within their paediatric test battery.  Of these participants 68% (n=36) reported to always 
include HFT.  Whilst 28% (n=15) reported to sometimes include HFT and majority of these 
participants (80%; n=12) did not provide any reasons as to why HFT is not always included.  
Some participants (20%; n=3 ) stipulated reasons such as a lack of training in conducting and 
interpretation of HFT; a lack of clinical protocols; believing that HFT is not clinically relevant; 
or that it is case dependent.  Only 4% of participants with HFT (n=2) reported never including 
HFT, even though it is available in their clinical setting.  
The remainder of the participants (53%; n=60) reported that HFT is never included in 
their paediatric test battery for neonates and infants with definitive middle ear pathologies.  
These participants provided various reasons as to why HFT is not being included (Figure 4.2).  
The most common reason is the lack of HF probe tone, followed by a lack of training in 
conducting and interpretation of HFT, as well as a lack of clinical protocols and budgetary 
constraints. 
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Figure 4.2. Reasons why HFT is not included in basic paediatric test battery.  
The question on the age range for which HFT was used was answered by 50% of the 
participants (n=53).  Participants were provided with ten options and were only allowed to select 
one.  It was found that HFT is used in four main age ranges, namely: 0 to 6 months; 0 to 9 
months; up to 1 year and up to 6 years of age (Figure 4.3). 
 
 
 
 
 
 
Figure 4.3. Age range HFT was used. 
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Most participants (43%; n=23) reported using HFT mainly for infants ranging from birth 
to nine months of age.  A smaller percentage of participants (23%; n=12) utilised HFT for birth 
to six months (which is the recommended age range) of age. 
The availability of departmental clinical protocols for HFT.  Participants (50%; n=53) 
performing HFT had to indicate whether clinical protocols were available in their department or 
practice.  Of these participants, the majority (70%, n=37) reported to have clinical protocols, 
whilst 30% (n=16) indicated that no clinical protocols were available.  
Participants with no clinical protocols available for performing HFT (n=16).  These 
participants provided reasons as to why clinical protocols are not available.  Reasons included: 
‘lack of knowledge on application and interpretation of HFT’; ‘in the process of developing a 
protocol’; ‘every audiologist uses their own norms’; ‘caseloads are not comprised of many 
neonates and infants to develop a protocol’; ‘lack of protocols available and normative data that 
is available is not clear enough for practical application of HFT’.  Many participants also 
reported that they were ‘unsure’ as to why clinical protocols were not available.  
These participants (n=16; 30%) also indicated which norms and classification system are 
used for the interpretation of HFT.  Some participants (31%; n=5), reportedly use the norms 
stipulated in the equipment manuals, but the majority (44%; n=7) were unsure as to which norms 
they used for the interpretation of HFT.  The majority of the participants (69%; n=11) were also 
unsure as to which classification system they used for the interpretation of HFT.  Only thirty-one 
percent of participants (n=5) reported using classifications systems such as quantitative measures 
(peak susceptance or peak compliance).  Participants were also requested to provide a reference 
or elaborate on the norms and classification systems used.  Participants reported making use of 
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the equipment manuals, relevant international research articles and books related to 
tympanometric testing.  Not all participants provided references. 
Participants with clinical protocols available performing HFT (n=37).  These 
participants indicated the type of clinical protocols used (Figure 4.4).  Participants were provided 
with four options and were allowed to choose more than one option. 
 
Figure 4.4. Current clinical protocols used.  
The majority of the participants reported using the international Newborn Hearing 
Screening Program (NHSP) Tympanometry Protocol v2.0 (51%; n=19) (Baldwin et al., 2008) 
and self-developed protocols (19%; n=7).  Twenty-four percent of participants (n=9) reported to 
also use other resources such as hospital protocols; a combination of various other protocols 
(participants did not provide more information on these protocols); university-developed 
instructional manuals; and hearing-aid company protocols.  
Participants also indicated norms used for the interpretation of HFT (Figure 4.5). 
Participants were provided with 11 options and were able to select more than one option. 
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Figure 4.5. Norms used by participants (with available clinical protocols).  
The majority of participants indicated that they use norms stipulated in the equipment 
manuals (27%; n=10) for interpretation.  A large number also reportedly used journal articles 
(22%; n=8), peak susceptance [≤ 0 mmho] (22%; n=8) for interpretation and many were also 
unsure (22%; n=8) as to which norms were used for the interpretation of HFT.  Some 
participants elaborated on the pass or refer criteria used (e.g. flat trace being indicative of 
abnormal results, a discernible peak being indicative of normal results or a peak compliance of at 
least 0.6mmho which is also indicative of a normal middle ear functioning). 
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Participants also indicated classification systems used for the interpretation of HFT 
(Figure 4.6).  
 
 
 
 
 
 
 
Figure 4.6. Classification systems used by participants (with available clinical protocols). 
The majority of the participants (46%; n=17) make use of classification systems such as 
quantitative measures (peak susceptance or peak compliance), whilst many participants (35%; 
n=13) are unsure as to which classification system is used for the interpretation of HFT.  Other 
classifications systems used by participants are reported to be described in journal articles (11%; 
n=4) and textbooks (8%; n=3). 
Audiologists’ knowledge of the clinical application of HFT and theoretical background 
of the infant’s middle ear system.  This section was answered by all participants (N1=113).  
Participants were allowed to select more than one option for all questions. 
Purpose of Tympanometry.  Participants were required to state what the purpose of 
tympanometry is and the following options were provided with four options (Figure 4.7). 
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Figure 4.7. The purpose of tympanometry described by participants (N1=113).  
All of the participants (N1=113) have stated that the purpose of tympanometry is to assess 
the functioning of the middle ear system.  In addition, some of these participants (n=42; 37%) 
have indicated that the purpose of tympanometry is also to determine the nature of the 
conductive lesion.  Both these responses are an appropriate description as to what the purpose of 
tympanometry is.  
Clinical application of HFT.  Participants were required to provide information with 
regard to the clinical application of HFT in their clinical setting.  Participants provided more than 
one clinical application (Table 4.2).   
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Table 4.2 
Clinical Application of HFT in the Clinical Setting  
Clinical Applications % n 
Unsure 22 25 
To obtain reliable and accurate results of middle ear pressure and 
compliance of infants with middle ear pathologies. 
18 20 
Used for the paediatric population only. 9 10 
To assess and determine the middle ear status or functioning in high risk 
populations. 
15 17 
To effectively assess the middle ear status or functioning and to identify 
MEE in infants birth to six months of age. 
15 17 
Valuable for hearing screening as it assists in identification, prevention 
and management of emerging hearing loss in infants. 
5 6 
Cross check principle for all audiological results. 5 6 
To make appropriate recommendations, referrals and management. 4 4 
Minimal clinical application in the setting. 3 3 
Diagnostic completeness. 3 3 
Assists with differential diagnosis. 2 2 
Other 3 3 
 
Knowledge of the infant middle ear system.  Participants were required to describe the 
infant middle ear system and participants were provided with seven options (Figure 4.8).  
 
 
 
 
 
 
 
Figure 4.8. Description of an infant’s middle ear system. 
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The majority of the participants (81%; n=92) were able to appropriately describe the 
infant middle ear system.  However, it is noted that many participants (27%; n=30) responded 
that they were unsure as to what the infant middle ear system should be like.  Other responses 
obtained described the infant middle ear system to be ‘dependent on the infant’s age’; to have 
‘differences in compliance when compared to adults’; ‘immature structure and function of the 
ET’, and ‘very prone to infection’. 
Acoustical differences between an infant and adult middle ear system.  Participants were 
required to state the acoustical differences between an infant and adult middle ear system and 
were provided with six options (Figure 4.9). 
 
Figure 4.9. Description of the acoustical differences between an infant and adult middle ear 
system. 
The majority of the participants (63%; n=71) have described the main differences 
between an infant and adult middle ear system to be ear canal impedance, reflection coefficient 
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responses and energy transmission, followed by (40%; n=45) resonance gain and resonance 
frequency.  Many participants (20%; n=23) were also found to be unsure as to what the 
acoustical differences are.  Some participants (4%; n=5) stipulated other acoustical differences 
(See Table 4.3).  
Maturational changes.  Participants were required to state whether maturational changes 
that occur in the infant’s middle ear system affect the acoustical properties of the ear.  
Participants were also requested to provide an explanation for their response.  However, this was 
not provided by all participants.  Most of the participants (86%, n=97) reported that maturational 
changes do occur in the infant middle ear system and have an effect on the acoustical properties 
of the infant’s ear.  Some of these of participants (34%; n=32) provided explanations, which 
have been described in Table 4.3.  
Table 4.3 
Reasons Provided by Participants as to Why Maturational Changes Affect the Acoustical 
Properties of the Infant’s Ear 
Reasons % N 
Development of the infant’s middle ear system takes place as the infant 
grows resulting in structural changes. 
33 11 
Acoustical changes, such as changes in eardrum compliance, energy 
transmission and sound pressure level, occur. 
15 5 
Mass-dominated system moving to stiffness-dominated system 12 4 
Changes to the natural resonance of the infant middle ear system occurs 12 4 
Age dependent 12 4 
Unsure 12 4 
 
A small percentage of participants (14 %, n=16) also reported that maturational changes 
that occur to the infant’s middle ear system, do not have an effect on the acoustical properties of 
the infant’s ear.  Some of these participants (44%; n=7) provided reasons for their response, such 
as ‘immaturity of the inner ear affect acoustics’; and ‘the development of the ET makes the infant 
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less susceptible to MEE but has no effect on acoustical properties of the ear’ and the majority of 
the participants were ‘unsure’, hence could not provide any reason for their response. 
Main Study Phase 2: Hearing Screening 
This section describes the results obtained for the second and third aim of the last main 
study phase. The aims determine the pass and refer rates of the screening tests, and the 
agreement of theses rates in the identification of possible middle ear pathology in neonates and 
infants.  
The results are divided into two sub-sections, namely the four hearing screening tests and 
three hearing screening tests.  This was due to equipment malfunction of the OAE screener 
which resulted in two different sample sizes for each section (Table 4.4).  The number of right 
and left ears on which the statistical analysis was performed is presented in Table 4.4. 
Table 4.4 
Description of Sample Size 
Total Number of Participants  
Number of 
Hearing Screening 
Tests Performed 
Types of Hearing Screening 
Tests Performed 
80 4 
Otoscopic examination 
LFT (226Hz probe tone) 
HFT (1000Hz probe tone) 
DOAEs 
73 3 
Otoscopic examination 
LFT (226Hz probe tone) 
HFT (1000Hz probe tone) 
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Table 4.5 
Number of Ears Screened (N2 = 303) 
Number of Hearing 
Screening Tests 
Performed 
Hearing Screening Tests Ear 
Number of 
Participants 
4 HFT (1000Hz probe tone) Right 79 
Left 79 
LFT (226Hz probe tone) Right 79 
Left 79 
Otoscopy Right 79 
Left 79 
DPOAEs Right 30 
Left 38 
3 HFT (1000Hz probe tone) Right 72 
Left 73 
LFT (226Hz probe tone) Right 72 
Left 73 
Otoscopy Right 73 
Left 73 
 
Note:  
 Pass rate: A negative result indicating that no possible middle ear pathology has been 
identified. 
 Refer rate: A positive result indicating that possible middle ear pathology has been 
identified. 
Main aim 2: Pass and refer rates of screening tests.  
This section describes the results of the second main aim of the main study.  The table 
below describes the pass and refer rates of the various screening tests for the four hearing 
screening sample size. 
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Table 4.6 
Pass and Refer Rates of Hearing Screening Tests (HFT, LFT, Otoscopy and DPOAEs) 
Four Hearing Screening Tests 
HFT 
Ear Right (n=79) Left (n=79) 
 
N % n % 
Pass 43 54 41 52 
Refer 36 46 38 48 
LFT 
Ear Right (n=79) Left (n=79) 
 
N % n % 
Pass 67 84 68 86 
Refer 13 16 11 14 
Otoscopy 
Ear Right (n=79) Left (n=79) 
 
N % n % 
Pass 36 46 35 44 
Refer 43 54 44 56 
DPOAEs 
Ear Right (n=30) Left (n=38) 
 
N % n % 
Pass 8 27 14 37 
Refer 22 28 24 63 
  
LFT obtained the highest pass rates bilaterally when compared to the other screening 
tests.  The pass rates were 84% (n =67) in the right ear and 86% (n=68) in the left ear.  The pass 
rates for HFT were significantly lower than LFT.  Pass rates for HFT in the right ear was 54% 
(n=43) and 52% (n=41) in the left ear.  It was also found that the pass and refer rates obtained for 
HFT and otoscopy were relatively similar.  The lowest pass rates were obtained for DPOAEs.  
This pass rate was lower when compared to HFT and LFT.  
The table below describes the pass and refer rates of the various screening tests for the 
three hearing screening sample size 
USE OF HFT IN SOUTH AFRICA 88 
 
 
Table 4.7 
Pass and Refer Rates of Hearing Screening Tests (HFT, LFT and Otoscopy) 
 
Similarly to the four hearing screening sample size, the highest pass rates were obtained 
with LFT bilaterally (right 99%, n =71; left 93%, n=68) when compared to the other screening 
tests.  Lower pass rates were obtained for both the HFT and otoscopy.  Furthermore, the pass and 
refer rates for HFT and otoscopy were not as similar as in the four hearing screening sample. 
Main aim 3: Agreement of the pass and refer rates between HFT and other 
screening tests.  
This section describes the results of the third main aim of the main study.  The measure 
of agreement used for the purpose of this section is Cohen’s kappa and the interpretive values 
used are illustrated in Table 4.8 (Fleiss, 1981). 
 
Three Hearing Screening Test 
HFT 
Ear Right (n=72) Left (n=73) 
 
N % n % 
Pass 62 86 61 84 
Refer 10 14 12 16 
LFT 
Ear Right (n=72) Left (n=73) 
 
N % n % 
Pass 71 99 68 93 
Refer 1 1 5 7 
Otoscopy 
Ear Right (n=72) Left (n=73) 
 
N % n % 
Pass 55 76 51 70 
Refer 17 24 22 30 
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Table 4.8 
Values used for Interpretation of the Cohen’s Kappa (Fleiss, 1981) 
Values Interpretation  
< 0.40 Poor agreement 
0.40 - 0.59 Fair agreement 
0.60 - 0.74 Good agreement 
> 0.75 Excellent agreement 
 
The table below describes the agreement of the pass and refer rates among the various 
hearing screening tests. 
Table 4.9  
Agreement of the Pass and Refer Rates for all Hearing Screening Tests 
Four Hearing Screening Tests 
Screening Tests Right Ear Left Ear 
HFT and LFT 0.1656 0.1931 
HFT and Otoscopy 0.7237* 0.7983* 
HFT and  DPOAEs 0.2697 0.2893 
LFT and Otoscopy 0.1335 0.1812 
LFT and  DPOAEs 0.1667 0.1284 
Three Hearing Screening Tests 
HFT and LFT 0.1606 0.1534 
HFT and Otoscopy 0.5062 0.6264* 
LFT and Otoscopy 0.0872 0.1534 
*Good or excellent agreement 
It is evident from the findings that the highest level of agreement was obtained between 
HFT and otoscopy.  In the four hearing screening sample size an excellent agreement (0.7983) 
was found in the left ear, whilst a good agreement (0.7237) was found in the right ear.    
Similarly, a good agreement (0.6264) between HFT and otoscopy was found in the left ear of the 
three hearing screening sample size, whilst a fair agreement (0.5062) was found in the right ear.  
A poor agreement was found between HFT and LFT as well as the LFT and otoscopy in both the 
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four and three hearing screening tests.  The agreement between DPOAEs and the other screening 
tests in the four hearing screening sample size was also poor. 
This chapter highlighted the results of the research and were organised, analysed and 
described as it relates to the aims of the research study.   
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Chapter Five 
Discussion 
This chapter relates and compares the results presented in chapter four to relevant 
literature in order to highlight trends and difference in the results obtained.  The discussion will 
allow for conclusions to be drawn with regard to the use of HFT in neonates and infants.  This 
chapter will address the first phase of the main study (survey questionnaire), followed by the last 
phase of the main study (hearing screening).  
Main Study Phase 1: Survey Questionnaire 
Main aim 1: Use of HFT in current clinical practice.  
Availability of tympanometry equipment in paediatric audiology departments or 
practices.  The majority of the participants have access to tympanometry whilst only a small 
percentage of these participants reported to have access to HFT.  These participants were found 
to mainly be employed within the public health sector.  Furthermore, majority of the participants 
who reported to not use HFT was also mainly found to be employed within the public health 
sector. 
South Africa consists of both the public and private health care sector (South African 
Rights Commission, 2009).  The inequitable distribution of resources between the public and 
private health care sector is the greatest challenge that the South African health system is facing 
as a result of financial instability (South African Rights Commission, 2009).  This appears to be 
evident in the current study as the reason for majority of the participants not using HFT was 
mainly ascribed to budgetary constraints.  These budgetary constraints contributed to the limited 
availability of HFT in clinical settings.  Al-Khatib (2010) confirms that the HFT is limited due to 
the high cost of the tympanometry equipment.  This may negatively impact the availability of 
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services within the health care sector which in turn may result in delayed identification of middle 
ear pathologies in the paediatric population. 
The majority of the South African population relies on services provided by the public 
health sector rather than on private health care sector.  However, expenditure in the private 
health sector is found to outweigh that in the public health sector resulting in an over-serviced 
private health sector and under-serviced public health sector (Department of Health [DoH], n. d.; 
South African Rights Commission, 2009).  This may support the findings of the current study as 
majority of the participants with no access to HFT were mainly found to be in government 
hospitals and primary health care clinics, resulting in an under-serviced public health sector.  It 
has been reported for the unequal distribution and poor maintenance of equipment to be a major 
issue in service delivery since 1997 (DoH, 1997).  
It has been noted that participants who reported to have access to HFT were found to be 
mainly working in the public health sector.  According to challenges faced by the South African 
health system, it was expected for HFT to be more available within the private health sector but 
rather there appears to be a relatively equal distribution of HFT equipment among the private and 
public health sector for participants who have access to HFT.  This distribution of equipment in 
South Africa cannot be generalized due to the small sample size of the current study.   
 Due to the above mentioned long standing challenges and financial instability in the 
South African health systems, audiologists working within both the private and public health 
care sector are recommended to continually be proactive by motivating for the importance of 
using HFT in their clinical setting.  This is of utmost importance in light of the fact that OM is 
the most common cause of HL and frequently occurring middle ear pathology in neonates and 
infants (Zand et al., 2003; NIDCD, 2010; Marschark & Hauser, 2012).  A multidisciplinary team 
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approach is essential to attain the goal of EHDI (Garcia et al., 2009; Swanepoel, 2006).  
Collaboration in clinical practice allows for better quality of care for patients and for 
professionals to share knowledge and skills (Buttaro, Trybulski & Sandeberg-Cook, 2013).  
Therefore audiologists should encourage collaborative work with other professionals (e.g. 
paediatricians and otolaryngologists) to ensure equipment availability for accurate identification 
or diagnosis of OM in the neonatal and infant population. 
Current clinical practice of HFT in paediatric audiological assessment. 
Inclusion of HFT in a paediatric audiological assessment.  CHL is the most common 
reason for neonates and infants failing NHS, hence the inclusion of immittance screening in NHS 
is recommended (ASHA, 1997; HPCSA, 2007; Doyle et al., 1997).  
The results of the current study confirm the inclusion of tympanometry as clinical 
practice by participants.  In the current study LFT was the most often used type of tympanometry 
closely followed by HFT.  It is postulated that this is due to the simplicity in performing LFT, in 
addition to the fact that results are easier to interpret when compared to results recorded using 
HFT (Lantz et al., 2004; Baldwin, 2006).  The lack of equipment and the lack of training in 
conducting and interpreting HFT may be attributed as to why HFT is not being included in the 
participants' clinical setting.  Calibration issues and equipment limitations (especially older 
equipment) are also reported as reasons why clinicians use LFT rather than HFT (Fowler & 
Shanks, 2002).  According to Al-Khatib (2010) knowledge and training is essential in operating 
tympanometry equipment.  The above discussion highlights the need for this as it may result in 
more audiologists performing HFT as well as increase in confidence in interpreting and 
conducting HFT on neonates and infants. 
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Many participants reportedly use a combination of two or more tympanometry tests in 
their clinical practice.  LFT and HFT is found to be used in combination by the majority of the 
participants (n=45).  This practice concurs with the recommendation made by Harris et al. (2005) 
and Alaerts et al. (2007) that both the LFT and HFT should be included in clinical practice.  This 
is due to the fact that both these audiological screening tests are found to be sensitive in 
identifying middle ear pathologies in neonates and infants.  However, one needs to take into 
consideration that Harris et al. (2005) suggested the use of HFT in infants up to nine months of 
age, much older than the ages reported in the current study.  Whereas, in Alaerts et al’s. (2007) 
study an age dependent protocol (birth to nine months) is recommended in order to provide a 
guideline for the use of both HFT and LFT in clinical practice for neonates and infants.  The age 
dependent protocol corresponds to the findings of the current study.  This supports the 
participants’ use of both HFT and LFT in clinical practice and further indicating that the 
inclusion of HFT may be beneficial in the older paediatric population. 
Hence, the population age for which HFT was used by participants in the current study 
was also found to be relevant.  Participants in this study mainly used HFT for infants ranging 
from birth to nine months of age.  HFT has been found to be relevant in this age range by both 
Alaerts et al. (2007) and Hoffman et al. (2013).  However, it has been noted that otoscopic 
examination was not performed in Alaerts et al’s. (2007) study. 
  Otoscopic examination is a significant subjective technique required in the identification 
of middle ear pathologies (Palmu, 2001).  Despite its challenges when performed in the 
paediatric population, an otoscopic examination ensures no obstructions within the EAC that 
may affect tympanometric results (Bluestone & Klein, 2007).  Abnormalities of the EAC are 
common in neonates younger than four days old and this is usually as a result of vernix occlusion 
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(Doyle et al, 1997).  Hence, the findings obtained by Alaerts et al. (2007) may not be generalised 
for all neonates and infants from birth to nine months of age.  This may result in obtaining 
different tympanometric results to those with confirmed middle-ear pathologies (Baldwin, 2006).  
Therefore, it is recommended for audiologists to use these findings as a guideline. 
 Numerous authors have also reported that HFT is most accurate for the detection of 
middle ear pathologies in infants six months and younger (Keefe & Levi, 1996; Rhodes et al., 
1999; ASHA, 2004; Baldwin, 2006; JCIH, 2007; Baldwin et al., 2008; Kei & Mazlan, 2012).  In 
the current study only a small percentage of participants were found to use HFT in infants up to 
six months of age.  In addition, a minority of participants was also found to utilise HFT for 
participants up to one year of age and up to six years of age.  The use of HFT in this older 
population may result in the inaccurate identification and decreased accuracy in the diagnosis of 
middle ear pathologies (Bosaghzadeh, 2011; ASHA, 2004).  Misdiagnosis may in turn result in 
HL as well as delayed speech and language development.  However, the use of HFT in the older 
population is supported by Harris et al. (2005).  Hoffman et al. (2013) recommends that future 
research be conducted on older infants, as HFT could be suitable in the older paediatric 
population.  Hence, it remains uncertain up to which age HFT should be used (Hoffman et al., 
2013).  From the above discussion there is variability in age for which HFT is used and therefore 
it has been recommended by Baldwin et al. (2008) for HFT to be used up to the corrected age of 
six months.  
It is difficult to accurately compare and relate the age ranges for which HFT is applicable 
as not all research studies have clearly stipulated if they refer to GA, CA or chronological age.  
Furthermore, it has also been seen as a limitation of the current study for not including questions 
regarding to whether the participants refer to GA, CA or chronological age when stipulating the 
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age range for the use of HFT.  Despite this, HFT has shown to be applicable in premature 
neonates and infants.  Prematurity is a common risk factor for HL (Marlow, Hunt & Marlow, 
2000; Rosenblum, 2014) and research studies such as Garcia et al. (2009), Kilic et al. (2012), Do 
Carmo et al. (2012) and Hoffman et al. (2013) found HFT to be useful in neonates and infants 
with risk factors for HL.  However, the various risk factors present in participants were not 
always stipulated by researchers.   
The availability of departmental clinical protocols for HFT.  Clinical protocols should be 
available in the clinical setting, especially when working with neonates and infants.  Clinical 
protocols offer a level of efficiency; clinical guidance and assist the professional in evaluating 
data quickly (Clark & Benson, 2008; Ditty, 2012).   
Despite these recommendations, a small percentage of participants in the current study 
are performing HFT with no clinical protocols available in their clinical setting.  The 
development and implementation of clinical protocols are strongly tied to quality assurance, 
continuity of care, professional development and patient satisfaction (Clark & Benson, 2008).  
However, clinical protocols or clear guidelines for HFT are limited and none have been 
universally acceptable (ASHA, 2004; Alaerts et al., 2007; Kei & Mazlan, 2012).  Therefore 
clinicians are required to be cautious when interpreting HFT and advised that this should be 
interpreted in light of other audiological results (ASHA, 2004).  Participants in the current study 
cited the lack of availability of protocols and unclear normative data as reasons for clinical 
protocols not being readily available in their clinical setting.  It is postulated that the lack of clear 
guidelines for the interpretation of HFT explains why participants (both with and without clinical 
protocols) were unsure with regard to the norms and classification systems used for the 
interpretation of HFT.  
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The interpretation and classification of HFT is controversial and clinically challenging 
for professionals (Marchant et al., 1986; Sutton et al., 1996; Margolis et al., 2003; Baldwin, 
2006; Baldwin et al., 2008; Cai, 2010).  Participants in the current study used various systems to 
classify HFT results.  The systems reported by participants included mostly quantitative 
measures such as peak susceptance and peak compliance.  These quantitative measures have 
been reported by researchers to be applicable for infants below six months of age (Marchant et 
al., 1986; Sutton et al., 1996). 
Participants in the current study most often made use of the international NHSP 
Tympanometry Protocol v2.0 to classify HF tympanograms (Baldwin et al., 2008).  The 
international NHSP Tympanometry Protocol v2.0 proposes a simple classification method that 
results in either normal (positive peak) or  abnormal (flat traces or negative peaks) 
tympanograms which is indicative of a middle ear pathology being respectively, either absent or 
present (Baldwin et al., 2008).  This protocol is also based on clinical research that has illustrated 
the efficiency of a simple normal and abnormal classification of HF tympanograms for infants 
below six months of age (Baldwin et al., 2008). 
Participants were also found to use peak susceptance of ≤ 0 mmho to interpret HFT.  This 
method was devised by Marchant et al. (1986) and has been found to correlate with otoscopic 
examination of MEE and evidence of MEE at myringotomy (Marchant et al., 1986).  However, 
according to Hoffman et al. (2013) this method did not consider tympanograms at negative 
pressure.  These types of tympanograms are of importance as it indicates an abnormal middle ear 
system due to ET dysfunction (Harlor & Bower, 2009; Maico Diagnostics, 2010; GSI, 2011).  
Infants and neonates are more prone to middle ear pathologies due to the ETs being smaller and 
more horizontal than they are in adults.  This makes it difficult for fluid to drain out of the ear 
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(NICD, 2010).  Baldwin (2006) adapted Marchant’s methodology, using admittance 
measurements rather than susceptance to interpret HF tympanograms.  This adapted method 
allows fewer tympanograms to be unclassified (Baldwin, 2006).  It would therefore be the 
preferred method for audiologists to use for the interpretation of HF tympanograms.   
In addition, participants with clinical protocols used their own pass or refer criteria as 
normative data for the interpretation of HFT.  Participants elaborated the pass or refer criteria to 
be described as normal (discernible peak) and abnormal (flat trace) tympanograms, similarly to 
that stipulated in the international NHSP Tympanometry Protocol V 2.0 (Baldwin et al., 2008).  
There is no established choice of a pass or refer criteria and further research is required within 
this field to obtain data to better interpret HFT using this method (Baldwin, 2006).  Therefore 
even though pass and refer criterion have been provided by researchers, the use of this data has 
been reported to be problematic (Baldwin et al., 2008; Wilson; 2008). 
Furthermore, participants with clinical protocols reported to also determine the 
compliance of the peak of at least 0.6 mmho as proposed by Margolis et al. (2003) to classify 
tympanograms as normal and abnormal.  This protocol indicates a pass or fail criterion of 0.6 
mmho for negative tail compensated static admittance.  It has been shown to be useful for 
neonates from birth to one month of chronological age (Margolis et al., 2003).  However, this 
criterion was shown to be problematic as it presented with a very low sensitivity and resulted in 
smaller peaked HF tympanograms to be interpreted as abnormal (Margolis et al., 2003; Baldwin 
et al., 2008).  Margolis et al.(2003) has not validated their findings on a group of neonates and 
infants with reliable evidence of middle ear pathology and therefore this may produce different 
tympanometric results to those with definitive middle-ear pathologies (Baldwin, 2006).  In 
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addition, according to Swanepoel et al. (2007) the study was performed on a small sample size, 
and the effect of age range and gender was not considered (Swanepoel et al., 2007).   
In a South African study, Swanepoel et al. (2007) found significant higher static peak 
admittance for males which were attributed to the difference in middle ear and TM sizes for 
females and males.  Statistically significant differences in peak admittance values were also 
obtained for younger and older neonates highlighting a general increase in admittance with 
increasing age.  Hence, these differences indicate the consideration of gender and age when 
establishing interpretation methods for HFT (Swanepoel et al., 2007).  Despite these 
considerations, Swanepoel et al. (2007) and Margolis et al. (2003) has also shown some 
similarities in findings and therefore it would be recommended for Margolis criteria (Margolis et 
al., 2003) to be used as a guideline. 
 Not many participants in the current study made use of the Jerger and Liden system 
despite this being viewed as good clinical practice.  The Jerger and Liden system has been found 
to successfully classify LF tympanograms.  It has however not successfully been applied with the 
infant population due to a number of tympanograms being unclassified (Baldwin, 2006; Cai, 
2010).   
 According to Hoffman et al. (2013) normative data or trace classification system of 
choice remains unclear.  It may be postulated that participants make use of norms and 
classification systems which they are most familiar with and that are easy to use, despite their 
limitations.  It is also not always clearly stated in literature as to whether the norms or 
classification methods provided by researchers are based on the use of screening or diagnostic 
HFT equipment. 
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Even though participants have reported to have clinical protocols, there is currently no 
universal agreement on the interpretation of HFT data (Kei & Mazlan, 2012).  Hence, careful 
interpretation HFT results are required in combination with other audiological results (ASHA, 
2004).  This further highlights the need for the development of standardized clinical protocols 
that is age and gender dependent.  In addition, it has been reported from earlier studies that HFT 
was not fully put into clinical practice due to the difficulties in interpreting tympanograms and 
the controversial classification systems (Holte et al., 1991; Meyer & Jardine, 1997; Sutton et al., 
1996).  This was also evident in the current clinical practice in South Africa. 
Audiologists’ knowledge of the clinical application of HFT and theoretical background 
of the infant’s middle ear system.  All participants provided appropriate responses regarding the 
purpose of tympanometry.  Although various clinical applications for HFT were also provided by 
participants in the current study, most were unsure.  It is postulated that this is why only 50% of 
participants use HFT in their clinical setting despite the fact that the HPCSA (2007) and ASHA 
(1997) has recommended its use in NHS.  The most commonly reported clinical application was 
found to be obtaining reliable and accurate results of middle ear pressure and compliance of the 
infants with middle ear pathologies.  Some participants also stated more specifically that HFT is 
used to determine middle ear status or functioning in the high risk populations or infants’ birth to 
six months of age.  It was noted that not all participants indicated the age range for which HFT is 
used and this is of significance as clinicians require knowing that adult tympanometry protocols 
are not applicable to the neonatal and infant population due to anatomical and acoustical 
difference that exist (Baldwin et al., 2008).  The use of adult tympanometry protocols may result 
in inaccurate results in this population (Hunter & Margolis, 1992; Keef & Levi, 1996).  
However, due to the anatomical and acoustical difference there are some controversial 
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suggestions noted in literature with regard to the choice of probe-tone frequency in relation to 
age (Alaerts et al., 2007).  This may be the result of participants being unsure of the age range for 
which HFT is clinically applicable; hence the variability in age ranges reported by participants 
which have been discussed above. 
The discussion above highlights the significance of having knowledge with regard to the 
anatomy and physiology of the neonatal and infant middle ear system as well as the acoustical 
differences when compared to an adult middle ear system.  Most of the participants were able to 
appropriately describe the neonate or infant middle ear system.  However, many participants also 
reported they were unsure and this is of concern as knowledge of the anatomical differences 
provides probable causal factors to test outcome discrepancies in the adult and neonatal or infant 
population (Cai, 2010).  The neonate and infant EAC and middle ear are structurally immature 
and mass- rather than stiffness-dominated (Baldwin, 2006; Baldwin et al., 2008; André, Sanches 
& Caravallo, 2012).  Further anatomic differences occur with developmental changes which 
influences the tympanograms (Lantz et al., 2004; Baldwin et al., 2008). 
Participants were also able to appropriately identify the acoustical differences between a 
neonate or infant and adult middle ear system, although many were also unsure in this regard.  It 
was noted that a smaller percentage reported that there were no acoustical differences.  It has 
been described by numerous authors that acoustical differences occur as the result of 
developmental changes which are found only to disappear by six months of age (Baldwin, 2006; 
Alaerts et al., 2007; Baldwin et al., 2008; Cai, 2010).  The majority of the participants described 
the main differences between a neonate or infant and adult middle ear system as ear canal 
impedance, reflection coefficient responses and energy transmission, followed by resonance gain 
and resonance frequency.  These acoustical differences have been reported by both earlier and 
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recent authors (Keefe & Bulen, 1993; Alaerts et al., 2007).  Not many participants referred to the 
frequency range for which energy transmission is most efficient as one of the acoustical 
differences between a neonate or infant and adult middle ear system.  It has been reported that in 
neonates and infants between 1000 Hz to 4000 Hz energy transmission is best whilst between 
220 Hz and 660 Hz is seen as the worst (Keefe & Bulen, 1993). 
Most of the participants also reported that maturational changes that occur in the neonate 
or infant middle ear system do have an effect on the acoustical properties of the infant’s ears.  
This is confirmed by numerous authors (Holte et al, 1991; Baldwin, 2006; Alaerts et al., 2007; 
Baldwin et al., 2008; Cai, 2010).  It has also been reported for both mechanical and acoustical 
properties of the neonate or infants’ middle ear system to be affected during the course of 
postnatal development (Cai, 2010).  This is a result of the middle ear structures being important 
components of the conductive mechanism which undergo significant changes during postnatal 
development in the first four months of life (Holte et al, 1991; Hall, 2000; Cai, 2010).  
 A small percentage of participants reported that maturational changes that do occur to 
the infant’s middle ear system, do not have an effect on the acoustical properties of the infant’s 
ear.  It is important for audiologists to have knowledge about maturational changes as this will 
assist the clinician in understanding the development of hearing sensitivity and adds more 
significant interpretation of audiologic measures in neonates and infants, including UNHS 
outcomes (Cai, 2010).  The use of HFT (1000Hz probe tone) is more applicable for the use of 
neonate and infants due to their great mass contribution, lower middle ear compliance and higher 
resistance (Purdy & Williams, 2000; Alaerts et al., 2007).  LFT is only successfully used to 
evaluate middle ear functioning in infants over six months old due to the acoustical and 
anatomical differences (Baldwin, 2006; Baldwin et al, 2008).  
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It is essential for audiologists working in the field of paediatric audiology to have 
appropriate knowledge and necessary skills in the identification of middle ear pathologies in 
neonates and infants (Lewis, 2000, p. 173).  The above discussion indicates the need for more 
clinical and in-service training of hearing health professionals on the importance, performance 
and interpretation of HFT.  The limited availability of clinical protocols for HFT in South Africa 
confirms that audiologists are performing HFT despite being unsure of current best-practice 
guidelines.  This highlights the need for the development of universal evidence-based guidelines 
for the use of HFT in neonates and infants.  
Main Study Phase 2: Hearing Screening 
Main aim 2 and 3: Agreement between the pass and refer rates of screening tests. 
HFT and LFT.  A poor agreement was obtained between HFT and LFT.  This may be 
attributed to HFT being highly sensitive in the identification of OM in neonates and infants.  
LFT is also unable to detect subtle changes in the middle ear system if compared to HFT (Harris 
et al., 2005; Cai, 2010).  Therefore, normal LF tympanograms may be recorded in neonates and 
infants even in the presence of MEE (Hunter & Margolis, 1992; Keef & Levi, 1996).  This may 
be evident in the current study as LFT presented with a high pass rate bilaterally in both sample 
sizes when compared to HFT.  
However, this is also found to be in contrast to two studies (Do Carmo et al., 2012; 
Alaerts et al., 2007).  In Do Carmo et al. (2012) study LFT was found to present with a lower 
percentage (57.55%) and HFT obtained a higher percentage (72.64%) of normal type A 
tympanograms in neonates and infants less than seven months of age.  In Alaerts et al’s. (2007) 
study LFT was also found to present with a low pass rate (35%) and HFT obtained a higher pass 
rate (91%) in neonates younger than three months of age.  Furthermore, in infants between three 
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and nine months of age LFT presented with a lower pass rate (57%) compared to HFT (70%) 
(Alaerts et al., 2007).  The population in both these studies also presented with risk factors for 
HL as that of the current study. 
 Literature has reported that LFT has a high rate of false negative and false positive 
results when performed on neonates or infants under seven months of age (Meyer et al., 1997; 
Purdy & Williams, 2002; Macedo de Resende et al., 2012; Hoffman et al., 2013).  LF 
tympanogram shapes obtained in neonates and infants are different than those seen in older 
paediatric population and adults (Keefe & Levi, 1996; Meyer et al., 1997).  This may be 
attributed to the anatomical and acoustical difference which exists between the infant and adult 
middle ear transmission system (Keefe & Levi, 1996; Petrak, 2002).  Therefore, LFT has been 
accepted as the criterion standard to differentiate a CHL from a sensori-neural hearing loss in 
adults and the older paediatric population.  LFT is also known to have a low sensitivity when 
used in neonates and infants younger than six months of age (Baldwin, 2006; Alaerts et al., 2007; 
Baldwin et al., 2008). 
Although, according to Do Carmo et al (2012) HFT can also present with false negative 
and false positive results, although not as high as for LFT.  This could be due to the increased 
complexity of the tympanograms as well as the increased occurrence of double peaked 
tympanograms in neonates and infants.  As a result highlighting the need for better interpretation 
of HF tympanograms (Hoffman et al., 2013; Do Carmo et al., 2012).  This has also been a 
prominent factor implicated by participants in main study phase one, further indicating the 
significant need for the development of standardised clinical protocols. 
In contrast to the poor agreement obtained in the current study, Harris et al’s (2005) study 
found a strong agreement between LFT and HFT in identifying the presence and absence of 
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middle ear pathologies.  This may be as a result of the age of the population used in Harris et 
al’s. (2005) study, as LFT is found to be valid in the older paediatric populations (Alaerts et al., 
2007).  Harris et al. (2005) revealed that even though the use of LFT was found to be a 
successful predictor of the presence or absence of fluid in the middle ear (with a sensitivity of 
80% and a specificity of 100%), the LF probe tone still identified three out of 10 cases as normal 
while they were identified as abnormal by HFT results.  In addition, it was found that the HF 
probe tones (667 Hz and 1000 Hz) presented with more consistent findings when compared to 
that of a LF probe tone (226 Hz).  MFT tympanograms can show persistence of changes in the 
mass and stiffness balance of the middle ear which is not established by LFT (Harris et al., 
2005).  This indicates that LFT may also result in false negative and false positive results in the 
older paediatric population and not only in neonates and infants younger than six months of age.   
It is also important to note that the method used to interpret tympanograms may also be a 
contributory factor for results of the current study to be in contrast to Harris et al’s (2005) study. 
As the number of tympanograms classified as normal and abnormal may differ between the 
studies.  The Jerger and Liden classification method was used by Harris et al. (2005) and the 
current study to interpret LF tympanograms.  This method of interpretation has been effective in 
classifying the results by pattern in the older paediatric population and adults (Liden 1969; Jerger 
1970; Baldwin et al., 2008).  The LF tympanograms are typically single-peaked and easier to 
interpret (Baldwin et al., 2008).   
The method of interpretation used for HF tympanograms in the current study is different 
to that used by Harris et al. (2005).  The current study used the GSI equipment manual (GSI, 
2011) to interpret HF tympanograms according to graphic representation and percentile areas 
based on the Margolis et al’s. (2003) study, whereas Harris et al. (2005) made use of the 
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Vanhuyse model.  The Vanhuyse model has shown to be effective in classifying HF 
tympanograms but it has been reported by Alaerts et al. (2007) to be more complex and less 
applicable to a clinical hearing assessment.  Hence, the recommendation of a simple visual 
admittance classification method for the interpretation of HF tympanograms (Alaerts et al., 
2007).  This simple visual admittance classification method was found to have a high prevalence 
(91%) of single peaked HF tympanograms (infants younger than three months of age) in Alaerts 
et al’s. (2007) study.  These results were found to correspond with Kei et al’s. (2003) and 
Margolis et al’s. (2003) findings which revealed a prevalence of 92% and 91% single -peaked 
HF tympanograms respectively.  These findings further indicated the efficiency of a simple 
visual admittance classification method for the interpretation of HF tympanograms, which was 
the method of choice used in the current study. 
However, in Baldwin’s (2006) study the number of single peaked tympanograms was 
shown to decrease with age.  Limitations of these studies are that they have not validated their 
findings on neonates and infants with reliable evidence of confirmed middle ear pathologies 
(Baldwin, 2006).  This was also a limitation of the current study, as the presence or absence of 
middle ear pathologies were not confirmed by an otolaryngologist and thus only the pass and 
refer rates of the various screening tests could be described.  A combination of otolaryngological 
examination and tympanometry evaluation is sensitive to and important in the identification of 
OM especially in the neonatal and infant population (Garcia et al., 2009; Kilic et al., 2012). 
In addition, Hoffman et al. (2013) states that the visual admittance classification methods 
are dependent on the examiners experience as well as the subjective judgment of a distinct peak. 
Therefore, this may also be a causative factor to the poor agreement obtained between the HFT 
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and LFT.  However, the interpretation method used in the current study showed to be effective in 
classifying HF tympanograms accurately as a good inter rater reliability was obtained. 
HFT and otoscopy.  A fair to good agreement was obtained between HFT and otoscopy 
in the current study.  This has been shown by numerous studies (Garcia et al., 2009; Kilic et al., 
2012).  In these studies, the age range of participants varied, yet HFT has shown to have the best 
correlation with otoscopic results.  The participants in these studies also presented with similar 
risk factors for HL as participants in the current study.  The age of participants in these studies 
ranged from birth to four months of age (Garcia et al., 2009) and two hours to nine days of age 
(Kilic et al., 2012).  This confirms the validity of using HFT with neonates and infants birth to 
six months of age.  It further highlights the importance of conducting both HFT and otoscopy to 
confirm the presence or absence of middle ear pathology.   
In the current study, a standard otoscope was used to perform the otologic examination as 
part of the hearing screening protocol.  However, studies have found it to have the least 
sensitivity and specificity when compared to other otologic instruments, such as pneumatic 
otoscope, otomicroscope and video-otoscope (Wilson, 2008).  
Pneumatic otoscopy has found to be more accurate in the detection of MEE (Alper et al., 
2004; Harris et al., 2005; Al-Khatib, 2010; Finitzo et al, 1992; Vaughn-Jones & Mills, 1992).  
Pneumatic otoscopy is mainly used by otolaryngologists in the diagnosis of OM, despite that it 
does not always improve diagnostic accuracy of middle ear pathologies in the paediatric 
population (Alper et al., 2004; Al-Khatib, 2010).  Nevertheless, otoscopic examination with the 
use of a standard otoscope is the routine method used by audiologists and in general practice 
(Palmu, 2001).   
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The lack of a confirmed diagnosis of middle ear pathology by an otolaryngologist when 
there was a distinct possibility based on otoscopy and HFT results comprised the validity of the 
screening tests in the current study in identifying middle ear pathologies.   
LFT and otoscopy.  A poor agreement was found in the current study between pass and 
refer rates for LFT and otoscopy.  The poor agreement between these screening tests was also 
found in other studies (Garcia et al., 2009; Kilic et al., 2012). In these studies LFT was 
performed on a population age where it is reported to be invalid due to its poor sensitivity 
(Baldwin, 2006; Baldwin et al., 2008; Wilson, 2008). 
Overall when determining the agreement for HFT and LFT with otoscopy, it must be 
taken in consideration that an otoscopic examination is a subjective technique.  An otoscopic 
examination is prone to observer bias and subjective to variability in technique (Palmu, 2001).  
This may be a contributory factor for not obtaining better agreements for HFT and LFT with 
otoscopy.  Otoscopic examination results should be compared to tympanometry results (Palmu, 
2001) as in the current study.  Hence, validation of otoscopic skills is highly recommended for 
professionals working with the paediatric population.  This however requires considerable time 
and resources (Palmu, 2001). 
Furthermore, in the current study otoscopic examinations was performed by the 
researcher and the research assistants, who were all audiologists.  However, inter-tester 
reliability was not established in order to determine the agreement in measurements taken by two 
different individuals.  This would have increased the reliability of results obtained and this has 
been acknowledged as a limitation of the study.  
HFT and DPOAEs.  HFT was found to present with a poor agreement with DPOAEs in 
the four hearing screening sample size as DPOAEs obtained significantly low pass and refer 
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rates.  This is contrary to findings of other studies (Koivunen et al., 2000; Swanepoel et al., 2006; 
Garcia et al., 2009; Camboim et al., 2012 & Kilic et al., 2012).  In these studies HFT presented 
with significant agreement with OAEs.  In Swanepoel et al’s. (2006) study NHS was performed 
on neonates and infants from birth to 12 months of age and normal HF tympanograms were 
obtained in 87% (pass result) of the sample ears whilst DPOAEs presented with a high pass rate 
of 93%.  HFT is reported to correlate with OAEs in both normal ears as well as ears with middle 
ear pathologies (Camboim et al., 2012).  Therefore, HFT and DPOAEs was expected to present 
with relatively similar pass and refer rates and thus agreement in the current study. 
Despite that HFT has been reported by numerous studies to be highly sensitive in the 
identification of middle ear pathologies, it has been found that HFT can present with decreased 
sensitivity and this can be attributed to the presence of MEE in a number of ears with present but 
decreased OAEs (Sutton et al., 1996; Kei et al., 2003; Swanepoel et al., 2007).  This leads to an 
overlap of true positive HFT results and false negative OAE results, resulting in decreased 
immittance sensitivity.   
LFT and DPOAEs.  In the current study LFT and DPOAEs were found to have a poor 
agreement in the four hearing screening sample size as DPOAEs obtained significantly low pass 
and refer rates.  This was also evident in a study conducted by Kilic et al. (2012).  These results 
can be attributed to research confirming that LFT is invalid within the participant age range of 
the current study.   
In addition, Do Carmo et al’s. (2012) study found LFT to present with a predominance of 
normal results, regardless of the outcome of the OAE results.  This indicated decreased 
sensitivity of LFT in the identification of middle ear pathologies in neonates and infants with risk 
factors for HL (Do Carmo et al., 2012).  The current study may support these findings as a high 
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pass rates (normal results) were obtained by LFT bilaterally compared to other screening tests.  
However, LFT has found to present with results which are more consistent with OAEs in the 
presence of a normal middle ear functioning (Camboim et al., 2012).  This does not appear to be 
evident in the current study as significant low pass rates were obtained for DPOAEs bilaterally. 
  Furthermore, there may be several other reasons as to why a poor agreement was 
obtained between HFT and DPOAEs, and LFT and DPOAEs which are explored below. 
However, it should be noted that when comparing the current study to research findings , 
majority of studies made use of TEOAEs in their test battery (Koivunen et al., 2000;  Garcia et 
al., 2009; Camboim et al., 2012; Kilic et al., 2012) whilst in the current study DPOAEs were 
utilised.  In clinical practice, TEOAEs have been used mainly for NHS and has shown 
correlation with behavioral audiometric thresholds (Campbell, 2012).  TEOAEs are also more 
tolerant to noise and movement than DPOAEs (Cunningham, 2011).  
Furthermore, the level of noise in the recording is a significant variable in the validity of 
OAE screening results.  Therefore valid and reliable OAE results are dependent on the screening 
environment being very quiet and vibration free as possible (AAA, 2011).  Thus this poor 
agreement may be attributed to the challenges experienced at various screening sites when using 
DPOAEs. 
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Table 5.1 
Challenges Experienced at Various Testing Sites 
Site Description Noise 
Rahima Moosa 
Mother and Child 
Hospital 
Participants were 
screened in four 
different settings.  
 Participants from 
the medical and 
caesar wards 
were screened in 
the nurses’ duty 
rooms and 
emergency 
rooms. 
 Participants from 
the KMC wards 
were screened in 
any KMC room 
that was 
unoccupied. 
 Speech Therapy 
Department 
 Audiology 
Department  
Medical wards:  
 The room door could not be closed fully. 
 Nurses and doctors would enter the room on a 
regular basis to obtain medication and hospital 
records. 
 Noise of the refrigerator where medicines were 
stored for patients. 
 Doctors ward rounds. 
 Nurses meetings. 
 Baby monitors going on and off on a regular basis. 
 Other neonates and infants crying excessively in 
the ward. 
KMC wards: The ward was located next to the 
NICU, where continuous noise of the baby monitors 
affected the testing. 
Speech Therapy Department: Noise from the 
children in the waiting area as well as therapist 
giving therapy in their rooms could be heard. Testing 
at times took place in the department due to the 
audiology department being occupied. 
Audiology Department: Noise of the generators and 
outside environmental noise of the cars affected the 
testing. 
 
Door of Hope of 
Children’s 
Mission 
Testing was 
conducted in an 
isolation room, 
which was 
unoccupied at the 
time for testing. 
The isolation room was located next to the dining 
room where meetings were held in the mornings and 
near the lounge area where neonates and infants were 
being fed by the volunteers.  
The crying of the neonates and infants as well as the 
meetings held increased the noise levels which made 
it difficult to perform DPOAEs. 
Mother Teresa A separate room for 
hearing screening 
was not available.  
Testing was 
conducted in a room 
where space was 
available to set up 
the equipment.  
The day of testing volunteers arrived from various 
organizations to spend time and assist the 
housemothers with the neonates and infants. This 
caused a disturbance as volunteers would walk into 
the rooms whilst testing to fetch the neonates and 
infants.   
Volunteers singing with the neonates and infants in 
the opposite room could also be heard. 
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Other common factors that may affect DPOAE screening are physiologic factors such as 
the sucking, movement, crying and the breathing noise of neonates and infants (AAA, 2011).  
All of which could lead to an increased number of false positive results (Palmu, 2001).  In the 
current study, otoscopy and HFT were performed first and therefore by the time it came to 
performing DPOAEs neonates and infants would usually be awake or restless.  All these 
challenges resulted in longer screening times.  Despite this, the researcher tried to always obtain 
results from neonates and infants that were asleep or quiet.   
The appropriate selection and placement of the probe tip to obtain an optimal acoustic 
seal can to some extent negate the influence of background noise (AAA, 2011).  An optimal 
probe seal was ensured for every neonate and infant screened, however controlling background 
and other physiologic noise such as breathing and sucking noise was not always within the 
researcher’s control.  
These factors all contributed to the challenges experienced with performing DPOAEs in 
the current study.  It has been confirmed that OAEs are difficult to obtain in settings with high 
ambient noise levels (Olusanya et al., 2008a; Olusanya et al., 2008b).  This may result in 
difficulty completing OAE screening on neonates and infants in the LF range less than 1000 Hz 
(AAA, 2011; Gorga et al, 2000). Reliable results have shown to be obtained at 2000, 3000 and 
4000 Hz (Gorga et al, 2000).  For the current study, the default DPOAE protocol was used (GN 
Otometrics, 2014).  
The clinical implications of the DPOAE screener malfunctioning during data collection 
needs to be considered.  Equipment malfunction is one of the risks in NHS programmes as this 
result in invalid screening results (AAA, 2011).  It is the responsibility of the audiologist to 
evaluate risk factors associated with the screening programmes and to develop procedures to 
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minimize or eliminate those factors (AAA, 2011).  The researcher noted that the DPOAE was 
unable to calibrate the probe fit and provide reliable results.  Hence, the use of the DPOAE 
screener was discontinued resulting in two sample sizes in the current study (Table 4.4).  The 
equipment was sent in for repairs and no other DPOAE screener was readily available during the 
period of data collection.  It is important for audiologists to undergo proper training in using the 
equipment, identifying factors that may impact on validity of the results, maintenance of 
equipment and repeating screening results to ensure reliability. 
Despite these challenges OAEs are also very sensitive to the conductive components of 
hearing (Kemp, 2002).  DPOAEs can be affected by outer or middle ear dysfunction as no results 
will be recorded if the neonate or infant presents with ear canal debris, MEE, and other 
pathologies such as otosclerosis or ossicular discontinuity (JCIH, 2007; Kemp, 2002).  However, 
it has been reported that OAEs may not be affected by mild middle ear dysfunction (Picanco et 
al., 2012).  Hence, OAEs is also not an adequate way to determine middle ear dysfunction and 
this may be due to numerous reasons such as poor probe fit, unfavorable testing conditions, as 
well as SNHL (Baldwin, 2006). 
AABR is therefore recommended for NHS as it can be recorded in the first few hours of 
life, when OAEs cannot be obtained (Kemp, 2002).  AABR is much more robust with less failure 
as result of mild middle ear pathologies.  However, when infants present with severe OM, a refer 
result may be obtained (Taylor & Brooks, 2000; Hall, Smith & Popelka, 2004).  AABR could not 
be utilised for the purpose of this study as equipment was not available to the researcher for the 
period required.  Nevertheless, DPOAEs still presented to be a very useful screening test.  The 
dependence on a “normal or close to normal functioning middle ear system” makes OAEs a 
functional measure for comparison to tympanometry results (Swanepoel et al., 2007, p.54).  This 
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provides sensitivity and specificity estimates for HFT when air and BC ABR measurements are 
unavailable (Swanepoel et al., 2007). 
Overall it must be taken in consideration that the poor agreements obtained among the 
screening tests can also be attributed to the common fact that neonates and infants are a difficult 
to test population.  As well as any obstruction in the EAC (e.g. vernix caseosa, debris and 
cerumen) that may block the probe tip, thickened TM or crust on the TM as a sequelae of an OM 
episode may produce confounding tympanometric results (Palmu, 2001, Baldwin, 2006).  This 
further highlights the importance of performing an otoscopic examination prior to tympanometry 
screening (Kent, 2004; Bluestone & Klein, 2007; Kooper, 2008).  
MEE is a commonly identified among neonates and infants (Engel, Mahler, Anteunis, 
Marres & Zielhuis, 2001; Boone et al., 2005).  A recent study has pointed out that OME may 
contribute up to 67% of the false positive newborn hearing screens (Boone et al., 2005).  HFT 
has therefore been the frequency of choice due to its high sensitivity in correctly identifying 
middle ear components in early infancy (Baldwin, 2006).  Hoffman et al. (2013) has reported the 
uncertainty up to which age HFT is used as well as the interpretation method of choice (Hoffman 
et al., 2013).  The variability and uncertainty of this has been made evident by participants’ 
responses in the survey questionnaires.  Hoffman et al. (2013) has also reported for HFT to be 
superior to LFT in neonates and infants.  This has also been shown to be evident in the current 
study as HFT was found to present with overall better Kappa values than LFT when compared to 
other audiological screening tests.  
Comparing results of pass and refer rates and agreements among various screening tests 
for this current study with previous research studies is challenging as there are no findings that 
have evaluated these elements on HFT using the same test parameters, interpretation methods, 
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sample size, age range and participant population.  Nevertheless, the above discussion has 
highlighted the following: 
 LFT may also produce inaccurate results in the older paediatric population. 
 Further research on the use of HFT in the older paediatric population is required. 
 Need for standardized clinical protocols or guidelines for the interpretation of HFT. 
 Importance of performing otoscopy prior to tympanometry and DPOAEs. 
 Importance of suitable test environment to obtain reliable and accurate results. 
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Chapter Six 
Conclusion 
This chapter provides a summary of the results obtained for the current study, followed 
by a critical review and implications of the study and ends with recommendations for future 
research. 
Overview of Results 
Main study phase 1: Survey questionnaire. 
Main aim 1: Use of HFT in current clinical practice.  
Availability of tympanometry equipment in paediatric audiology departments or 
practices.  Majority of the participants reported to have access to a tympanometer in their 
practice or department.  However, of these participants only 50% had access to HFT.  
Current clinical practice of HFT in paediatric audiological assessment. 
Inclusion of HFT in paediatric audiological assessments.  The majority of participants 
who have access to tympanometry reportedly included tympanometry in their basic paediatric 
test battery.  Many participants used a combination of LFT and HFT.  The majority of the 
participants using HFT reported to always include HFT in their paediatric test battery.  
Participants who reported to never include HFT in their paediatric test battery said this was 
mainly due to a lack of equipment.  HFT was also found to mainly be used for infants ranging 
from birth to nine months of age. 
The availability of departmental clinical protocols for HFT.  Most of the participants 
using HFT reported to have clinical protocols.  The majority of these participants reported to be 
using the international NHSP tympanometry protocol v2.0 (Baldwin et al., 2008) or self-
developed protocols.  Many participants were also found to be unsure as to which norms and 
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classification systems are used for the interpretation of HFT.  The majority of the participants 
were also ‘unsure’ as to why no clinical protocols were available in their clinical setting as well 
as to which norms and classification systems are used for the interpretation of HFT. 
Audiologists’ knowledge of the clinical application of HFT and theoretical background of 
the infant’s middle ear system.  Most of the participants were able to appropriately indicate what 
the purpose of tympanometry is.  The most commonly reported clinical application of HFT was 
stipulated to obtain reliable and accurate results of middle ear pressure and compliance of the 
infants with middle ear pathologies.  The majority of the participants appropriately described the 
infant’s middle ear system and acoustical differences.  However, many participants were also 
unsure.  Most of the participants also reported that maturational changes do have an effect on the 
acoustical properties of the infant’s middle ear.  
Main study phase 2: Hearing screening. 
Main aim 2: Pass and refer rates of screening tests.  The highest pass rates were 
obtained by LFT bilaterally when compared to the other screening tests in both the four and three 
hearing screening sample size.  In the four hearing screening sample size the pass rates for HFT 
was significantly lower than LFT.  However, the pass and refer rates of HFT and otoscopy are 
relatively similar.  The lowest pass rates were obtained for DPOAEs and were significantly 
lower when compared to HFT and LFT.  In the three hearing screening sample size lower pass 
rates were obtained for both the HFT and otoscopy.  However, the pass and refer rates for HFT 
and otoscopy was not as similar to the four hearing screening sample size. 
Main aim 3: Agreement of the pass and refer rates between HFT and other screening tests. 
 A fair to good agreement was obtained between HFT and otoscopy. 
 A poor agreement was obtained between HFT and LFT. 
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 A poor agreement was obtained between HFT and DPOAEs. 
 A poor agreement was obtained between LFT and otoscopy. 
 A poor agreement was obtained between LFT and DPOAEs. 
Overall HFT and DPOAEs, and HFT and otoscopy were found to present with better 
Kappa results when compared to LFT and DPOAEs, and LFT and otoscopy. 
Critical Evaluation of the Study 
Strengths of the study. 
 The validity of the survey questionnaire was established prior to data collection was 
found to have good face- and content validity.  
 The use of the Survey Monkey website allowed for survey questionnaires to be 
distributed to large number of participants at a time.  It also facilitated easy access to 
data. 
 Good response rate was obtained from the survey questionnaires. 
 Large sample size was obtained which was representative of the population age for 
which HFT should be used.  
 Calibration of equipment was confirmed prior to testing. 
 This was the first study that specifically focused on the use of HFT in South Africa. 
Limitations of the study. 
 Missing data was noted on survey questionnaires that were hand distributed.  This 
resulted in incomplete questionnaires and decreased sample size as these 
questionnaires were excluded from the main study.   
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 Although a pilot study was done for the survey questionnaires, there is still a 
possibility to misinterpret questions.  Participants were provided with the 
researcher’s contact details on the cover letter for any queries.  
 The following questions were not included in the survey questionnaire and this 
would have allowed for a more detailed analysis of the results: 
- Is the age of the participants for which HFT is used, GA, CA or chronological 
age? 
- Is the tympanometer (LFT and HFT) available in their clinical setting a screening 
or diagnostic tympanometer? 
 Sensitivity and specificity of the hearing screening tests could not be established as a 
confirmed diagnosis of the presence or absence of middle ear pathologies were not 
made by an otolaryngologist.  
 The OAE screener malfunctioned during the data collection period resulting in a 
decreased sample size of participants with DPOAE results. 
 High noise levels were experienced at various sites which affected DPOAE 
screening.  This is a significant variable in obtaining valid and reliable DPOAE 
results.  However, DPOAE screening was repeated and every attempt was made to 
perform the screening in favorable conditions; to ensure reliable and valid results are 
obtained. 
 A sound level meter was not used to determine the level of noise in the screening 
environment.  This would have allowed the researcher to monitor the level of noise 
during DPOAE screening. 
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 Inter-tester reliability was not done for otoscopic examination; therefore the 
agreement in measurements taken by two different individuals could not be 
determined.  This would have increased the reliability of results obtained. 
 Duration of performing HFT was not recorded in order determine the approximate 
time required as well as the effects of timing on reliability and validity. 
 NHS also involves the use of an AABR (JCIH, 2007; HPCSA, 2007).  This screening 
test could not be included in the study as equipment was not available.  The inclusion 
of the AABR would have added an additional dimension as it can assist in 
distinguishing between possible SNHL and CHL. 
Implications of the Study 
 Undergraduate curricula should include more in-depth training on the importance and use of 
HFT as this will increase audiologists’ confidence level in performing HFT. 
 Continuing professional development activities should be offered on use of HFT in order to 
increase audiologists’ knowledge in this field and improve their current clinical practice. 
 Clinical protocols for audiological screening and assessments of neonates and infants should 
include HFT.  These protocols should include information on the interpretation of HFT.  
 Suppliers of audiological equipment should ensure that appropriate training is given to 
audiologists on the HFT equipment (screening or diagnostic) supplied as well as on the 
interpretation of normative data specific to the equipment.   
 It is essential that audiologists (both in the private and public health care sector) have access 
to audiological equipment that is relevant for use in the paediatric population.  Equipment 
should be well-maintained and timeously repaired.  Funding must be made available in the 
public health care sector for the procurement and maintenance of equipment. 
USE OF HFT IN SOUTH AFRICA 121 
 
 
Recommendations for Future Research 
Preliminary answers and many more questions were raised by this study that can be 
answered by conducting research in the following areas:  
 To obtain clear and specific normative data for HFT that is age dependent within the 
age range of birth to six months. 
 To investigate the follow up results of neonates and infants failing NHS measures 
including HFT. 
 To determine the sensitivity and specificity of HFT on premature neonates and infants 
who refer NHS. 
 The development, implementation and effectiveness of national, evidence-based 
guidelines for HFT. 
 To determine the use of HFT in current clinical practice by ENTs. 
 To determine the reliability and validity of a standard otoscope vs. a pneumatic 
otoscope in the diagnosis of middle ear pathologies in neonates and infants.  
 To investigate the various middle ear acoustics of premature babies in comparison to 
full term neonates and infants and its effects on NHS measures. 
Overall, this study concludes that there is room to improve South African audiologists’ 
knowledge and theoretical background within this area, as well as the significance of performing 
HFT for the correct paediatric population age. 
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‘I have walked that long road to freedom.  
I have tried not to falter; I have made missteps along the way. But I have 
discovered the secret that after climbing a great hill, one only finds that 
there are many more hills to climb. I have taken a moment here to rest, to 
steal a view of the glorious vista that surrounds me, to look back on the 
distance I have come. But I can only rest for a moment, for with freedom 
come responsibilities and I dare not linger, for my long walk is not ended.’ 
*~ Nelson Mandela ~* 
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Appendix A: Informed consent for survey questionnaire 
 
SPEECH PATHOLOGY AND AUDIOLOGY 
 School of Human & Community Development 
Faculty of Humanities 
University of the Witwatersrand 
Private Bag 3, WITS, 2050 
Tel: (011) 717 4577 Fax: (011) 717 4572 
  
 
 
Title of Study: The use and clinical utility of high frequency tympanometry (HFT) in South 
Africa. 
Dear Audiologist, 
My name is Heena Chania. I am an Audiology Masters student from the University of the 
Witwatersrand. As part of the requirements for my studies I am required to complete a research 
dissertation. The aim of this study is to determine the availability and use of HFT in South 
Africa.      
Hearing is a critical element in the development of speech, language and cognition in young 
children. Otitis media (OM) is one of the most common causes of hearing loss in young infants. 
The correct diagnosis of OM is critical in managing this frequently occurring childhood disorder. 
One of the most important acoustic immittance measures used to reliably and accurately 
diagnose OM in young infants is high frequency tympanometry (HFT). The purpose of this study 
is to determine the availability and use HFT by South African audiologists. I therefore wish to 
further investigate (i) the availability of HFT equipment and clinical protocols in clinical 
practice; (ii) opinions regarding current clinical skills in classification and interpretation of HFT, 
and (iii) the awareness of the importance of making use of HFT within the paediatric population.  
I hereby invite you to participate in this pilot /main study in order to assist the researcher in 
enhancing the validity of this research study. A quantitative, descriptive, cross-sectional survey 
design will be employed for the purposes of the study. This study requires approximately 300 
audiologists or speech therapist and audiologists to participate, in order to make accurate 
generalisation and to obtain a precise representation of the population. The study requires you to 
complete a survey questionnaire and to return the questionnaire via email. Your participation will 
require a maximum of 20 minutes to complete the questionnaire. The survey questionnaire has 
been developed by the researcher and it consists of open and closed ended questions. The 
questions in the survey questionnaire are related to the availability and use of HFT in your 
clinical setting. This questionnaire has also been evaluated for its reliability and has been 
validated by qualified audiologists.  
There are no known risks associated with your participation in this research. The information 
obtained from this study will be of relevance to audiologist working with the paediatric 
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population. The findings will provide evidence of clinical practice in South Africa that can be 
used to inform student training, the development of national guidelines and motivation for 
appropriate equipment across all health care sectors. This will lead to better assessment and 
management of young infants with OM and reduce the occurrence of hearing loss. Results of this 
study will be accessible to all professionals. 
Your participation in this research study is voluntary. A refusal to participate will involve no 
consequence or loss of benefits to which you are entitled. You may withdraw from the study at 
any stage should you wish, without any negative consequences. No persons will be identifiable 
as only participant numbers will be used for the research report. Every effort will be made to 
guarantee confidentiality and all personal information will only be reviewed by the research team 
(researcher and academic supervisor). Personal information will be safely stored and no other 
parties will have access to this. This information will be destroyed after a period of five years.  
Pleases complete the tear off slip at the bottom to provide written consent to participate in this 
pilot study. Should you require further information or if you would like feedback on the results, 
please feel free to contact me on 083 651 995 or email: hchania@gmail.com or my research 
supervisor Dr. Karin Joubert on 011 717 4561 or email: karin.joubert@wits.co.za or my research 
co-supervisor on 011 717 4581 or email: dhanashree.pillay@wits.co.za. Alternatively, you may 
contact the administrator of the Medical Ethics Committee at the University of the 
Witwatersrand, Anisa Keshav on 011 717 1234 or e-mail: Anisa.Keshav@wits.ac.za or the 
chairperson, Prof. Cleaton-Jones on 011 717 2301 for additional enquiries. 
Your participation will be highly appreciated. 
Thank you for your time, 
Kind Regards 
Heena Chania 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  
Informed Consent         
 ‘The use and clinical utility of high frequency tympanometry in South Africa’  
I, ____________________________________________ (name of participant), the undersigned, 
agree to participate in this pilot study.  I have been informed of the aims and benefits of the study 
as well as my rights as a participant.  
___________________________________  Date: _____________________ 
             (Participant signature)  
 __________________________________  Date: _____________________ 
(Researcher signature) 
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Appendix B: Cover letter for survey questionnaire   
SPEECH PATHOLOGY AND AUDIOLOGY 
 School of Human & Community Development 
Faculty of Humanities 
University of the Witwatersrand 
Private Bag 3, WITS, 2050 
Tel: (011) 717 4577 Fax: (011) 717 4572 
 
 
Title of Study: The use and clinical utility of high frequency tympanometry (HFT) in South 
Africa. 
Dear Audiologist, 
Good day, my name is Heena Chania.  I am an Audiology Masters student from the University of 
the Witwatersrand. As part of the requirements for my studies I am required to complete a 
research dissertation.  The aim of this study is to determine the availability and use of high 
frequency tympanometry in South Africa. 
Hearing is a critical element in the development of speech, language and cognition in young 
children. Otitis media (OM) is one of the most common causes of hearing loss in young infants. 
The correct diagnosis of OM is critical in managing this frequently occurring childhood disorder. 
One of the most important acoustic immittance measures used to reliably and accurately 
diagnose OM in young infants is high frequency tympanometry (HFT). The purpose of this study 
is to determine the availability and use HFT by South African audiologists. 
I therefore wish to further investigate (i) the availability of HFT equipment and clinical protocols 
in clinical practice; (ii) opinions regarding current clinical skills in classification and 
interpretation of HFT, and (iii) the awareness of the importance of making use of HFT within the 
paediatric population.    
I hereby invite you to participate in this study in order to assist the researcher in enhancing the 
validity of this research study. A quantitative, descriptive, cross-sectional survey design will be 
employed for the purposes of the study. This study requires approximately 300 audiologists or 
speech therapists and audiologists to participate, in order to make accurate generalisation and to 
obtain a precise representation of the population. The study requires you to complete a survey 
questionnaire and to return it via email/post. The return of the completed survey questionnaire 
will imply that consent has been granted to participate in this study. Your participation will 
require a maximum of 25 minutes to complete the questionnaire. The survey questionnaire has 
been developed by the researcher and consists of open and closed ended questions. The questions 
in the survey questionnaire are related to the availability and use of HFT in your clinical setting. 
This questionnaire has also been evaluated for its reliability and has been validated by qualified 
audiologists.  
There are no known risks associated with your participation in this research. The information 
obtained from this study will be of relevance to audiologists working with the paediatric 
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population. The findings will provide evidence of clinical practice in South Africa that can be 
used to inform student training, the development of national guidelines and motivation for 
appropriate equipment across all health care sectors. This will lead to better assessment and 
management of young infants with OM and reduce the occurrence of hearing loss. Results of this 
study will be accessible to all professionals. 
Your participation in this research study is voluntary. A refusal to participate will involve no 
consequence or loss of benefits to which you are entitled. You may withdraw from the study at 
any stage should you wish, without any negative consequences.No persons will be identifiable as 
only participant numbers will be used for the research report. Every effort will be made to 
guarantee confidentiality and all personal information will only be reviewed by the research team 
(researcher and academic supervisor).  Personal information will be safely stored and no other 
parties will have access to this.  This information will be destroyed after a period of five years.  
Should you require further information or if you would like feedback on the results, please feel 
free to contact me on 083 651 995 or email: hchania@gmail.com or my research supervisor Dr. 
Karin Joubert on 011 717 4561 or email: karin.joubert@wits.co.za or my research co-supervisor 
on 011 717 4581 or email: dhanashree.pillay@wits.co.za. Alternatively, you may contact the 
administrator of the Medical Ethics Committee at the University of the Witwatersrand, Anisa 
Keshav on 011 717 1234 or e-mail: Anisa.Keshav@wits.ac.za or the chairperson, Prof. Cleaton-
Jones on 011 717 2301 for additional enquiries. 
Your participation will be highly appreciated. 
Thank you for your time, 
Kind Regards 
Heena Chania 
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Appendix C: Survey questionnaire 
Participant Number :_______________________( for office use only) 
QUESTIONNAIRE 
 
The clinical utility and use of high frequency tympanometry (HFT) (1000Hz) in South Africa 
 
Aim: The aim of this study is to investigate the use and clinical utility of HFT in both the public and 
private health sectors in South Africa. 
Informed consent:  By completing and returning this questionnaire, it is implied that participants have 
read the information letter and understand the aims of this research study, and therefore consent to 
participating in the study. 
Please answer the questions below by ticking the appropriate box/s and elaborate in the spaces 
provided where necessary. 
Participant email address:_________________________ 
      
Section 1: Biographical Information 
1.1.Qualification √ For official use only 
a. Audiologist  1 
b. Speech Therapist and Audiologist  2 
c. Other (please specify below)  3 
   A 
1.2.What is the highest qualification you have obtained? 
√ For official use only 
a. Undergraduate degree in Audiology  1 
b. Undergraduate degree in Speech Therapy and Audiology 
 2 
c. Masters degree in Audiology  3 
d. Doctoral degree in Audiology  4 
e. Other (please specify below)  5 
   B 
 
1.3. Are you currently practicing in the field of audiology? 
√ For official use only 
a. Yes  1 
b. No  2 
1.4. Which province do you work in? √ For official use only 
a. North West  1 
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b. Gauteng  2 
c. Free state  3 
d. Limpopo  4 
e. Eastern Cape  5 
f. Western Cape  6 
g. Kwa-Zulu Natal  7 
h. Northern Cape  8 
i. Mpumalanga  9 
 
1.5. Workplace (Please tick all appropriate boxes) √ For official use only 
a. Private Practice  1 
b. Private Hospital  2 
c. Government Hospital  3 
d. Government/ Primary Health Clinics  4 
e. Government Schools  5 
 f. Private Schools  6 
g. Other (please specify below) 
  7 
  C 
1.6. Which population do you work with? √ For official use only 
a. Paediatrics only  1 
b. Adults only  2 
c. Both adults and paediatrics  3 
 
1.7. Please specify the age-range of the population chosen in 1.6. 
For official use only 
  
  
D 
1.8. For how long have you been practicing in the field of audiology? 
(Please indicate in years and months) For official use only 
  
  
E 
1.8. How many years of clinical experience do you have in working in 
paediatric audiology? (Please indicate in years and months) 
For official use only 
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F 
 
1.9. What percentage of your current caseload is comprised 
of infants or young children (0-6 years) with middle ear 
pathologies? 
√ For official use only 
a. 0 - 15%   1 
b. 16 - 25 %   2 
c. 26 - 50%   3 
d. 51 - 75%   4 
e. 76-100%   5 
 
Section 2: Equipment 
This section only to be completed by audiologists and dually registered speech therapist and 
audiologists working with the paediatric population 
2.1. Do you have access to a tympanometer in your clinical 
setting? √ For official use only 
a. Yes  1 
b. No  2 
If 'no', please specify why you do not have a tympanometer? 
G 
2.2. Is tympanometry included in your basic paediatric 
audiological test battery? √ For official use only 
a.Yes  1 
b. No   2 
Please answer the applicable questions 2.3, 2.4 & 2.5 below, based on your selection for question 2.2 
above 
2.3 If yes, which tympanometry tests do you use for the 
paediatric population in your clinical practice? (Please tick 
all appropriate boxes) 
√ For official use only 
a. Low frequency tympanometry (LFT) (226 Hz probe tone) 
 1 
b. Multi-frequency tympanometry (MFT) (series of sweeps: 
250 Hz – 2000 Hz)  2 
c. 667 Hz probe tone  3 
d. HFT (1000 Hz probe tone)  4 
e. Unsure  5 
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2.5. If 'no', please indicate the reason why tympanometry is 
not being included in your basic paediatric audiological test 
battery?(Please tick all appropriate boxes) √ For official use only 
a. Lack of equipment  1 
b. Time constraints  2 
c. Not clinically relevant  3 
d. Costly/Budgetary constraints  4 
e. Lack of training  5 
f. Lack of clinical protocol or guidelines   6 
g. Case dependent  7 
h. Other (please specify below)  8 
  
 I 
2.6. How often is HFT included in your basic paediatric 
audiological test battery for infants or young children with 
definitive middle ear pathologies? 
√ For official use only 
a. Always  1 
b. Sometimes  2 
c. Never  3 
Please answer either question 2.7 or 2.8  below, based on your selection for question 2.2 above 
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2.7. If you perform HFT, please specify what percentage of 
the time is HFT being utilised in such cases? 
√ For official use only 
a. 0-15%  1 
b. 16-25%  2 
c. 26-50%  3 
d. 51- 75%  4 
e. 76- 100%  5 
2.8 If you do not perform HFT, please indicate the reason 
why HFT is not being included in your basic paediatric 
audiological test battery?(Please tick all appropriate boxes) 
√ For official use only 
a. Lack of equipment  1 
b. Time constraints  2 
c. Not clinically relevant  3 
d. Costly/Budgetary constraints  4 
e. Lack of training conducting HFT  5 
f. Lack of training in interpretation of HFT  6 
g. Lack of  clinical protocols or guidelines   7 
h. Case dependent  8 
i. Other (please specify below)  9 
  
 J 
2.9. How would you rate your confidence level in 
interpreting HFT on a scale of 1 to 10 (1 being the least 
confident and 10 being the most confident)? 
√ For official use only 
a. 1  1 
b. 2  2 
c. 3  3 
d. 4  4 
e. 5  5 
f. 6  6 
g. 7  7 
h. 8  8 
i. 9  9 
j. 10  10 
Section 3: Current clinical practice 
3.1. Are there clinical protocols/guidelines available for 
HFT in your clinical setting? √ For official use only 
a. Yes  1 
b. No  2 
If ‘no’, please provide a reason  K 
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3.2. If 'yes', which clinical guideline/protocol for HFT is 
used in your clinical setting? √ For official use only 
a. Best practice guidelines (provide reference below)  1 
b. New born hearing screening programme (NHSP) 
Tympanometry protocol v2.0  2 
d. 'I have developed my own protocol'  4 
c. Other (please specify and provide reference below)  3 
Please elaborate and/or provide reference on your 
selection: 
 L 
3.3. Do you experience challenges in interpreting HFT 
results?  √ For official use only 
a. Yes  1 
b. No  2 
If ‘yes’, please indicate the challenges experienced? 
 M 
3.4. Which norms do you use to interpret HFT? (Please tick 
all appropriate boxes) √ For official use only 
a. Equipment manual, please explain   1 
b. Journal Article, please provide reference  2 
c. Textbook, please provide reference  3 
d. Pass/ Fail criteria (please explain the criteria)  4 
e. ANSI  5 
f. Component compensation method  6 
g. Static admittance  7 
h. Peak susceptance ≤ 0 mmho  8 
i. Unsure  9 
j. 'Not applicable as I do not perform HFT, therefore do not 
use any norms’  10 
k. Other (please specify below)  11 
Please elaborate and/or provide reference on your 
selection: 
 N 
3.5. Which classification systems or models do you use to 
interpret HFT? (Please tick all appropriate boxes) √ For official use only 
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a. Quantitative measures (peak susceptance or peak 
compliance)  1 
b. Journal Article, please provide reference  2 
c. Textbook, please provide reference  3 
d. Beery et al., 1975 classification system  4 
f. ANSI  6 
g. Marchant et al. (1986) classification system  7 
i. Jerger/ Liden system  8 
j. Vanhuyse  Model  9 
k. Unsure  10 
l. 'Not applicable as I do not perform HFT'  11 
m. Other (please specify below)  12 
Please elaborate and/or provide reference on your 
selection:  
 O 
3.6. What other aspects do you take into consideration 
when performing HFT? (Please tick all appropriate boxes) √ For official use only 
a. Otoscopy   1 
b. Movement of infant and crying   2 
c. Conical tips  3 
d. Obstructions free ear canal  4 
e.  Positioning of the infants or child’s head  5 
f. Positioning of the pinnae  6 
g. Results to be repeated  7 
h. Exact  value of ear canal volume  8 
i. 'Not applicable as I do not perform HFT'  9 
j. Pressure changes  10 
k. Other (please specify below)  11 
  
 P 
3.7. What precautions do you take against cross infections 
when performing HFT? √ For official use only 
a. Disinfection &/or sterilization of probe tips between uses  1 
b. Use of protective vinyl/ latex gloves  2 
c. Handwashing after each patient  3 
d. Disinfection &/or sterilization of all surface areas in contact 
with bodily fluids  4 
e. Use of wipes or paper towels  5 
f. Use of appropriate disposable supplies where possible  6 
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g. ' Not applicable, as I do not perform HFT'  7 
h. Other (please specify below)  8 
  
 Q 
Section 4: Knowledge 
4.1. What is the purpose of tympanometry? (Please tick all 
appropriate boxes) √ For official use only 
a. To assess the functioning of the middle ear system  1 
b. Assess the cochlear functioning  2 
c. Assess the hearing status  3 
d. To determine the nature of the conductive lesion  4 
f. Other (please specify below)  5 
  
 R 
4.2. In your opinion, what is the clinical application of HFT 
in your clinical setting? √ For official use only 
  
 S 
4.3. The infant middle ear system is described as (Please 
tick all appropriate boxes): √ For official use only 
a. Mass-dominated   1 
b. Structurally immature  2 
c. Acoustically mature  3 
d. Stiffness-dominated  4 
e. Adult-like  5 
h. Unsure  6 
i. Other (please specify below)  7 
   T 
4.4. What are the acoustical differences between an infant 
and adult middle ear system? (Please tick all appropriate 
boxes) 
√ For official use only 
a. Ear canal impedance, reflection coefficient responses, and 
energy transmission.  1 
b. No acoustical differences  2 
c. Resonance gain & Resonant frequency  3 
d. 1000 Hz & 4000 Hz  4 
g. Unsure  5 
h. Other (please specify below)  6 
   U 
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4.5. Do maturational changes that occur to the infants’ 
middle ear system affect the acoustical properties of the 
infant ear? 
√ For official use only 
a. Yes  1 
b. No  2 
Please motivate your answer : 
 V 
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Appendix D: Letter of permission from Dr. George Mukhari Hospital 
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Appendix E: Informed consent for hearing screening 
SPEECH PATHOLOGY AND AUDIOLOGY 
 School of Human & Community Development 
Faculty of Humanities 
University of the Witwatersrand 
Private Bag 3, WITS, 2050 
Tel: (011) 717 4577 Fax: (011) 717 4572 
 
 
  
Title of Study: The clinical utility and use of high frequency tympanometry (HFT) in South 
Africa. 
Dear Sir/Madam 
My name is Heena Chania. I am an Audiology Masters student from the University of the 
Witwatersrand. As part of the requirements for my studies I am required to complete a research 
dissertation. The aim of this study is to determine the clinical utility, availability and use of HFT 
in South Africa.  
Hearing is a critical element in the development of speech, language and cognition in young 
children. Otitis media (OM) is one of the most common causes of hearing loss in young infants. 
The correct diagnosis of OM is critical in managing this frequently occurring childhood disorder. 
One of the most important acoustic immittance measures used to reliably and accurately 
diagnose OM in young infants is HFT. The purpose of this study is to determine the availability 
and use of HFT by South African audiologists.  
I therefore wish to further investigate (i) the clinical utility, (ii) the availability of HFT 
equipment and clinical protocols in clinical practice; (iii) opinions regarding current clinical 
skills in classification and the interpretation of HFT, and (iii) the awareness of the importance of 
making use of HFT within the paediatric population.    
I hereby ask your permission for the patient to be a participant of this study. Should permission 
be granted to, the researcher will perform the following audiological tests on the patient namely; 
otoscopy, tympanometric testing and OAEs. The results obtained from these audiological testing 
will be provided to you on the day. 
There are no known risks associated with the patient’s participation in this research. The 
information obtained from this study will be of relevance to audiologist working with the 
paediatric population. The findings will provide evidence of clinical practice in South Africa that 
can be used to inform student training, the development of national guidelines and motivation for 
appropriate equipment across all health care sectors. This will lead to better assessment and 
management of young infants with OM and reduce the occurrence of hearing loss. Results of this 
study will be accessible to all professionals. 
Yours and that of the patient’s participation in this research study are voluntary. A refusal to 
participate will involve no consequence or loss of benefits to which you are entitled. You may 
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withdraw from the study at any stage should you wish, without any negative consequences. No 
persons will be identifiable, as only participant numbers; will be used for the research report. 
Every effort will be made to guarantee confidentiality; personal information will only be 
reviewed by the research team (researcher and academic supervisor). Personal information will 
be safely stored and no other parties will have access to it.  This information will be destroyed 
after a mandatory period of five years.  
Pleases complete the tear off slip at the bottom to provide written consent to participate in this 
pilot study. Should you require further information or if you would like feedback on the results, 
please feel free to contact me on 083 651 995 or email: hchania@gmail.com or my research 
supervisor Dr. Karin Joubert on 011 717 4561 or email: karin.joubert@wits.co.za or my research 
co-supervisor on 011 717 4581 or email: dhanashree.pillay@wits.co.za. Alternatively, you may 
contact the administrator of the Medical Ethics Committee at the University of the 
Witwatersrand, Anisa Keshav on 011 717 1234 or e-mail: Anisa.Keshav@wits.ac.za or the 
chairperson, Prof. Cleaton-Jones on 011 717 2301 for additional enquiries. 
Your participation will be highly appreciated. 
Thank you for your time, 
Kind Regards 
Heena Chania                               
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  
Informed Consent         
 ‘The use and clinical utility of high frequency tympanometry (HFT) in South Africa’   
I, ____________________________________________ (name of caregiver), the undersigned, 
provides permission for Heena Chania to conduct the audiological tests required for the purpose 
of this research on my child.  I have been informed of the aims and benefits of the study. All my 
questions have been answered, and I know that I can withdraw from the study at any time 
without any negative consequences. I am also aware that confidentiality will be maintained 
throughout the study.   
___________________________________  Date: _____________________ 
             (Participant signature)  
 __________________________________  Date: _____________________ 
(Researcher signature) 
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Appendix F: Hearing screening form 
HEARING SCREENING 
Patient Information 
Participant number:________________ 
Date:__________________
__ 
Date of 
Birth:_________________ 
Hospital #: 
_______________ 
Site/Ward 
#:_____ 
Diagnosis: 
_______________ 
Birth Weight: ____________kg 
Current 
Weight:__________kg 
GA:__________ 
CA:__________ 
Gender: 
_________________ 
Risk Factors 
NICU >48hrs   Caregiver concerns   Herpes   Head Trauma   
NNJ 
(photo/trans.) 
  Maternal malaria   Rubella   Other:  
Premature   Cranio-facial anomalies   Syphillis   
Meningitis   Mechanical ventilation   Chemo   
Birth Asphyxia   Ototoxic medication   ECMO   
Head trauma   Syndromes associated 
with HL 
  LBW   
Taxoplasmosis   Neurogenerative disorders   CMV   
Maternal HIV   Hyperbilirubinemia       
Audiological Testing 
Otoscopy DPOAE's 
R 
Normal 
Dull 
TM 
Red 
TM 
Bulging Retracted R L Comments 
Infection Vernix Other: PASS Refer PASS Refer 
 
L 
Normal 
Dull 
TM 
Red 
TM 
Bulging Retracted 1000Hz 1000Hz 1000Hz 1000Hz 
Infection Vernix Other: 2000Hz 2000Hz 2000Hz 2000Hz 
Tympanometry 3000Hz 3000Hz 3000Hz 3000Hz 
226 Hz 
 
R L Comments 4000Hz 4000Hz 4000Hz 4000Hz 
EV: 
  
 
5000Hz 5000Hz 5000Hz 5000Hz 
dapa 
  
6000Hz 6000Hz 6000Hz 6000Hz 
c/z: 
  
Recommendations 
Typ
e:   
No additional risk: d/c from screening 
  
1000Hz 
R L Comments Diagnostic testing   
Positive 
Peak:Normal 
Positive 
Peak:Normal 
 
Re-screen 
  
Negative 
Peak: 
Abnormal 
Negative Peak: 
Abnormal 
Refer to ENT 
  
Other: Other: 
Refer to Paeditrician   
Other (please specify below)   
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Appendix G: Letter of permission from Rahima Moosa Mother and Child Hospital 
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Appendix H: Informed consent from Doors of Hope Children’s Mission 
Title of Study: The clinical utility and use of high frequency tympanometry (HFT) in South 
Africa. 
 
Dear Sir/Madam       Date: ______________ 
Good day, my name is Heena Chania.  I am an Audiology Masters student from the University of 
the Witwatersrand. As part of the requirements for my studies I am required to complete a 
research dissertation.  The aim of this study is to determine the clinical utility, availability and 
use of high frequency tympanometry (HFT) in South Africa.            
Hearing is a critical element in the development of speech, language and cognition in young 
children. Otitis media (OM) is one of the most common causes of hearing loss in young infants. 
The correct diagnosis of OM is critical in managing this frequently occurring childhood disorder. 
One of the most important acoustic immittance measures used to reliably and accurately 
diagnose OM in young infants is HFT. The purpose of this study is to determine the clinical 
utility, the availability and use of HFT by South African audiologists. I therefore wish to further 
investigate (i) The clinical utility of HFT; (ii) the availability of HFT equipment and clinical 
protocols in clinical practice; (iii) opinions regarding current clinical skills in classification and 
the interpretation of HFT, and (iii) the awareness of the importance of making use of HFT within 
the paediatric population.    
I hereby ask permission to conduct this study at Door of Hope Children’s Mission. I have chosen 
to conduct this study at your site as this research study requires a great sample of infants to be 
screened for hearing, which I will obtain at your home. Should permission be granted, the 
researcher will perform the following audiological screening tests on approximately 100 in or out 
paediatric patients (0 to 6 months of age) namely; otoscopy, tympanometric testing, and 
otoacoustic emissions (OAEs). These screening tests are a part of the paediatric hearing 
screening protocol. You will be provided with immediate results and be informed if further 
follow–ups are required. There are no known risks associated with the research. The 
participation in this research study is voluntary. A refusal of the caregiver or patient to 
participate will involve no consequence or loss of benefits to which the participant is entitled. 
The participant may withdraw from the study at any stage should they wish to, without any 
consequences. 
No persons will be identifiable as only participant numbers; will be used for the research report. 
Every effort will be made to guarantee confidentiality; personal information will only be 
reviewed by the research team (researcher and academic supervisor).  Personal information will 
be safely stored and no other parties will have access to this.  This information will be destroyed 
after a mandatory period of five years.  
The information obtained from this study will be of relevance to audiologist working with the 
paediatric population. The findings will provide evidence of clinical practice in South Africa that 
can be used to inform student training, the development of national guidelines and motivation for 
appropriate equipment across all health care sectors. This will lead to better assessment and 
management of young infants with OM and reduce the occurrence of hearing loss. Results of this 
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study will be accessible to all professionals. 
Pleases complete the tear off slip at the bottom to provide written consent for the researcher to 
conduct this study at your site. Should you require further information or if you would like 
feedback on the results, please feel free to contact me on 083 651 995 or email: 
hchania@gmail.com or my research supervisor Dr. Karin Joubert on 011 717 4561 or email: 
karin.joubert@wits.co.za or my research co-supervisor on 011 717 4581 or email: 
dhanashree.pillay@wits.co.za. Alternatively, you may contact the administrator of the Medical 
Ethics Committee at the University of the Witwatersrand, Anisa Keshav on 011 717 1234 or e-
mail: Anisa.Keshav@wits.ac.za or the chairperson, Prof. Cleaton-Jones on 011 717 2301 for 
additional enquiries. 
Your approval will be highly appreciated. 
Thank you for your time, 
Kind Regards,      
___________________________    
Heena Chania  
Junior Speech Therapsit and Audiologist 
(012) 521 5917/3371 
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Appendix I: Informed consent from Mother Teresa’s 
 
SPEECH PATHOLOGY AND AUDIOLOGY 
 School of Human & Community Development 
Faculty of Humanities 
University of the Witwatersrand 
Private Bag 3, WITS, 2050 
Tel: (011) 717 4577 Fax: (011) 717 4572 
 
 
Title of Study:   
The use and clinical utility of high frequency tympanometry (HFT) in South Africa. 
Dear Sir/Madam       Date: ______________ 
Good day, my name is Heena Chania.  I am an Audiology Masters student from the University of 
the Witwatersrand. As part of the requirements for my studies I am required to complete a 
research dissertation.  The aim of this study is to determine the clinical utility, availability and 
use of high frequency tympanometry (HFT) in South Africa.            
Hearing is a critical element in the development of speech, language and cognition in young 
children. Otitis media (OM) is one of the most common causes of hearing loss in young infants. 
The correct diagnosis of OM is critical in managing this frequently occurring childhood disorder. 
One of the most important acoustic immittance measures used to reliably and accurately 
diagnose OM in young infants is HFT. The purpose of this study is to determine the clinical 
utility, the availability and use of HFT by South African audiologists.  
I therefore wish to further investigate (i) The clinical utility of HFT; (ii) the availability of HFT 
equipment and clinical protocols in clinical practice; (iii) opinions regarding current clinical 
skills in classification and the interpretation of HFT, and (iii) the awareness of the importance of 
making use of HFT within the paediatric population.    
I hereby ask permission to conduct this study at Mother Teresa. I have chosen to conduct this 
study at your site as this research study requires a great sample of infants to be screened for 
hearing, which I will obtain at your home. Should permission be granted, the researcher will 
perform the following audiological screening tests on approximately 100 in or out paediatric 
patients (0 to 6 months of age) namely; otoscopy, tympanometric testing, and otoacoustic 
emissions (OAE’s). These screening tests are a part of the paediatric hearing screening protocol. 
You will be provided with immediate results and be informed if further follow–ups are required. 
There are no known risks associated with the research. The participation in this research study is 
voluntary. A refusal of the caregiver or patient to participate will involve no consequence or loss 
of benefits to which the participant is entitled. The participant may withdraw from the study at 
any stage should they wish to, without any consequences. 
No persons will be identifiable as only participant numbers; will be used for the research report. 
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Every effort will be made to guarantee confidentiality; personal information will only be 
reviewed by the research team (researcher and academic supervisor).  Personal information will 
be safely stored and no other parties will have access to this.  This information will be destroyed 
after a mandatory period of five years.  
The information obtained from this study will be of relevance to audiologist working with the 
paediatric population. The findings will provide evidence of clinical practice in South Africa that 
can be used to inform student training, the development of national guidelines and motivation for 
appropriate equipment across all health care sectors. This will lead to better assessment and 
management of young infants with OM and reduce the occurrence of hearing loss. Results of this 
study will be accessible to all professionals. 
Pleases complete the tear off slip at the bottom to provide written consent for the researcher to 
conduct this study at your site. 
Should you require further information or if you would like feedback on the results, please feel 
free to contact me on 083 651 9995 or email: hchania@gmail.com or my research supervisor Dr. 
Karin Joubert on 011 717 4561 or email: karin.joubert@wits.co.za or my research co-supervisor 
on 011 717 4581 or email: dhanashree.pillay@wits.co.za.You may alternatively contact the 
administrator of the Medical Ethics Committee at the University of the Witwatersrand, Anisa 
Keshav on 011 717 1234 or e-mail: Anisa.Keshav@wits.ac.za or the chairperson, Prof. Cleaton-
Jones on 011 717 2301 for additional enquiries. 
Your approval will be highly appreciated. 
Thank you for your time, 
Kind Regards,      
___________________________    
Heena Chania  
Junior Speech Therapsit and Audiologist 
(012) 521 5917/3371 
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Appendix J: Calibration certificate for GSI Auto Tymp 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix F: Calibration certificate for AccuScreener 
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Appendix K: Calibration Certificate for Madsen AccuScreener 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix L: Ethical clearance certificate 
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Appendix L: Ethical clearance certificate 
 
 
 
 
 
 
 
 
 
 
 
 
 
